{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 258305, "items": [{"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T08:27:03Z", "timestamp": 1574497623475}, "reference-count": 106, "publisher": "Wiley", "issue": "1", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 1002, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clin Exp Immunol"], "published-print": {"date-parts": [[2013, 1]]}, "DOI": "10.1111/j.1365-2249.2012.04657.x", "type": "journal-article", "created": {"date-parts": [[2012, 8, 20]], "date-time": "2012-08-20T12:15:15Z", "timestamp": 1345464915000}, "page": "36-45", "source": "Crossref", "is-referenced-by-count": 113, "title": ["Suppression, subversion and escape: the role of regulatory T cells in cancer progression"], "prefix": "10.1111", "volume": "171", "author": [{"given": "K.", "family": "Oleinika", "sequence": "first", "affiliation": [{"name": "Chemokine Research Group, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences; University of Glasgow; Glasgow; UK"}]}, {"given": "R. J.", "family": "Nibbs", "sequence": "additional", "affiliation": [{"name": "Chemokine Research Group, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences; University of Glasgow; Glasgow; UK"}]}, {"given": "G. J.", "family": "Graham", "sequence": "additional", "affiliation": [{"name": "Chemokine Research Group, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences; University of Glasgow; Glasgow; UK"}]}, {"given": "A. R.", "family": "Fraser", "sequence": "additional", "affiliation": [{"name": "Chemokine Research Group, Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences; University of Glasgow; Glasgow; UK"}]}], "member": "311", "published-online": {"date-parts": [[2012, 12, 3]]}, "reference": [{"key": "10.1111/j.1365-2249.2012.04657.x-BIB0001|cei4657-cit-0001", "doi-asserted-by": "crossref", "first-page": "991", "DOI": "10.1038/ni1102-991", "article-title": "Cancer immunoediting: from immunosurveillance to tumor escape", "volume": "3", "author": "Dunn", "year": "2002", "journal-title": "Nature Immunol"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0002|cei4657-cit-0002", "doi-asserted-by": "crossref", "first-page": "104", "DOI": "10.1111/j.1600-065X.2011.01007.x", "article-title": "Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication", "volume": "241", "author": "Quezada", "year": "2011", "journal-title": "Immunol Rev"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0003|cei4657-cit-0003", "doi-asserted-by": "crossref", "first-page": "381", "DOI": "10.1038/sj.bjc.6605198", "article-title": "A critical analysis of the tumour immunosurveillance controversy for 3-MCA- induced sarcomas", "volume": "101", "author": "Schreiber", "year": "2009", "journal-title": "Br J Cancer"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0004|cei4657-cit-0004", "doi-asserted-by": "crossref", "first-page": "1565", "DOI": "10.1126/science.1203486", "article-title": "Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion", "volume": "331", "author": "Schreiber", "year": "2011", "journal-title": "Science"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0005|cei4657-cit-0005", "doi-asserted-by": "crossref", "first-page": "646", "DOI": "10.1016/j.cell.2011.02.013", "article-title": "Hallmarks of cancer: the next generation", "volume": "144", "author": "Hanahan", "year": "2011", "journal-title": "Cell"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0006|cei4657-cit-0006", "doi-asserted-by": "crossref", "first-page": "1163", "DOI": "10.1136/gutjnl-2011-300970", "article-title": "Suppression of tumour-specific CD4+ T cells by regulatory T cells is associated with progression of human colorectal cancer", "volume": "61", "author": "Betts", "year": "2012", "journal-title": "Gut"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0007|cei4657-cit-0007", "doi-asserted-by": "crossref", "first-page": "903", "DOI": "10.1038/nature06309", "article-title": "Adaptive immunity maintains occult cancer in an equilibrium state", "volume": "450", "author": "Koebel", "year": "2007", "journal-title": "Nature"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0008|cei4657-cit-0008", "doi-asserted-by": "crossref", "first-page": "141", "DOI": "10.1038/nature03954", "article-title": "Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance", "volume": "437", "author": "Willimsky", "year": "2005", "journal-title": "Nature"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0009|cei4657-cit-0009", "doi-asserted-by": "crossref", "first-page": "2619", "DOI": "10.4049/jimmunol.164.5.2619", "article-title": "Mice bearing late-stage tumors have normal functional systemic T cell responses in vitro and in vivo", "volume": "164", "author": "Radoja", "year": "2000", "journal-title": "J Immunol"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0010|cei4657-cit-0010", "first-page": "3969", "article-title": "T-lymphocytes infiltrating sites of tumor rejection and progression display identical V-beta usage but different cytotoxic activities", "volume": "154", "author": "Kurt", "year": "1995", "journal-title": "J Immunol"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0011|cei4657-cit-0011", "doi-asserted-by": "crossref", "first-page": "639", "DOI": "10.1093/intimm/12.5.639", "article-title": "TCR V-beta usage and clonality of T cells isolated from progressing and rejected tumor sites before and after in vitro culture", "volume": "12", "author": "Kurt", "year": "2000", "journal-title": "Int Immunol"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0012|cei4657-cit-0012", "doi-asserted-by": "crossref", "first-page": "295", "DOI": "10.1038/nri1806", "article-title": "Regulatory T cells, tumour immunity and immunotherapy", "volume": "6", "author": "Zou", "year": "2006", "journal-title": "Nat Rev Immunol"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0013|cei4657-cit-0013", "doi-asserted-by": "crossref", "first-page": "15", "DOI": "10.1007/s11523-012-0208-y", "article-title": "Targeting regulatory T cells", "volume": "7", "author": "Menetrier-Caux", "year": "2012", "journal-title": "Target Oncol"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0014|cei4657-cit-0014", "doi-asserted-by": "crossref", "first-page": "2155", "DOI": "10.4049/jimmunol.178.4.2155", "article-title": "Natural regulatory T cells and de novo-induced regulatory T cells contribute independently to tumor-specific tolerance", "volume": "178", "author": "Zhou", "year": "2007", "journal-title": "J Immunol"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0015|cei4657-cit-0015", "doi-asserted-by": "crossref", "first-page": "2457", "DOI": "10.1158/0008-5472.CAN-04-3232", "article-title": "Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma", "volume": "65", "author": "Ormandy", "year": "2005", "journal-title": "Cancer Res"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0016|cei4657-cit-0016", "doi-asserted-by": "crossref", "first-page": "909", "DOI": "10.1007/s00262-011-1046-y", "article-title": "Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer", "volume": "60", "author": "Ladoire", "year": "2011", "journal-title": "Cancer Immunol Immunother"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0017|cei4657-cit-0017", "doi-asserted-by": "crossref", "first-page": "1697", "DOI": "10.1038/sj.bjc.6605040", "article-title": "T-regulatory cell modulation: the future of cancer immunotherapy?", "volume": "100", "author": "Nizar", "year": "2009", "journal-title": "Br J Cancer"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0018|cei4657-cit-0018", "first-page": "1151", "article-title": "Immunological self-tolerance maintained by activated T-cells expressing Il-2 receptor alpha-chains (Cd25) - breakdown of a single mechanism of self-tolerance causes various autoimmune-diseases", "volume": "155", "author": "Sakaguchi", "year": "1995", "journal-title": "J Immunol"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0019|cei4657-cit-0019", "doi-asserted-by": "crossref", "first-page": "424", "DOI": "10.1016/j.smim.2011.10.002", "article-title": "Two modes of immune suppression by Foxp3(+) regulatory T cells under inflammatory or non-inflammatory conditions", "volume": "23", "author": "Yamaguchi", "year": "2011", "journal-title": "Semin Immunol"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0020|cei4657-cit-0020", "doi-asserted-by": "crossref", "first-page": "330", "DOI": "10.1038/ni904", "article-title": "Foxp3 programs the development and function of CD4(+)CD25(+) regulatory T cells", "volume": "4", "author": "Fontenot", "year": "2003", "journal-title": "Nat Immunol"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0021|cei4657-cit-0021", "doi-asserted-by": "crossref", "first-page": "1903", "DOI": "10.1073/pnas.0811556106", "article-title": "Heterogeneity of natural Foxp3(+) T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity", "volume": "106", "author": "Komatsu", "year": "2009", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0022|cei4657-cit-0022", "doi-asserted-by": "crossref", "first-page": "1000", "DOI": "10.1038/ni.1774", "article-title": "Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo", "volume": "10", "author": "Zhou", "year": "2009", "journal-title": "Nat Immunol"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0023|cei4657-cit-0023", "doi-asserted-by": "crossref", "first-page": "1667", "DOI": "10.1126/science.1191996", "article-title": "Stability of the regulatory T cell lineage in vivo", "volume": "329", "author": "Rubtsov", "year": "2010", "journal-title": "Science"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0024|cei4657-cit-0024", "doi-asserted-by": "crossref", "first-page": "6659", "DOI": "10.1073/pnas.0509484103", "article-title": "Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development", "volume": "103", "author": "Gavin", "year": "2006", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0025|cei4657-cit-0025", "doi-asserted-by": "crossref", "first-page": "899", "DOI": "10.1016/j.immuni.2009.03.019", "article-title": "Functional delineation and differentiation dynamics of human CD4(+) T cells expressing the FoxP3 transcription factor", "volume": "30", "author": "Miyara", "year": "2009", "journal-title": "Immunity"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0026|cei4657-cit-0026", "doi-asserted-by": "crossref", "first-page": "262", "DOI": "10.1016/j.immuni.2011.12.012", "article-title": "Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells", "volume": "36", "author": "Miyao", "year": "2012", "journal-title": "Immunity"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0027|cei4657-cit-0027", "doi-asserted-by": "crossref", "first-page": "218", "DOI": "10.1016/j.clim.2011.04.014", "article-title": "Expanded subpopulation of FoxP3(+) T regulatory cells in renal cell carcinoma co-express Helios, indicating they could be derived from natural but not induced Tregs", "volume": "140", "author": "Elkord", "year": "2011", "journal-title": "Clin Immunol"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0028|cei4657-cit-0028", "doi-asserted-by": "crossref", "first-page": "1595", "DOI": "10.1016/j.molimm.2010.02.001", "article-title": "A role for the transcription factor Helios in human CD4(+)CD25(+) regulatory T cells", "volume": "47", "author": "Getnet", "year": "2010", "journal-title": "Mol Immunol"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0029|cei4657-cit-0029", "doi-asserted-by": "crossref", "first-page": "3433", "DOI": "10.4049/jimmunol.0904028", "article-title": "Expression of helios, an ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3(+) T regulatory cells", "volume": "184", "author": "Thornton", "year": "2010", "journal-title": "J Immunol"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0030|cei4657-cit-0030", "doi-asserted-by": "crossref", "first-page": "942", "DOI": "10.1038/nm1093", "article-title": "Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival", "volume": "10", "author": "Curiel", "year": "2004", "journal-title": "Nat Med"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0031|cei4657-cit-0031", "doi-asserted-by": "crossref", "first-page": "2000", "DOI": "10.1158/0008-5472.CAN-08-2360", "article-title": "Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome", "volume": "69", "author": "Gobert", "year": "2009", "journal-title": "Cancer Res"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0032|cei4657-cit-0032", "doi-asserted-by": "crossref", "first-page": "5716", "DOI": "10.1158/0008-5472.CAN-06-0261", "article-title": "Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege", "volume": "66", "author": "Ishida", "year": "2006", "journal-title": "Cancer Res"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0033|cei4657-cit-0033", "doi-asserted-by": "crossref", "first-page": "847", "DOI": "10.1084/jem.194.6.847", "article-title": "Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells", "volume": "194", "author": "Iellem", "year": "2001", "journal-title": "J Exp Med"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0034|cei4657-cit-0034", "doi-asserted-by": "crossref", "first-page": "823", "DOI": "10.1084/jem.194.6.823", "article-title": "Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses", "volume": "194", "author": "Sutmuller", "year": "2001", "journal-title": "J Exp Med"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0035|cei4657-cit-0035", "doi-asserted-by": "crossref", "first-page": "2286", "DOI": "10.1002/ijc.23392", "article-title": "CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3(+) regulatory T cells in gastric cancer", "volume": "122", "author": "Mizukami", "year": "2008", "journal-title": "Int J Cancer"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0036|cei4657-cit-0036", "first-page": "422", "article-title": "CCL17 and CCL22 chemokines within tumor microenvironment are related to infiltration of regulatory T cells in esophageal squamous cell carcinoma", "volume": "23", "author": "Maruyama", "year": "2010", "journal-title": "Dis Esophagus"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0037|cei4657-cit-0037", "doi-asserted-by": "crossref", "first-page": "226", "DOI": "10.1038/nature10169", "article-title": "Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells", "volume": "475", "author": "Facciabene", "year": "2011", "journal-title": "Nature"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0038|cei4657-cit-0038", "doi-asserted-by": "crossref", "first-page": "1746", "DOI": "10.4049/jimmunol.182.3.1746", "article-title": "Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer", "volume": "182", "author": "Tan", "year": "2009", "journal-title": "J Immunol"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0039|cei4657-cit-0039", "doi-asserted-by": "crossref", "first-page": "2409", "DOI": "10.1182/blood-2005-06-2399", "article-title": "IL-2 administration increases CD4(+)CD25(hi) Foxp3(+) regulatory T cells in cancer patients", "volume": "107", "author": "Ahmadzadeh", "year": "2006", "journal-title": "Blood"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0040|cei4657-cit-0040", "doi-asserted-by": "crossref", "first-page": "1052", "DOI": "10.1158/1078-0432.CCR-08-1296", "article-title": "Increased Intratumoral FOXP3-positive regulatory immune cells during interleukin-2 treatment in metastatic renal cell carcinoma", "volume": "15", "author": "Jensen", "year": "2009", "journal-title": "Clin Cancer Res"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0041|cei4657-cit-0041", "doi-asserted-by": "crossref", "first-page": "919", "DOI": "10.1084/jem.20050463", "article-title": "Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4(+)CD25(+) regulatory T cell proliferation", "volume": "202", "author": "Ghiringhelli", "year": "2005", "journal-title": "J Exp Med"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0042|cei4657-cit-0042", "doi-asserted-by": "crossref", "first-page": "1875", "DOI": "10.1084/jem.20030152", "article-title": "Conversion of peripheral CD4(+)CD25(-) naive T cells to CD4(+)CD25(+) regulatory T cells by TGF-beta induction of transcription factor Foxp3", "volume": "198", "author": "Chen", "year": "2003", "journal-title": "J Exp Med"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0043|cei4657-cit-0043", "doi-asserted-by": "crossref", "first-page": "2883", "DOI": "10.4049/jimmunol.178.5.2883", "article-title": "Tumor evasion of the immune system by converting CD4(+) CD25(-) T cells into CD4(+) CD25(+) T regulatory cells: role of tumor-derived TGF-beta", "volume": "178", "author": "Liu", "year": "2007", "journal-title": "J Immunol"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0044|cei4657-cit-0044", "first-page": "2871", "article-title": "Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25(-) into CD25(+) T regulatory cells", "volume": "109", "author": "Curti", "year": "2007", "journal-title": "Blood"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0045|cei4657-cit-0045", "doi-asserted-by": "crossref", "first-page": "2570", "DOI": "10.1172/JCI31911", "article-title": "Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase", "volume": "117", "author": "Sharma", "year": "2007", "journal-title": "J Clin Invest"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0046|cei4657-cit-0046", "doi-asserted-by": "crossref", "first-page": "736", "DOI": "10.1158/0008-5472.CAN-10-1797", "article-title": "Analysis of the T-cell receptor repertoires of tumor-infiltrating conventional and regulatory T cells reveals no evidence for conversion in carcinogen-induced tumors", "volume": "71", "author": "Hindley", "year": "2011", "journal-title": "Cancer Res"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0047|cei4657-cit-0047", "doi-asserted-by": "crossref", "first-page": "7301", "DOI": "10.1158/0008-5472.CAN-06-0556", "article-title": "Comparative analysis of regulatory and effector T cells in progressively growing versus rejecting tumors of similar origins", "volume": "66", "author": "Bui", "year": "2006", "journal-title": "Cancer Res"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0048|cei4657-cit-0048", "doi-asserted-by": "crossref", "first-page": "4488", "DOI": "10.1158/0008-5472.CAN-05-4217", "article-title": "Tumor-induced expansion of regulatory T cells by conversion of CD4(+)CD25(-) lymphocytes is thymus and proliferation independent", "volume": "66", "author": "Valzasina", "year": "2006", "journal-title": "Cancer Res"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0049|cei4657-cit-0049", "first-page": "791", "article-title": "Nature of immunosuppressor T cells and their factors in tumor-bearing host (Tbh)", "volume": "116", "author": "Greene", "year": "1976", "journal-title": "J Immunol"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0050|cei4657-cit-0050", "doi-asserted-by": "crossref", "first-page": "1303", "DOI": "10.1002/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5", "article-title": "Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma", "volume": "77", "author": "Clemente", "year": "1996", "journal-title": "Cancer"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0051|cei4657-cit-0051", "doi-asserted-by": "crossref", "first-page": "18538", "DOI": "10.1073/pnas.0509182102", "article-title": "Intraepithelial CD8(+) tumor-infiltrating lymphocytes and a high CD8(+)/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer", "volume": "102", "author": "Sato", "year": "2005", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0052|cei4657-cit-0052", "doi-asserted-by": "crossref", "first-page": "1960", "DOI": "10.1126/science.1129139", "article-title": "Type, density, and location of immune cells within human colorectal tumors predict clinical outcome", "volume": "313", "author": "Galon", "year": "2006", "journal-title": "Science"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0053|cei4657-cit-0053", "doi-asserted-by": "crossref", "first-page": "5373", "DOI": "10.1200/JCO.2006.05.9584", "article-title": "Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse", "volume": "24", "author": "Bates", "year": "2006", "journal-title": "J Clin Oncol"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0054|cei4657-cit-0054", "doi-asserted-by": "crossref", "first-page": "2866", "DOI": "10.1002/cncr.22282", "article-title": "Tumor infiltrating FOXP3(+) regulatory T-cells are associated with recurrence in pathologic stage INSCLC patients", "volume": "107", "author": "Petersen", "year": "2006", "journal-title": "Cancer"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0055|cei4657-cit-0055", "doi-asserted-by": "crossref", "first-page": "2586", "DOI": "10.1200/JCO.2006.09.4565", "article-title": "Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection", "volume": "25", "author": "Gao", "year": "2007", "journal-title": "J Clin Oncol"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0056|cei4657-cit-0056", "doi-asserted-by": "crossref", "first-page": "1743", "DOI": "10.1007/s00262-007-0318-z", "article-title": "Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival", "volume": "56", "author": "Griffiths", "year": "2007", "journal-title": "Cancer Immunol Immunother"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0057|cei4657-cit-0057", "doi-asserted-by": "crossref", "first-page": "5423", "DOI": "10.1158/1078-0432.CCR-06-0369", "article-title": "Prevalence of FOXP3(+) regulatory T cells increases during the progression of pancreatic ductal adenocarcinorna and its premalignant lesions", "volume": "12", "author": "Hiraoka", "year": "2006", "journal-title": "Clin Cancer Res"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0058|cei4657-cit-0058", "doi-asserted-by": "crossref", "first-page": "1875", "DOI": "10.1016/j.ejca.2008.05.017", "article-title": "Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer", "volume": "44", "author": "Perrone", "year": "2008", "journal-title": "Eur J Cancer"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0059|cei4657-cit-0059", "doi-asserted-by": "crossref", "first-page": "2028", "DOI": "10.1158/1078-0432.CCR-07-4554", "article-title": "Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8(+)/regulatory T-cell ratio: which variable determines survival of cervical cancer patients?", "volume": "14", "author": "Jordanova", "year": "2008", "journal-title": "Clin Cancer Res"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0060|cei4657-cit-0060", "doi-asserted-by": "crossref", "first-page": "2591", "DOI": "10.4049/jimmunol.174.5.2591", "article-title": "CD8+T cell immunity against a tumor/self-antigen is augmented by CD4(+) T helper cells and hindered by naturally occurring T regulatory cells", "volume": "174", "author": "Antony", "year": "2005", "journal-title": "J Immunol"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0061|cei4657-cit-0061", "doi-asserted-by": "crossref", "first-page": "771", "DOI": "10.1084/jem.20041130", "article-title": "Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells", "volume": "200", "author": "Turk", "year": "2004", "journal-title": "J Exp Med"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0062|cei4657-cit-0062", "doi-asserted-by": "crossref", "first-page": "186", "DOI": "10.1200/JCO.2008.18.7229", "article-title": "Tumor-infiltrating FOXP3(+) T regulatory cells show strong prognostic significance in colorectal cancer", "volume": "27", "author": "Salama", "year": "2009", "journal-title": "J Clin Oncol"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0063|cei4657-cit-0063", "doi-asserted-by": "crossref", "first-page": "350", "DOI": "10.1002/path.2774", "article-title": "Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review", "volume": "222", "author": "Nosho", "year": "2010", "journal-title": "J Pathol"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0064|cei4657-cit-0064", "doi-asserted-by": "crossref", "first-page": "193", "DOI": "10.3324/haematol.11702", "article-title": "Correlation of high numbers of intratumoral FOXP3(+) regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma", "volume": "93", "author": "Tzankov", "year": "2008", "journal-title": "Haematologica"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0065|cei4657-cit-0065", "doi-asserted-by": "crossref", "first-page": "465", "DOI": "10.1158/1078-0432.CCR-05-1886", "article-title": "Prognostic value of tumor-infiltrating CD4(+) T-cell subpopulations in head and neck cancers", "volume": "12", "author": "Badoual", "year": "2006", "journal-title": "Clin Cancer Res"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0066|cei4657-cit-0066", "doi-asserted-by": "crossref", "first-page": "4", "DOI": "10.1186/1476-4598-9-4", "article-title": "Different subsets of tumor infiltrating lymphocytes correlate with NPC progression in different ways", "volume": "9", "author": "Zhang", "year": "2010", "journal-title": "Mol Cancer"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0067|cei4657-cit-0067", "doi-asserted-by": "crossref", "first-page": "1073", "DOI": "10.1093/carcin/bgp127", "article-title": "Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability", "volume": "30", "author": "Colotta", "year": "2009", "journal-title": "Carcinogenesis"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0068|cei4657-cit-0068", "doi-asserted-by": "crossref", "first-page": "1759", "DOI": "10.1586/era.11.102", "article-title": "Brain cancer immunoediting: novel examples provided by immunotherapy of malignant gliomas", "volume": "11", "author": "Pellegatta", "year": "2011", "journal-title": "Exp Rev Anticancer Ther"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0069|cei4657-cit-0069", "first-page": "5211", "article-title": "Induction of tumor immunity by removing CD25(+)CD4(+) T cells: a common basis between tumor immunity and autoimmunity", "volume": "163", "author": "Shimizu", "year": "1999", "journal-title": "J Immunol"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0070|cei4657-cit-0070", "doi-asserted-by": "crossref", "first-page": "3267", "DOI": "10.1002/1521-4141(200211)32:11<3267::AID-IMMU3267>3.0.CO;2-1", "article-title": "Depletion of CD25(+) regulatory cells uncovers immune responses to shared murine tumor rejection antigens", "volume": "32", "author": "Golgher", "year": "2002", "journal-title": "Eur J Immunol"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0071|cei4657-cit-0071", "first-page": "3128", "article-title": "Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody", "volume": "59", "author": "Onizuka", "year": "1999", "journal-title": "Cancer Res"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0072|cei4657-cit-0072", "doi-asserted-by": "crossref", "first-page": "1750", "DOI": "10.4049/jimmunol.176.3.1750", "article-title": "CD25(+) regulatory T cell depletion augments immunotherapy of micrometastases by an IL-21-secreting cellular vaccine", "volume": "176", "author": "Comes", "year": "2006", "journal-title": "J Immunol"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0073|cei4657-cit-0073", "doi-asserted-by": "crossref", "first-page": "90", "DOI": "10.4049/jimmunol.174.1.90", "article-title": "Dendritic cells loaded with stressed tumor cells elicit long-lasting protective tumor immunity in mice depleted of CD4(+)CD25(+) regulatory T cells", "volume": "174", "author": "Prasad", "year": "2005", "journal-title": "J Immunol"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0074|cei4657-cit-0074", "first-page": "99", "article-title": "Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells", "volume": "1174", "author": "Rech", "year": "2009", "journal-title": "Cancer Vaccines"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0075|cei4657-cit-0075", "doi-asserted-by": "crossref", "first-page": "575", "DOI": "10.1038/sj.jid.5700122", "article-title": "CD25 expression is correlated with histological grade and response to denileukin diftitox in cutaneous T-cell lymphoma", "volume": "126", "author": "Talpur", "year": "2006", "journal-title": "J Invest Dermatol"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0076|cei4657-cit-0076", "doi-asserted-by": "crossref", "first-page": "3623", "DOI": "10.1172/JCI25947", "article-title": "Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells", "volume": "115", "author": "Dannull", "year": "2005", "journal-title": "J Clin Invest"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0077|cei4657-cit-0077", "doi-asserted-by": "crossref", "first-page": "269", "DOI": "10.1097/COC.0b013e318187dd40", "article-title": "A phase II trial of denileukin diftitox in patients with previously treated advanced non-small cell lung cancer", "volume": "32", "author": "Gerena-Lewis", "year": "2009", "journal-title": "Am J Clin Oncol Cancer Clin Trials"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0078|cei4657-cit-0078", "doi-asserted-by": "crossref", "first-page": "582", "DOI": "10.1097/01.cji.0000175468.19742.10", "article-title": "Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB(389)IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma", "volume": "28", "author": "Attia", "year": "2005", "journal-title": "J Immunother"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0079|cei4657-cit-0079", "doi-asserted-by": "crossref", "first-page": "4919", "DOI": "10.4049/jimmunol.179.7.4919", "article-title": "Administration of a CD25-directed immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivo", "volume": "179", "author": "Powell", "year": "2007", "journal-title": "J Immunol"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0080|cei4657-cit-0080", "first-page": "211", "article-title": "Immune-response to syngeneic or autologous testicular cells in mice. 1. Augmented delayed footpad reaction in cyclophosphamide-treated mice", "volume": "38", "author": "Yoshida", "year": "1979", "journal-title": "Clin Exp Immunol"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0081|cei4657-cit-0081", "doi-asserted-by": "crossref", "first-page": "336", "DOI": "10.1002/eji.200324181", "article-title": "CD4(+)CD25(+) regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative", "volume": "34", "author": "Ghiringhelli", "year": "2004", "journal-title": "Eur J Immunol"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0082|cei4657-cit-0082", "first-page": "1671", "article-title": "Effect of low-dose cyclophosphamide on the immune system of cancer patients\u2009-\u2009depletion of Cd4+, 2H4+ suppressor-inducer T-cells", "volume": "48", "author": "Berd", "year": "1988", "journal-title": "Cancer Res"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0083|cei4657-cit-0083", "doi-asserted-by": "crossref", "first-page": "309", "DOI": "10.1097/00002371-199607000-00006", "article-title": "Enhancing the effect of THERATOPE STn-KLH cancer vaccine in patients with metastatic breast cancer by pretreatment with low-dose intravenous cyclophosphamide", "volume": "19", "author": "MacLean", "year": "1996", "journal-title": "J Immunother"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0084|cei4657-cit-0084", "doi-asserted-by": "crossref", "first-page": "641", "DOI": "10.1007/s00262-006-0225-8", "article-title": "Metronomic cyclophosphamide regimen selectively depletes CD4(+) CD25(+) regulatory T cells and restores T and NK effector functions in end stage cancer patients", "volume": "56", "author": "Ghiringhelli", "year": "2007", "journal-title": "Cancer Immunol Immunother"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0085|cei4657-cit-0085", "doi-asserted-by": "crossref", "first-page": "2136", "DOI": "10.1016/j.juro.2007.01.143", "article-title": "Low dose metronomic oral cyclophosphamide for hormone resistant prostate cancer: a phase II study", "volume": "177", "author": "Lord", "year": "2007", "journal-title": "J Urol"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0086|cei4657-cit-0086", "doi-asserted-by": "crossref", "first-page": "2862", "DOI": "10.1182/blood-2004-06-2410", "article-title": "Inhibition of CD4(+)25(+) T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide", "volume": "105", "author": "Lutsiak", "year": "2005", "journal-title": "Blood"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0087|cei4657-cit-0087", "doi-asserted-by": "crossref", "first-page": "523", "DOI": "10.1111/j.1365-2249.2007.03521.x", "article-title": "Increase of CD4(+)CD25(+) regulatory T cells in the peripheral blood of patients with metastatic carcinoma: a Phase I clinical trial using cyclophosphamide and immunotherapy to eliminate CD4(+)CD25(+) T lymphocytes", "volume": "150", "author": "Audia", "year": "2007", "journal-title": "Clin Exp Immunol"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0088|cei4657-cit-0088", "doi-asserted-by": "crossref", "first-page": "1233", "DOI": "10.1038/mt.2010.34", "article-title": "Metronomic chemotherapy enhances antitumor effects of cancer vaccine by depleting regulatory T lymphocytes and inhibiting tumor angiogenesis", "volume": "18", "author": "Chen", "year": "2010", "journal-title": "Mol Ther"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0089|cei4657-cit-0089", "first-page": "S246", "article-title": "Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER-2/neu in a murine mammary carcinoma model", "volume": "88", "author": "Eralp", "year": "2004", "journal-title": "Breast Cancer Res Treat"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0090|cei4657-cit-0090", "doi-asserted-by": "crossref", "first-page": "219", "DOI": "10.1016/j.clim.2008.07.013", "article-title": "Differential impairment of regulatory T cells rather than effector T cells by paclitaxel-based chemotherapy", "volume": "129", "author": "Zhang", "year": "2008", "journal-title": "Clin Immunol"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0091|cei4657-cit-0091", "doi-asserted-by": "crossref", "first-page": "567", "DOI": "10.1046/j.1440-1711.2002.01127.x", "article-title": "Role of CD4(+)CD25(+) immunoregulatory T cells in the induction of autoimmune gastritis", "volume": "80", "author": "Laurie", "year": "2002", "journal-title": "Immunol Cell Biol"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0092|cei4657-cit-0092", "doi-asserted-by": "crossref", "first-page": "438", "DOI": "10.1097/CJI.0b013e3180600ff9", "article-title": "Inability to mediate prolonged reduction of regulatory T cells after transfer of autologous CD25-depleted PBMC and interleukin-2 after lymphodepleting chemotherapy", "volume": "30", "author": "Powell", "year": "2007", "journal-title": "J Immunother"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0093|cei4657-cit-0093", "doi-asserted-by": "crossref", "first-page": "623", "DOI": "10.1007/s00262-007-0400-6", "article-title": "Adoptive transfer of T(reg) depleted autologous T cells in advanced renal cell carcinoma", "volume": "57", "author": "Thistlethwaite", "year": "2008", "journal-title": "Cancer Immunol Immunother"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0094|cei4657-cit-0094", "doi-asserted-by": "crossref", "first-page": "1734", "DOI": "10.1126/science.271.5256.1734", "article-title": "Enhancement of antitumor immunity by CTLA-4 blockade", "volume": "271", "author": "Leach", "year": "1996", "journal-title": "Science"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0095|cei4657-cit-0095", "doi-asserted-by": "crossref", "first-page": "15074", "DOI": "10.1073/pnas.96.26.15074", "article-title": "Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy", "volume": "96", "author": "Kwon", "year": "1999", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0096|cei4657-cit-0096", "first-page": "2444", "article-title": "Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockade", "volume": "60", "author": "Hurwitz", "year": "2000", "journal-title": "Cancer Res"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0097|cei4657-cit-0097", "doi-asserted-by": "crossref", "first-page": "711", "DOI": "10.1056/NEJMoa1003466", "article-title": "Improved survival with ipilimumab in patients with metastatic melanoma", "volume": "363", "author": "Hodi", "year": "2010", "journal-title": "N Eng J Med"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0098|cei4657-cit-0098", "doi-asserted-by": "crossref", "first-page": "7746", "DOI": "10.4049/jimmunol.175.11.7746", "article-title": "Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade", "volume": "175", "author": "Maker", "year": "2005", "journal-title": "J Immunol"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0099|cei4657-cit-0099", "doi-asserted-by": "crossref", "first-page": "5136", "DOI": "10.4049/jimmunol.176.9.5136", "article-title": "Comment on \u2018analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade\u2019", "volume": "176", "author": "O'Mahony", "year": "2006", "journal-title": "J Immunol"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0100|cei4657-cit-0100", "doi-asserted-by": "crossref", "first-page": "564", "DOI": "10.1038/sj.gene.6364026", "article-title": "Cloning and characterization of GITR ligand", "volume": "4", "author": "Kim", "year": "2003", "journal-title": "Genes Immun"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0101|cei4657-cit-0101", "doi-asserted-by": "crossref", "first-page": "135", "DOI": "10.1038/ni759", "article-title": "Stimulation of CD25+CD4+regulatory T cells through GITR breaks immunological self-tolerance", "volume": "3", "author": "Shimizu", "year": "2002", "journal-title": "Nat Immunol"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0102|cei4657-cit-0102", "doi-asserted-by": "crossref", "first-page": "885", "DOI": "10.1084/jem.20050940", "article-title": "Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3(+)CD25(+)CD4(+) regulatory T cells", "volume": "202", "author": "Ko", "year": "2005", "journal-title": "J Exp Med"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0103|cei4657-cit-0103", "doi-asserted-by": "crossref", "first-page": "1935", "DOI": "10.1172/JCI27745", "article-title": "CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells", "volume": "116", "author": "Quezada", "year": "2006", "journal-title": "J Clin Invest"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0104|cei4657-cit-0104", "doi-asserted-by": "crossref", "first-page": "7747", "DOI": "10.1158/0008-5472.CAN-08-3289", "article-title": "Tumor vaccines expressing Flt3 ligand synergize with CTLA-4 blockade to reject preimplanted tumors", "volume": "69", "author": "Curran", "year": "2009", "journal-title": "Cancer Res"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0105|cei4657-cit-0105", "doi-asserted-by": "crossref", "first-page": "1103", "DOI": "10.1084/jem.20082205", "article-title": "OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis", "volume": "206", "author": "Hirschhorn-Cymerman", "year": "2009", "journal-title": "J Exp Med"}, {"key": "10.1111/j.1365-2249.2012.04657.x-BIB0106|cei4657-cit-0106", "doi-asserted-by": "crossref", "first-page": "1537", "DOI": "10.1182/blood-2008-12-195792", "article-title": "Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired", "volume": "114", "author": "Ahmadzadeh", "year": "2009", "journal-title": "Blood"}], "container-title": ["Clinical & Experimental Immunology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2249.2012.04657.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 20]], "date-time": "2017-06-20T23:02:25Z", "timestamp": 1497999745000}, "score": 59.101048, "subtitle": ["Regulatory T cells in cancer progression"], "issued": {"date-parts": [[2012, 12, 3]]}, "references-count": 106, "journal-issue": {"published-print": {"date-parts": [[2013, 1]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.1111/j.1365-2249.2012.04657.x", "relation": {"cites": []}, "ISSN": ["0009-9104"], "issn-type": [{"value": "0009-9104", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T23:42:27Z", "timestamp": 1575243747449}, "reference-count": 68, "publisher": "Springer Science and Business Media LLC", "issue": "1", "license": [{"URL": "http://creativecommons.org/licenses/by/4.0", "start": {"date-parts": [[2018, 2, 15]], "date-time": "2018-02-15T00:00:00Z", "timestamp": 1518652800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Nat Commun"], "published-print": {"date-parts": [[2018, 12]]}, "DOI": "10.1038/s41467-018-02911-y", "type": "journal-article", "created": {"date-parts": [[2018, 2, 9]], "date-time": "2018-02-09T10:36:14Z", "timestamp": 1518172574000}, "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 18, "title": ["CD1d-dependent immune suppression mediated by regulatory B cells through modulations of iNKT cells"], "prefix": "10.1038", "volume": "9", "author": [{"given": "K.", "family": "Oleinika", "sequence": "first", "affiliation": []}, {"given": "E. C.", "family": "Rosser", "sequence": "additional", "affiliation": []}, {"given": "D. E.", "family": "Matei", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Nistala", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Bosma", "sequence": "additional", "affiliation": []}, {"given": "I.", "family": "Drozdov", "sequence": "additional", "affiliation": []}, {"ORCID": "http://orcid.org/0000-0001-9761-2625", "authenticated-orcid": false, "given": "C.", "family": "Mauri", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2018, 2, 15]]}, "reference": [{"key": "2911_CR1", "doi-asserted-by": "publisher", "first-page": "477", "DOI": "10.1016/j.immuni.2012.02.008", "volume": "36", "author": "A Bosma", "year": "2012", "unstructured": "Bosma, A., Abdel-Gadir, A., Isenberg, D. A., Jury, E. C. & Mauri, C. Lipid-antigen presentation by CD1d(+) B cells is essential for the maintenance of invariant natural killer T cells. Immunity 36, 477\u2013490 (2012).", "journal-title": "Immunity"}, {"key": "2911_CR2", "doi-asserted-by": "publisher", "first-page": "221", "DOI": "10.1146/annurev-immunol-020711-074934", "volume": "30", "author": "C Mauri", "year": "2012", "unstructured": "Mauri, C. & Bosma, A. Immune regulatory function of B cells. Annu. Rev. Immunol. 30, 221\u2013241 (2012).", "journal-title": "Annu. Rev. Immunol."}, {"key": "2911_CR3", "doi-asserted-by": "publisher", "first-page": "5897", "DOI": "10.4049/jimmunol.170.12.5897", "volume": "170", "author": "VV Parekh", "year": "2003", "unstructured": "Tian, J., Zekzer, D., Hanssen, L., Lu, Y., Olcott, A. & Kaufman, D. L.\u00a0\u00a0Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J. Immunol. 167, 1081-1089 (2001).", "journal-title": "J. Immunol."}, {"key": "2911_CR4", "doi-asserted-by": "publisher", "first-page": "366", "DOI": "10.1038/nature12979", "volume": "507", "author": "P Shen", "year": "2014", "unstructured": "Shen, P. et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature 507, 366\u2013370 (2014).", "journal-title": "Nature"}, {"key": "2911_CR5", "author": "AR Khan", "volume": "6", "year": "2015", "unstructured": "Khan, A. R. et al. PD-L1hi B cells are critical regulators of humoral immunity. Nat. Commun. 6, 5997 (2015).", "journal-title": "Nat. Commun.", "DOI": "10.1038/ncomms6997", "doi-asserted-by": "publisher"}, {"key": "2911_CR6", "doi-asserted-by": "publisher", "first-page": "1040", "DOI": "10.1016/j.immuni.2014.10.016", "volume": "41", "author": "M Matsumoto", "year": "2014", "unstructured": "Matsumoto, M. et al. Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation. Immunity 41, 1040\u20131051 (2014).", "journal-title": "Immunity"}, {"key": "2911_CR7", "doi-asserted-by": "publisher", "first-page": "1114", "DOI": "10.1016/j.jaci.2010.01.018", "volume": "125", "author": "S Amu", "year": "2010", "unstructured": "Amu, S. et al. Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model. J. Allergy Clin. Immunol. 125, 1114\u20131124 (2010). e1118.", "journal-title": "J. Allergy Clin. Immunol."}, {"key": "2911_CR8", "doi-asserted-by": "publisher", "first-page": "819", "DOI": "10.1038/ni1225", "volume": "6", "author": "M Koch", "year": "2005", "unstructured": "Koch, M. et al. The crystal structure of human CD1d with and without alpha-galactosylceramide. Nat. Immunol. 6, 819\u2013826 (2005).", "journal-title": "Nat. Immunol."}, {"key": "2911_CR9", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1016/S0065-2776(09)01201-2", "volume": "102", "author": "NR Cohen", "year": "2009", "unstructured": "Cohen, N. R., Garg, S. & Brenner, M. B. Antigen presentation by CD1 Lipids, T cells, and NKT cells in microbial immunity. Adv. Immunol. 102, 1\u201394 (2009).", "journal-title": "Adv. Immunol."}, {"key": "2911_CR10", "doi-asserted-by": "publisher", "first-page": "101", "DOI": "10.1038/nri3369", "volume": "13", "author": "PJ Brennan", "year": "2013", "unstructured": "Brennan, P. J., Brigl, M. & Brenner, M. B. Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions. Nat. Rev. Immunol. 13, 101\u2013117 (2013).", "journal-title": "Nat. Rev. Immunol."}, {"key": "2911_CR11", "doi-asserted-by": "publisher", "first-page": "13838", "DOI": "10.1073/pnas.251531798", "volume": "98", "author": "YN Naumov", "year": "2001", "unstructured": "Naumov, Y. N. et al. Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc. Natl Acad. Sci. USA 98, 13838\u201313843 (2001).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "2911_CR12", "doi-asserted-by": "publisher", "first-page": "31", "DOI": "10.1038/nri1531", "volume": "5", "author": "L Kaer Van", "year": "2005", "unstructured": "Van Kaer, L. Alpha-galactosylceramide therapy for autoimmune diseases: prospects and obstacles. Nat. Rev. Immunol. 5, 31\u201342 (2005).", "journal-title": "Nat. Rev. Immunol."}, {"key": "2911_CR13", "doi-asserted-by": "publisher", "first-page": "263", "DOI": "10.1016/j.cyto.2010.11.001", "volume": "53", "author": "J Novak", "year": "2011", "unstructured": "Novak, J. & Lehuen, A. Mechanism of regulation of autoimmunity by iNKT cells. Cytokine 53, 263\u2013270 (2011).", "journal-title": "Cytokine"}, {"key": "2911_CR14", "doi-asserted-by": "publisher", "first-page": "1127", "DOI": "10.1002/1529-0131(200105)44:5<1127::AID-ANR194>3.0.CO;2-W", "volume": "44", "author": "S Kojo", "year": "2001", "unstructured": "Kojo, S., Adachi, Y., Keino, H., Taniguchi, M. & Sumida, T. Dysfunction of T cell receptor AV24AJ18+, BV11+double-negative regulatory natural killer T cells in autoimmune diseases. Arthritis Rheum. 44, 1127\u20131138 (2001).", "journal-title": "Arthritis Rheum."}, {"key": "2911_CR15", "doi-asserted-by": "publisher", "first-page": "144", "DOI": "10.1006/clim.2001.5060", "volume": "100", "author": "HJ Vliet van der", "year": "2001", "unstructured": "van der Vliet, H. J. et al. Circulating V(alpha24+) Vbeta11+NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin. Immunol. 100, 144\u2013148 (2001).", "journal-title": "Clin. Immunol."}, {"key": "2911_CR16", "doi-asserted-by": "publisher", "first-page": "131", "DOI": "10.1046/j.1365-2249.1999.01018.x", "volume": "118", "author": "Y Yanagihara", "year": "1999", "unstructured": "Yanagihara, Y., Shiozawa, K., Takai, M., Kyogoku, M. & Shiozawa, S. Natural killer (NK) T cells are significantly decreased in the peripheral blood of patients with rheumatoid arthritis (RA). Clin. Exp. Immunol. 118, 131\u2013136 (1999).", "journal-title": "Clin. Exp. Immunol."}, {"key": "2911_CR17", "doi-asserted-by": "publisher", "first-page": "4375", "DOI": "10.4049/jimmunol.164.8.4375", "volume": "164", "author": "Z Illes", "year": "2000", "unstructured": "Illes, Z. et al. Differential expression of NK T cell V alpha 24J alpha Q invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. J. Immunol. 164, 4375\u20134381 (2000).", "journal-title": "J. Immunol."}, {"key": "2911_CR18", "doi-asserted-by": "publisher", "first-page": "8339", "DOI": "10.1073/pnas.0801375105", "volume": "105", "author": "EA Leadbetter", "year": "2008", "unstructured": "Leadbetter, E. A. et al. NK T cells provide lipid antigen-specific cognate help for B cells. Proc. Natl Acad. Sci. USA 105, 8339\u20138344 (2008).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "2911_CR19", "doi-asserted-by": "publisher", "first-page": "8345", "DOI": "10.1073/pnas.0802968105", "volume": "105", "author": "P Barral", "year": "2008", "unstructured": "Barral, P. et al. B cell receptor-mediated uptake of CD1d-restricted antigen augments antibody responses by recruiting invariant NKT cell help in vivo. Proc. Natl Acad. Sci. USA 105, 8345\u20138350 (2008).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "2911_CR20", "doi-asserted-by": "publisher", "first-page": "1784", "DOI": "10.1111/j.1600-6143.2012.04012.x", "volume": "12", "author": "S Heidt", "year": "2012", "unstructured": "Heidt, S., Hester, J., Shankar, S., Friend, P. J. & Wood, K. J. B cell repopulation after alemtuzumab induction-transient increase in transitional B cells and long-term dominance of naive B cells. Am. J. Transplant. 12, 1784\u20131792 (2012).", "journal-title": "Am. J. Transplant."}, {"key": "2911_CR21", "doi-asserted-by": "publisher", "first-page": "613", "DOI": "10.1002/art.21617", "volume": "54", "author": "MJ Leandro", "year": "2006", "unstructured": "Leandro, M. J., Cambridge, G., Ehrenstein, M. R. & Edwards, J. C. Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis. Arthritis Rheum. 54, 613\u2013620 (2006).", "journal-title": "Arthritis Rheum."}, {"key": "2911_CR22", "doi-asserted-by": "publisher", "first-page": "391", "DOI": "10.1016/j.immuni.2008.07.011", "volume": "29", "author": "AK Savage", "year": "2008", "unstructured": "Savage, A. K. et al. The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 29, 391\u2013403 (2008).", "journal-title": "Immunity"}, {"key": "2911_CR23", "doi-asserted-by": "publisher", "first-page": "1055", "DOI": "10.1038/ni.1641", "volume": "9", "author": "D Kovalovsky", "year": "2008", "unstructured": "Kovalovsky, D. et al. The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions. Nat. Immunol. 9, 1055\u20131064 (2008).", "journal-title": "Nat. Immunol."}, {"key": "2911_CR24", "doi-asserted-by": "publisher", "first-page": "4791", "DOI": "10.4049/jimmunol.181.7.4791", "volume": "181", "author": "RS Grajewski", "year": "2008", "unstructured": "Grajewski, R. S. et al. Activation of invariant NKT cells ameliorates experimental ocular autoimmunity by a mechanism involving innate IFN-gamma production and dampening of the adaptive Th1 and Th17 responses. J. Immunol. 181, 4791\u20134797 (2008).", "journal-title": "J. Immunol."}, {"key": "2911_CR25", "doi-asserted-by": "publisher", "first-page": "1645", "DOI": "10.4049/jimmunol.176.3.1645", "volume": "176", "author": "JA Cain", "year": "2006", "unstructured": "Cain, J. A., Smith, J. A., Ondr, J. K., Wang, B. & Katz, J. D. NKT cells and IFN-gamma establish the regulatory environment for the control of diabetogenic T cells in the nonobese diabetic mouse. J. Immunol. 176, 1645\u20131654 (2006).", "journal-title": "J. Immunol."}, {"key": "2911_CR26", "doi-asserted-by": "publisher", "first-page": "2321", "DOI": "10.4049/jimmunol.181.4.2321", "volume": "181", "author": "LT Mars", "year": "2008", "unstructured": "Mars, L. T. et al. Invariant NKT cells regulate experimental autoimmune encephalomyelitis and infiltrate the central nervous system in a CD1d-independent manner. J. Immunol. 181, 2321\u20132329 (2008).", "journal-title": "J. Immunol."}, {"key": "2911_CR27", "doi-asserted-by": "publisher", "first-page": "1830", "DOI": "10.1002/eji.200323885", "volume": "33", "author": "R Furlan", "year": "2003", "unstructured": "Furlan, R. et al. Activation of invariant NKT cells by alphaGalCer administration protects mice from MOG35-55-induced EAE: critical roles for administration route and IFN-gamma. Eur. J. Immunol. 33, 1830\u20131838 (2003).", "journal-title": "Eur. J. Immunol."}, {"key": "2911_CR28", "doi-asserted-by": "publisher", "first-page": "2157", "DOI": "10.4049/jimmunol.1000359", "volume": "185", "author": "M Monteiro", "year": "2010", "unstructured": "Monteiro, M. et al. Identification of regulatory Foxp3+invariant NKT cells induced by TGF-beta. J. Immunol. 185, 2157\u20132163 (2010).", "journal-title": "J. Immunol."}, {"key": "2911_CR29", "doi-asserted-by": "publisher", "first-page": "85", "DOI": "10.1038/ni.3047", "volume": "16", "author": "L Lynch", "year": "2015", "unstructured": "Lynch, L. et al. Regulatory iNKT cells lack expression of the transcription factor PLZF and control the homeostasis of T(reg) cells and macrophages in adipose tissue. Nat. Immunol. 16, 85\u201395 (2015).", "journal-title": "Nat. Immunol."}, {"key": "2911_CR30", "doi-asserted-by": "publisher", "first-page": "349", "DOI": "10.1126/science.273.5273.349", "volume": "273", "author": "M Sugita", "year": "1996", "unstructured": "Sugita, M. et al. Cytoplasmic tail-dependent localization of CD1b antigen-presenting molecules to MIICs. Science 273, 349\u2013352 (1996).", "journal-title": "Science"}, {"key": "2911_CR31", "doi-asserted-by": "publisher", "first-page": "4565", "DOI": "10.4049/jimmunol.1002529", "volume": "186", "author": "HD Goold", "year": "2011", "unstructured": "Goold, H. D., Escors, D., Conlan, T. J., Chakraverty, R. & Bennett, C. L. Conventional dendritic cells are required for the activation of helper-dependent CD8 T cell responses to a model antigen after cutaneous vaccination with lentiviral vectors. J. Immunol. 186, 4565\u20134572 (2011).", "journal-title": "J. Immunol."}, {"key": "2911_CR32", "doi-asserted-by": "publisher", "first-page": "943", "DOI": "10.1084/jem.20091314", "volume": "207", "author": "F Wermeling", "year": "2010", "unstructured": "Wermeling, F., Lind, S. M., Jordo, E. D., Cardell, S. L. & Karlsson, M. C. I. Invariant NKT cells limit activation of autoreactive CD1d-positive B cells. J. Exp. Med. 207, 943\u2013952 (2010).", "journal-title": "J. Exp. Med."}, {"key": "2911_CR33", "doi-asserted-by": "publisher", "first-page": "435", "DOI": "10.1038/nri3701", "volume": "14", "author": "KN Pollizzi", "year": "2014", "unstructured": "Pollizzi, K. N. & Powell, J. D. Integrating canonical and metabolic signalling programmes in the regulation of T cell responses. Nat. Rev. Immunol. 14, 435\u2013446 (2014).", "journal-title": "Nat. Rev. Immunol."}, {"key": "2911_CR34", "doi-asserted-by": "publisher", "first-page": "574", "DOI": "10.1038/nri3874", "volume": "15", "author": "K Man", "year": "2015", "unstructured": "Man, K. & Kallies, A. Synchronizing transcriptional control of T cell metabolism and function. Nat. Rev. Immunol. 15, 574\u2013584 (2015).", "journal-title": "Nat. Rev. Immunol."}, {"key": "2911_CR35", "doi-asserted-by": "publisher", "first-page": "1146", "DOI": "10.1038/ni.2731", "volume": "14", "author": "YJ Lee", "year": "2013", "unstructured": "Lee, Y. J., Holzapfel, K. L., Zhu, J., Jameson, S. C. & Hogquist, K. A. Steady-state production of IL-4 modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells. Nat. Immunol. 14, 1146\u20131154 (2013).", "journal-title": "Nat. Immunol."}, {"key": "2911_CR36", "doi-asserted-by": "publisher", "first-page": "728", "DOI": "10.1038/ni.3437", "volume": "17", "author": "I Engel", "year": "2016", "unstructured": "Engel, I. et al. Innate-like functions of natural killer T cell subsets result from highly divergent gene programs. Nat. Immunol. 17, 728\u2013739 (2016).", "journal-title": "Nat. Immunol."}, {"key": "2911_CR37", "doi-asserted-by": "publisher", "first-page": "10735", "DOI": "10.1073/pnas.1306691110", "volume": "110", "author": "S Tsukumo", "year": "2013", "unstructured": "Tsukumo, S. et al. Bach2 maintains T cells in a naive state by suppressing effector memory-related genes. Proc. Natl Acad. Sci. USA 110, 10735\u201310740 (2013).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "2911_CR38", "doi-asserted-by": "publisher", "first-page": "2244", "DOI": "10.1002/art.22732", "volume": "56", "author": "AS Williams", "year": "2007", "unstructured": "Williams, A. S. et al. Interferon-gamma protects against the development of structural damage in experimental arthritis by regulating polymorphonuclear neutrophil influx into diseased joints. Arthritis Rheum. 56, 2244\u20132254 (2007).", "journal-title": "Arthritis Rheum."}, {"key": "2911_CR39", "doi-asserted-by": "publisher", "first-page": "7868", "DOI": "10.4049/jimmunol.178.12.7868", "volume": "178", "author": "JG Evans", "year": "2007", "unstructured": "Evans, J. G. et al. Novel suppressive function of transitional 2 B cells in experimental arthritis. J. Immunol. 178, 7868\u20137878 (2007).", "journal-title": "J. Immunol."}, {"key": "2911_CR40", "doi-asserted-by": "publisher", "first-page": "1623", "DOI": "10.1126/science.278.5343.1623", "volume": "278", "author": "J Cui", "year": "1997", "unstructured": "Cui, J. et al. Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science 278, 1623\u20131626 (1997).", "journal-title": "Science"}, {"key": "2911_CR41", "doi-asserted-by": "publisher", "first-page": "459", "DOI": "10.1016/S1074-7613(00)80289-7", "volume": "6", "author": "YH Chen", "year": "1997", "unstructured": "Chen, Y. H., Chiu, N. M., Mandal, M., Wang, N. & Wang, C. R. Impaired NK1+T cell development and early IL-4 production in CD1-deficient mice. Immunity 6, 459\u2013467 (1997).", "journal-title": "Immunity"}, {"key": "2911_CR42", "doi-asserted-by": "publisher", "first-page": "14080", "DOI": "10.1073/pnas.0700326104", "volume": "104", "author": "M Gray", "year": "2007", "unstructured": "Gray, M., Miles, K., Salter, D., Gray, D. & Savill, J. Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells. Proc. Natl Acad. Sci. USA 104, 14080\u201314085 (2007).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "2911_CR43", "doi-asserted-by": "publisher", "first-page": "409", "DOI": "10.1126/science.1071632", "volume": "297", "author": "TT Lu", "year": "2002", "unstructured": "Lu, T. T. & Cyster, J. G. Integrin-mediated long-term B cell retention in the splenic marginal zone. Science 297, 409\u2013412 (2002).", "journal-title": "Science"}, {"key": "2911_CR44", "doi-asserted-by": "publisher", "first-page": "3354", "DOI": "10.1128/IAI.00422-07", "volume": "75", "author": "AA Belperron", "year": "2007", "unstructured": "Belperron, A. A., Dailey, C. M., Booth, C. J. & Bockenstedt, L. K. Marginal zone B-cell depletion impairs murine host defense against Borrelia burgdorferi infection. Infect. Immun. 75, 3354\u20133360 (2007).", "journal-title": "Infect. Immun."}, {"key": "2911_CR45", "doi-asserted-by": "publisher", "first-page": "12474", "DOI": "10.1073/pnas.1504790112", "volume": "112", "author": "EE Vomhof-DeKrey", "year": "2015", "unstructured": "Vomhof-DeKrey, E. E. et al. Cognate interaction with iNKT cells expands IL-10-producing B regulatory cells. Proc. Natl Acad. Sci. USA 112, 12474\u201312479 (2015).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "2911_CR46", "doi-asserted-by": "publisher", "first-page": "1051", "DOI": "10.1084/jem.20021616", "volume": "197", "author": "G Galli", "year": "2003", "unstructured": "Galli, G. et al. CD1d-restricted help to B cells by human invariant natural killer T lymphocytes. J. Exp. Med. 197, 1051\u20131057 (2003).", "journal-title": "J. Exp. Med."}, {"key": "2911_CR47", "doi-asserted-by": "publisher", "first-page": "2158", "DOI": "10.1182/blood-2007-10-117309", "volume": "111", "author": "GA Lang", "year": "2008", "unstructured": "Lang, G. A., Devera, T. S. & Lang, M. L. Requirement for CD1d expression by B cells to stimulate NKT cell-enhanced antibody production. Blood 111, 2158\u20132162 (2008).", "journal-title": "Blood"}, {"key": "2911_CR48", "doi-asserted-by": "publisher", "first-page": "3984", "DOI": "10.1073/pnas.0700191104", "volume": "104", "author": "G Galli", "year": "2007", "unstructured": "Galli, G. et al. Invariant NKT cells sustain specific B cell responses and memory. Proc. Natl Acad. Sci. USA 104, 3984\u20133989 (2007).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "2911_CR49", "doi-asserted-by": "publisher", "first-page": "2600", "DOI": "10.1182/blood-2013-01-480665", "volume": "122", "author": "BK Chung", "year": "2013", "unstructured": "Chung, B. K. et al. Innate immune control of EBV-infected B cells by invariant natural killer T cells. Blood 122, 2600\u20132608 (2013).", "journal-title": "Blood"}, {"key": "2911_CR50", "doi-asserted-by": "publisher", "first-page": "24", "DOI": "10.1016/j.celrep.2014.08.043", "volume": "9", "author": "AH Tan", "year": "2014", "unstructured": "Tan, A. H. et al. Aberrant presentation of self-lipids by autoimmune B cells depletes peripheral iNKT cells. Cell Rep. 9, 24\u201331 (2014).", "journal-title": "Cell Rep."}, {"key": "2911_CR51", "doi-asserted-by": "publisher", "first-page": "531", "DOI": "10.1093/intimm/dxv033", "volume": "27", "author": "A Ray", "year": "2015", "unstructured": "Ray, A., Wang, L. & Dittel, B. N. IL-10-independent regulatory B-cell subsets and mechanisms of action. Int. Immunol. 27, 531\u2013536 (2015).", "journal-title": "Int. Immunol."}, {"key": "2911_CR52", "doi-asserted-by": "publisher", "first-page": "5569", "DOI": "10.4049/jimmunol.1100284", "volume": "186", "author": "NA Carter", "year": "2011", "unstructured": "Carter, N. A. et al. Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J. Immunol. 186, 5569\u20135579 (2011).", "journal-title": "J. Immunol."}, {"key": "2911_CR53", "doi-asserted-by": "publisher", "first-page": "1948", "DOI": "10.4049/jimmunol.1201718", "volume": "190", "author": "VV Parekh", "year": "2013", "unstructured": "Parekh, V. V., Wu, L., Olivares-Villagomez, D., Wilson, K. T. & Van Kaer, L. Activated invariant NKT cells control central nervous system autoimmunity in a mechanism that involves myeloid-derived suppressor cells. J. Immunol. 190, 1948\u20131960 (2013).", "journal-title": "J. Immunol."}, {"key": "2911_CR54", "doi-asserted-by": "publisher", "first-page": "2300", "DOI": "10.4049/jimmunol.179.4.2300", "volume": "179", "author": "K Coppieters", "year": "2007", "unstructured": "Coppieters, K. et al. A single early activation of invariant NK T cells confers long-term protection against collagen-induced arthritis in a ligand-specific manner. J. Immunol. 179, 2300\u20132309 (2007).", "journal-title": "J. Immunol."}, {"key": "2911_CR55", "doi-asserted-by": "publisher", "first-page": "e51215", "DOI": "10.1371/journal.pone.0051215", "volume": "7", "author": "M Horikoshi", "year": "2012", "unstructured": "Horikoshi, M. et al. Activation of invariant NKT cells with glycolipid ligand alpha-galactosylceramide ameliorates glucose-6-phosphate isomerase peptide-induced arthritis. PLoS ONE 7, e51215 (2012).", "journal-title": "PLoS ONE"}, {"key": "2911_CR56", "doi-asserted-by": "publisher", "first-page": "3704", "DOI": "10.1002/eji.200535235", "volume": "35", "author": "A Miellot", "year": "2005", "unstructured": "Miellot, A. et al. Activation of invariant NK T cells protects against experimental rheumatoid arthritis by an IL-10-dependent pathway. Eur. J. Immunol. 35, 3704\u20133713 (2005).", "journal-title": "Eur. J. Immunol."}, {"key": "2911_CR57", "doi-asserted-by": "publisher", "first-page": "3725", "DOI": "10.1172/JCI72308", "volume": "124", "author": "D Sag", "year": "2014", "unstructured": "Sag, D., Krause, P., Hedrick, C. C., Kronenberg, M. & Wingender, G. IL-10-producing NKT10 cells are a distinct regulatory invariant NKT cell subset. J. Clin. Invest. 124, 3725\u20133740 (2014).", "journal-title": "J. Clin. Invest."}, {"key": "2911_CR58", "doi-asserted-by": "publisher", "first-page": "3402", "DOI": "10.4049/jimmunol.1100224", "volume": "187", "author": "R Vasconcellos", "year": "2011", "unstructured": "Vasconcellos, R., Carter, N. A., Rosser, E. C. & Mauri, C. IL-12p35 subunit contributes to autoimmunity by limiting IL-27-driven regulatory responses. J. Immunol. 187, 3402\u20133412 (2011).", "journal-title": "J. Immunol."}, {"key": "2911_CR59", "doi-asserted-by": "publisher", "first-page": "13938", "DOI": "10.1073/pnas.96.24.13938", "volume": "96", "author": "SP Colgan", "year": "1999", "unstructured": "Colgan, S. P., Hershberg, R. M., Furuta, G. T. & Blumberg, R. S. Ligation of intestinal epithelial CD1d induces bioactive IL-10: critical role of the cytoplasmic tail in autocrine signaling. Proc. Natl Acad. Sci. USA 96, 13938\u201313943 (1999).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "2911_CR60", "doi-asserted-by": "publisher", "first-page": "423", "DOI": "10.1038/350423a0", "volume": "350", "author": "D Kitamura", "year": "1991", "unstructured": "Kitamura, D., Roes, J., Kuhn, R. & Rajewsky, K. A. B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350, 423\u2013426 (1991).", "journal-title": "Nature"}, {"key": "2911_CR61", "doi-asserted-by": "publisher", "first-page": "263", "DOI": "10.1016/0092-8674(93)80068-P", "volume": "75", "author": "R Kuhn", "year": "1993", "unstructured": "Kuhn, R., Lohler, J., Rennick, D., Rajewsky, K. & Muller, W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263\u2013274 (1993).", "journal-title": "Cell"}, {"key": "2911_CR62", "doi-asserted-by": "publisher", "first-page": "211", "DOI": "10.1016/S1074-7613(02)00365-5", "volume": "17", "author": "S Jung", "year": "2002", "unstructured": "Jung, S. et al. In vivo depletion of CD11c+dendritic cells abrogates priming of CD8+T cells by exogenous cell-associated antigens. Immunity 17, 211\u2013220 (2002).", "journal-title": "Immunity"}, {"key": "2911_CR63", "doi-asserted-by": "publisher", "first-page": "3112", "DOI": "10.4049/jimmunol.1200360", "volume": "189", "author": "HH Nguyen", "year": "2012", "unstructured": "Nguyen, H. H., Tran, B. T., Muller, W. & Jack, R. S. IL-10 acts as a developmental switch guiding monocyte differentiation to macrophages during a murine peritoneal infection. J. Immunol. 189, 3112\u20133120 (2012).", "journal-title": "J. Immunol."}, {"key": "2911_CR64", "doi-asserted-by": "publisher", "first-page": "2312", "DOI": "10.4049/jimmunol.0900185", "volume": "183", "author": "R Madan", "year": "2009", "unstructured": "Madan, R. et al. Nonredundant roles for B cell-derived IL-10 in immune counter-regulation. J. Immunol. 183, 2312\u20132320 (2009).", "journal-title": "J. Immunol."}, {"key": "2911_CR65", "doi-asserted-by": "publisher", "first-page": "139", "DOI": "10.1093/bioinformatics/btp616", "volume": "26", "author": "MD Robinson", "year": "2010", "unstructured": "Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).", "journal-title": "Bioinformatics"}, {"key": "2911_CR66", "doi-asserted-by": "publisher", "first-page": "75", "DOI": "10.1093/bioinformatics/btn577", "volume": "25", "author": "AL Tarca", "year": "2009", "unstructured": "Tarca, A. L. et al. A novel signaling pathway impact analysis. Bioinformatics 25, 75\u201382 (2009).", "journal-title": "Bioinformatics"}, {"key": "2911_CR67", "doi-asserted-by": "publisher", "first-page": "D457", "DOI": "10.1093/nar/gkv1070", "volume": "44", "author": "M Kanehisa", "year": "2016", "unstructured": "Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44, D457\u2013D462 (2016).", "journal-title": "Nucleic Acids Res."}, {"key": "2911_CR68", "unstructured": "Wingender, G., Krebs, P., Beutler, B. & Kronenberg, M. Antigen-specific cytotoxicity by invariant NKT cells in vivo is CD95/CD178-dependent and is correlated with antigenic potency. J. Immunol. 185, 2721-2729 (2010).", "DOI": "10.4049/jimmunol.1001018", "doi-asserted-by": "crossref"}], "container-title": ["Nature Communications"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/s41467-018-02911-y", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/s41467-018-02911-y.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/s41467-018-02911-y.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 2, 15]], "date-time": "2019-02-15T00:11:30Z", "timestamp": 1550189490000}, "score": 32.448044, "issued": {"date-parts": [[2018, 2, 15]]}, "references-count": 68, "journal-issue": {"published-print": {"date-parts": [[2018, 12]]}, "issue": "1"}, "alternative-id": ["2911"], "URL": "http://dx.doi.org/10.1038/s41467-018-02911-y", "relation": {"cites": []}, "ISSN": ["2041-1723"], "issn-type": [{"value": "2041-1723", "type": "electronic"}], "subject": ["General Biochemistry, Genetics and Molecular Biology", "General Physics and Astronomy", "General Chemistry"], "assertion": [{"value": "30 July 2017", "order": 1, "name": "received", "label": "Received", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "8 January 2018", "order": 2, "name": "accepted", "label": "Accepted", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "15 February 2018", "order": 3, "name": "first_online", "label": "First Online", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "The authors declare no competing financial interests.", "order": 1, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Competing interests"}}], "article-number": "684"}, {"institution": {"name": "US Dept of the Army", "place": ["-", "-"], "department": ["Funding", "Performing"], "acronym": ["USAMRMC", "-"]}, "indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T23:28:06Z", "timestamp": 1574810886765}, "publisher-location": "Fort Belvoir, VA", "reference-count": 0, "publisher": "Defense Technical Information Center", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2007, 3, 1]]}, "DOI": "10.21236/ada474695", "type": "report", "created": {"date-parts": [[2017, 7, 14]], "date-time": "2017-07-14T16:09:06Z", "timestamp": 1500048546000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Immune Suppression and Inflammation in the Progression of Breast Cancer"], "prefix": "10.21236", "author": [{"given": "Stephanie K.", "family": "Bunt", "sequence": "first", "affiliation": []}], "member": "9879", "original-title": [""], "deposited": {"date-parts": [[2017, 7, 14]], "date-time": "2017-07-14T16:09:06Z", "timestamp": 1500048546000}, "score": 26.814419, "subtitle": [""], "issued": {"date-parts": [[2007, 3, 1]]}, "references-count": 0, "URL": "http://dx.doi.org/10.21236/ada474695"}, {"institution": {"name": "US Dept of the Army", "place": ["-", "-"], "department": ["Funding", "Performing"], "acronym": ["USAMRMC", "-"]}, "indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T23:28:06Z", "timestamp": 1574810886790}, "publisher-location": "Fort Belvoir, VA", "reference-count": 0, "publisher": "Defense Technical Information Center", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2006, 3, 1]]}, "DOI": "10.21236/ada462452", "type": "report", "created": {"date-parts": [[2017, 7, 14]], "date-time": "2017-07-14T16:09:08Z", "timestamp": 1500048548000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Immune Suppression and Inflammation in the Progression of Breast Cancer"], "prefix": "10.21236", "author": [{"given": "Stephanie K.", "family": "Bunt", "sequence": "first", "affiliation": []}], "member": "9879", "original-title": [""], "deposited": {"date-parts": [[2017, 7, 14]], "date-time": "2017-07-14T16:09:08Z", "timestamp": 1500048548000}, "score": 26.814419, "subtitle": [""], "issued": {"date-parts": [[2006, 3, 1]]}, "references-count": 0, "URL": "http://dx.doi.org/10.21236/ada462452"}, {"institution": {"name": "US Dept of the Army", "place": ["-", "-"], "department": ["Funding", "Performing"], "acronym": ["USAMRMC", "-"]}, "indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T23:19:34Z", "timestamp": 1574810374145}, "publisher-location": "Fort Belvoir, VA", "reference-count": 0, "publisher": "Defense Technical Information Center", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2008, 3, 1]]}, "DOI": "10.21236/ada485052", "type": "report", "created": {"date-parts": [[2017, 7, 13]], "date-time": "2017-07-13T21:01:33Z", "timestamp": 1499979693000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Immune Suppression and Inflammation in the Progression of Breast Cancer"], "prefix": "10.21236", "author": [{"given": "Stephanie K.", "family": "Bunt", "sequence": "first", "affiliation": []}], "member": "9879", "original-title": [""], "deposited": {"date-parts": [[2017, 7, 13]], "date-time": "2017-07-13T21:01:33Z", "timestamp": 1499979693000}, "score": 26.814419, "subtitle": [""], "issued": {"date-parts": [[2008, 3, 1]]}, "references-count": 0, "URL": "http://dx.doi.org/10.21236/ada485052"}, {"indexed": {"date-parts": [[2019, 12, 18]], "date-time": "2019-12-18T16:24:09Z", "timestamp": 1576686249780}, "reference-count": 182, "publisher": "Springer Science and Business Media LLC", "issue": "1", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2018, 11, 15]], "date-time": "2018-11-15T00:00:00Z", "timestamp": 1542240000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "short-container-title": ["Nat Rev Nephrol"], "published-print": {"date-parts": [[2019, 1]]}, "DOI": "10.1038/s41581-018-0074-7", "type": "journal-article", "created": {"date-parts": [[2018, 11, 15]], "date-time": "2018-11-15T11:40:02Z", "timestamp": 1542282002000}, "page": "11-26", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 5, "title": ["Effector and regulatory B cells in immune-mediated kidney disease"], "prefix": "10.1038", "volume": "15", "author": [{"given": "Kristine", "family": "Oleinika", "sequence": "first", "affiliation": []}, {"ORCID": "http://orcid.org/0000-0001-9761-2625", "authenticated-orcid": false, "given": "Claudia", "family": "Mauri", "sequence": "additional", "affiliation": []}, {"given": "Alan D.", "family": "Salama", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2018, 11, 15]]}, "reference": [{"key": "74_CR1", "doi-asserted-by": "crossref", "first-page": "1771", "DOI": "10.1056/NEJMoa1404231", "volume": "371", "author": "L Guillevin", "year": "2014", "unstructured": "Guillevin, L. et al. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. N. Engl. J. Med. 371, 1771\u20131780 (2014).", "journal-title": "N. Engl. J. Med."}, {"key": "74_CR2", "doi-asserted-by": "crossref", "first-page": "211", "DOI": "10.1056/NEJMoa0909169", "volume": "363", "author": "RB Jones", "year": "2010", "unstructured": "Jones, R. B. et al. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N. Engl. J. Med. 363, 211\u2013220 (2010).", "journal-title": "N. Engl. J. Med."}, {"key": "74_CR3", "doi-asserted-by": "crossref", "first-page": "221", "DOI": "10.1056/NEJMoa0909905", "volume": "363", "author": "JH Stone", "year": "2010", "unstructured": "Stone, J. H. et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N. Engl. J. Med. 363, 221\u2013232 (2010).", "journal-title": "N. Engl. J. Med."}, {"key": "74_CR4", "doi-asserted-by": "crossref", "first-page": "843", "DOI": "10.1002/art.34331", "volume": "64", "author": "S Vita De", "year": "2012", "unstructured": "De Vita, S. et al. A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. Arthritis Rheum. 64, 843\u2013853 (2012).", "journal-title": "Arthritis Rheum."}, {"key": "74_CR5", "doi-asserted-by": "crossref", "first-page": "85ra46", "DOI": "10.1126/scitranslmed.3002231", "volume": "3", "author": "A Fornoni", "year": "2011", "unstructured": "Fornoni, A. et al. Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci. Transl Med. 3, 85ra46 (2011).", "journal-title": "Sci. Transl. Med."}, {"key": "74_CR6", "doi-asserted-by": "crossref", "first-page": "314", "DOI": "10.1016/j.clim.2011.02.018", "volume": "139", "author": "LL Liu", "year": "2011", "unstructured": "Liu, L. L. et al. Th17/Treg imbalance in adult patients with minimal change nephrotic syndrome. Clin. Immunol. 139, 314\u2013320 (2011).", "journal-title": "Clin. Immunol."}, {"key": "74_CR7", "doi-asserted-by": "crossref", "first-page": "4390", "DOI": "10.1182/blood-2004-11-4284", "volume": "105", "author": "GP Sims", "year": "2005", "unstructured": "Sims, G. P. et al. Identification and characterization of circulating human transitional B cells. Blood 105, 4390\u20134398 (2005).", "journal-title": "Blood"}, {"key": "74_CR8", "doi-asserted-by": "crossref", "first-page": "54", "DOI": "10.1126/science.272.5258.54", "volume": "272", "author": "R Ahmed", "year": "1996", "unstructured": "Ahmed, R. & Gray, D. Immunological memory and protective immunity: understanding their relation. Science 272, 54\u201360 (1996).", "journal-title": "Science"}, {"key": "74_CR9", "doi-asserted-by": "crossref", "first-page": "471", "DOI": "10.1016/j.immuni.2016.09.001", "volume": "45", "author": "L Mesin", "year": "2016", "unstructured": "Mesin, L., Ersching, J. & Victora, G. D. Germinal center B cell dynamics. Immunity 45, 471\u2013482 (2016).", "journal-title": "Immunity"}, {"key": "74_CR10", "doi-asserted-by": "crossref", "first-page": "1055", "DOI": "10.1128/CVI.00131-10", "volume": "17", "author": "SA Plotkin", "year": "2010", "unstructured": "Plotkin, S. A. Correlates of protection induced by vaccination. Clin. Vaccine Immunol. 17, 1055\u20131065 (2010).", "journal-title": "Clin. Vaccine Immunol."}, {"key": "74_CR11", "doi-asserted-by": "crossref", "first-page": "915", "DOI": "10.1084/jem.182.4.915", "volume": "182", "author": "MM Epstein", "year": "1995", "unstructured": "Epstein, M. M., Di Rosa, F., Jankovic, D., Sher, A. & Matzinger, P. Successful T cell priming in B cell-deficient mice. J. Exp. Med. 182, 915\u2013922 (1995).", "journal-title": "J. Exp. Med."}, {"key": "74_CR12", "doi-asserted-by": "crossref", "first-page": "1339", "DOI": "10.1084/jem.183.4.1339", "volume": "183", "author": "JA Phillips", "year": "1996", "unstructured": "Phillips, J. A. et al. CD4+ T cell activation and tolerance induction in B cell knockout mice. J. Exp. Med. 183, 1339\u20131344 (1996).", "journal-title": "J. Exp. Med."}, {"key": "74_CR13", "first-page": "2947", "volume": "157", "author": "DJ Topham", "year": "1996", "unstructured": "Topham, D. J., Tripp, R. A., Hamilton-Easton, A. M., Sarawar, S. R. & Doherty, P. C. Quantitative analysis of the influenza virus-specific CD4+ T cell memory in the absence of B cells and Ig. J. Immunol. 157, 2947\u20132952 (1996).", "journal-title": "J. Immunol."}, {"key": "74_CR14", "doi-asserted-by": "crossref", "first-page": "203", "DOI": "10.1016/j.immuni.2006.01.003", "volume": "24", "author": "V Angeli", "year": "2006", "unstructured": "Angeli, V. et al. B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity 24, 203\u2013215 (2006).", "journal-title": "Immunity"}, {"key": "74_CR15", "first-page": "9208", "volume": "72", "author": "D Homann", "year": "1998", "unstructured": "Homann, D. et al. Evidence for an underlying CD4 helper and CD8 T cell defect in B cell-deficient mice: failure to clear persistent virus infection after adoptive immunotherapy with virus-specific memory cells from muMT/muMT mice. J. Virol. 72, 9208\u20139216 (1998).", "journal-title": "J. Virol."}, {"key": "74_CR16", "doi-asserted-by": "crossref", "first-page": "20878", "DOI": "10.1073/pnas.0709205105", "volume": "104", "author": "JD Bouaziz", "year": "2007", "unstructured": "Bouaziz, J. D. et al. Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice. Proc. Natl Acad. Sci. USA 104, 20878\u201320883 (2007).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "74_CR17", "doi-asserted-by": "crossref", "first-page": "1639", "DOI": "10.1084/jem.189.10.1639", "volume": "189", "author": "OT Chan", "year": "1999", "unstructured": "Chan, O. T., Hannum, L. G., Haberman, A. M., Madaio, M. P. & Shlomchik, M. J. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J. Exp. Med. 189, 1639\u20131648 (1999).", "journal-title": "J. Exp. Med."}, {"key": "74_CR18", "doi-asserted-by": "crossref", "first-page": "1575", "DOI": "10.1136/ard.2010.148759", "volume": "70", "author": "K Chatzidionysiou", "year": "2011", "unstructured": "Chatzidionysiou, K. et al. Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries. Ann. Rheum. Dis. 70, 1575\u20131580 (2011).", "journal-title": "Ann. Rheum. Dis."}, {"key": "74_CR19", "doi-asserted-by": "crossref", "first-page": "73", "DOI": "10.1172/JCI5535", "volume": "104", "author": "M Tomana", "year": "1999", "unstructured": "Tomana, M. et al. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J. Clin. Invest. 104, 73\u201381 (1999).", "journal-title": "J. Clin. Invest."}, {"key": "74_CR20", "doi-asserted-by": "crossref", "first-page": "425", "DOI": "10.1016/S0140-6736(85)91147-X", "volume": "1", "author": "FJ Woude van der", "year": "1985", "unstructured": "van der Woude, F. J. et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener\u2019s granulomatosis. Lancet 1, 425\u2013429 (1985).", "journal-title": "Lancet"}, {"key": "74_CR21", "doi-asserted-by": "crossref", "first-page": "74", "DOI": "10.1038/ki.1973.14", "volume": "3", "author": "CB Wilson", "year": "1973", "unstructured": "Wilson, C. B. & Dixon, F. J. Anti-glomerular basement membrane antibody-induced glomerulonephritis. Kidney Int. 3, 74\u201389 (1973).", "journal-title": "Kidney Int."}, {"key": "74_CR22", "doi-asserted-by": "crossref", "first-page": "125", "DOI": "10.1016/j.clindermatol.2003.12.019", "volume": "22", "author": "EE Boh", "year": "2004", "unstructured": "Boh, E. E. Neonatal lupus erythematosus. Clin. Dermatol. 22, 125\u2013128 (2004).", "journal-title": "Clin. Dermatol."}, {"key": "74_CR23", "doi-asserted-by": "crossref", "first-page": "758", "DOI": "10.1053/j.ajkd.2005.01.001", "volume": "45", "author": "DJ Schlieben", "year": "2005", "unstructured": "Schlieben, D. J., Korbet, S. M., Kimura, R. E., Schwartz, M. M. & Lewis, E. J. Pulmonary-renal syndrome in a newborn with placental transmission of ANCAs. Am. J. Kidney Dis. 45, 758\u2013761 (2005).", "journal-title": "Am. J. Kidney Dis."}, {"key": "74_CR24", "doi-asserted-by": "crossref", "first-page": "807", "DOI": "10.1038/nri1702", "volume": "5", "author": "RB Colvin", "year": "2005", "unstructured": "Colvin, R. B. & Smith, R. N. Antibody-mediated organ-allograft rejection. Nat. Rev. Immunol. 5, 807\u2013817 (2005).", "journal-title": "Nat. Rev. Immunol."}, {"key": "74_CR25", "first-page": "348", "volume": "8", "author": "A Loupy", "year": "2012", "unstructured": "Loupy, A., Hill, G. S. & Jordan, S. C. The impact of donor-specific anti-HLA antibodies on late kidney allograft failure. Nat. Rev. Nephrol. 8, 348\u2013357 (2012).", "journal-title": "Nephrology"}, {"key": "74_CR26", "doi-asserted-by": "crossref", "first-page": "115", "DOI": "10.1016/j.smim.2011.09.002", "volume": "24", "author": "RN Smith", "year": "2012", "unstructured": "Smith, R. N. & Colvin, R. B. Chronic alloantibody mediated rejection. Semin. Immunol. 24, 115\u2013121 (2012).", "journal-title": "Semin. Immunol."}, {"key": "74_CR27", "doi-asserted-by": "crossref", "first-page": "1239", "DOI": "10.1097/TP.0b013e3181d72091", "volume": "89", "author": "F Porcheray", "year": "2010", "unstructured": "Porcheray, F. et al. Chronic humoral rejection of human kidney allografts associates with broad autoantibody responses. Transplantation 89, 1239\u20131246 (2010).", "journal-title": "Transplantation"}, {"key": "74_CR28", "doi-asserted-by": "crossref", "first-page": "662", "DOI": "10.1016/S0140-6736(66)92829-7", "volume": "2", "author": "F Kissmeye", "year": "1966", "unstructured": "Kissmeye, F., Olsen, S., Petersen, V. P. & Fjeldborg, O. Hyperacute rejection of kidney allografts associated with pre-existing humoral antibodies against donor cells. Lancet 2, 662\u2013665 (1966).", "journal-title": "Lancet"}, {"key": "74_CR29", "doi-asserted-by": "crossref", "first-page": "293", "DOI": "10.1681/ASN.2014111120", "volume": "27", "author": "C Lefaucheur", "year": "2016", "unstructured": "Lefaucheur, C. et al. IgG donor-specific anti-human HLA antibody subclasses and kidney allograft antibody-mediated injury. J. Am. Soc. Nephrol. 27, 293\u2013304 (2016).", "journal-title": "J. Am. Soc. Nephrol."}, {"key": "74_CR30", "doi-asserted-by": "crossref", "first-page": "520", "DOI": "10.3389/fimmu.2014.00520", "volume": "5", "author": "G Vidarsson", "year": "2014", "unstructured": "Vidarsson, G., Dekkers, G. & Rispens, T. IgG subclasses and allotypes: from structure to effector functions. Front. Immunol. 5, 520 (2014).", "journal-title": "Front. Immunol."}, {"key": "74_CR31", "doi-asserted-by": "crossref", "first-page": "709", "DOI": "10.1016/j.semarthrit.2016.09.011", "volume": "46", "author": "C Wunderlich", "year": "2017", "unstructured": "Wunderlich, C., Oliviera, I., Figueiredo, C. P., Rech, J. & Schett, G. Effects of DMARDs on citrullinated peptide autoantibody levels in RA patients-A longitudinal analysis. Semin. Arthritis Rheum. 46, 709\u2013714 (2017).", "journal-title": "Semin. Arthritis Rheum."}, {"key": "74_CR32", "doi-asserted-by": "crossref", "first-page": "4658", "DOI": "10.1073/pnas.1001074107", "volume": "107", "author": "H Huang", "year": "2010", "unstructured": "Huang, H., Benoist, C. & Mathis, D. Rituximab specifically depletes short-lived autoreactive plasma cells in a mouse model of inflammatory arthritis. Proc.\u00a0Natl Acad. Sci. USA 107, 4658\u20134663 (2010).", "journal-title": "Proc. Natl Acad. Sci. USA"}, {"key": "74_CR33", "doi-asserted-by": "crossref", "first-page": "67", "DOI": "10.1016/j.cellimm.2006.02.005", "volume": "238", "author": "D Rodriguez-Pinto", "year": "2005", "unstructured": "Rodriguez-Pinto, D. B cells as antigen presenting cells. Cell. Immunol. 238, 67\u201375 (2005).", "journal-title": "Cell. Immunol."}, {"key": "74_CR34", "doi-asserted-by": "crossref", "first-page": "280", "DOI": "10.1016/j.clim.2008.01.011", "volume": "127", "author": "SN Liossis", "year": "2008", "unstructured": "Liossis, S. N. & Sfikakis, P. P. Rituximab-induced B cell depletion in autoimmune diseases: potential effects on T cells. Clin. Immunol. 127, 280\u2013285 (2008).", "journal-title": "Clin. Immunol."}, {"key": "74_CR35", "doi-asserted-by": "crossref", "first-page": "7715", "DOI": "10.4049/jimmunol.177.11.7715", "volume": "177", "author": "H Noorchashm", "year": "2006", "unstructured": "Noorchashm, H. et al. B cell-mediated antigen presentation is required for the pathogenesis of acute cardiac allograft rejection. J. Immunol. 177, 7715\u20137722 (2006).", "journal-title": "J. Immunol."}, {"key": "74_CR36", "doi-asserted-by": "crossref", "first-page": "1052", "DOI": "10.1172/JCI70084", "volume": "124", "author": "Q Zeng", "year": "2014", "unstructured": "Zeng, Q. et al. B cells mediate chronic allograft rejection independently of antibody production. J. Clin. Invest. 124, 1052\u20131056 (2014).", "journal-title": "J. Clin. Invest."}, {"key": "74_CR37", "doi-asserted-by": "crossref", "first-page": "477", "DOI": "10.1016/j.kint.2016.10.009", "volume": "91", "author": "KY Shiu", "year": "2017", "unstructured": "Shiu, K. Y. et al. Graft dysfunction in chronic antibody-mediated rejection correlates with B cell-dependent indirect antidonor alloresponses and autocrine regulation of interferon-\u03b3 production by Th1 cells. Kidney Int. 91, 477\u2013492 (2017).", "journal-title": "Kidney Int."}, {"key": "74_CR38", "doi-asserted-by": "crossref", "first-page": "963", "DOI": "10.1093/intimm/dxf064", "volume": "14", "author": "J Yan", "year": "2002", "unstructured": "Yan, J. & Mamula, M. J. B and T cell tolerance and autoimmunity in autoantibody transgenic mice. Int.\u00a0Immunol. 14, 963\u2013971 (2002).", "journal-title": "Int. Immunol."}, {"key": "74_CR39", "doi-asserted-by": "crossref", "first-page": "441", "DOI": "10.1038/nri3857", "volume": "15", "author": "P Shen", "year": "2015", "unstructured": "Shen, P. & Fillatreau, S. Antibody-independent functions of B cells: a focus on cytokines. Nat. Rev. Immunol. 15, 441\u2013451 (2015).", "journal-title": "Nat. Rev. Immunol."}, {"key": "74_CR40", "doi-asserted-by": "crossref", "first-page": "475", "DOI": "10.1038/82717", "volume": "1", "author": "DP Harris", "year": "2000", "unstructured": "Harris, D. P. et al. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat. Immunol. 1, 475\u2013482 (2000). This study is the first to demonstrate that B cells are potent producers of cytokines, which are able to influence T cell responses.", "journal-title": "Nat. Immunol."}, {"key": "74_CR41", "doi-asserted-by": "crossref", "first-page": "421", "DOI": "10.1016/j.immuni.2009.01.006", "volume": "30", "author": "W Wojciechowski", "year": "2009", "unstructured": "Wojciechowski, W. et al. Cytokine-producing effector B cells regulate type 2 immunity to H. polygyrus. Immunity 30, 421\u2013433 (2009).", "journal-title": "Immunity"}, {"key": "74_CR42", "doi-asserted-by": "crossref", "first-page": "1001", "DOI": "10.1084/jem.20111675", "volume": "209", "author": "TA Barr", "year": "2012", "unstructured": "Barr, T. A. et al. B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells. J. Exp. Med. 209, 1001\u20131010 (2012).", "journal-title": "J. Exp. Med."}, {"key": "74_CR43", "doi-asserted-by": "crossref", "first-page": "310ra166", "DOI": "10.1126/scitranslmed.aab4176", "volume": "7", "author": "R Li", "year": "2015", "unstructured": "Li, R. et al. Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy. Sci. Transl Med. 7, 310ra166 (2015).", "journal-title": "Sci. Transl. Med."}, {"key": "74_CR44", "doi-asserted-by": "crossref", "first-page": "477", "DOI": "10.1186/s13075-014-0477-1", "volume": "16", "author": "J Sieber", "year": "2014", "unstructured": "Sieber, J. et al. Active systemic lupus erythematosus is associated with a reduced cytokine production by B cells in response to TLR9 stimulation. Arthritis Res. Ther. 16, 477 (2014).", "journal-title": "Arthritis Res. Ther."}, {"key": "74_CR45", "doi-asserted-by": "crossref", "first-page": "682", "DOI": "10.1038/ki.1993.98", "volume": "43", "author": "IL Noronha", "year": "1993", "unstructured": "Noronha, I. L., Kruger, C., Andrassy, K., Ritz, E. & Waldherr, R. In situ production of TNF-\u03b1, IL-1\u03b2 and IL-2R in ANCA-positive glomerulonephritis. Kidney Int. 43, 682\u2013692 (1993).", "journal-title": "Kidney Int."}, {"key": "74_CR46", "first-page": "5484", "volume": "158", "author": "C Haas", "year": "1997", "unstructured": "Haas, C., Ryffel, B. & LeHir, M. IFN-\u03b3 is essential for the development of autoimmune glomerulonephritis in MRL/lpr mice. J. Immunol. 158, 5484\u20135491 (1997).", "journal-title": "J. Immunol."}, {"key": "74_CR47", "doi-asserted-by": "crossref", "first-page": "603", "DOI": "10.1097/01.ASN.0000113316.52371.2E", "volume": "15", "author": "D Kerjaschki", "year": "2004", "unstructured": "Kerjaschki, D. et al. Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. J. Am. Soc. Nephrol. 15, 603\u2013612 (2004).", "journal-title": "J. Am. Soc. Nephrol."}, {"key": "74_CR48", "doi-asserted-by": "crossref", "first-page": "125", "DOI": "10.1056/NEJMoa035588", "volume": "349", "author": "M Sarwal", "year": "2003", "unstructured": "Sarwal, M. et al. Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N. Engl. J. Med. 349, 125\u2013138 (2003).", "journal-title": "N. Engl. J. Med."}, {"key": "74_CR49", "doi-asserted-by": "crossref", "first-page": "1769", "DOI": "10.1097/01.tp.0000250572.46679.45", "volume": "82", "author": "EW Tsai", "year": "2006", "unstructured": "Tsai, E. W. et al. CD20+ lymphocytes in renal allografts are associated with poor graft survival in pediatric patients. Transplantation 82, 1769\u20131773 (2006).", "journal-title": "Transplantation"}, {"key": "74_CR50", "doi-asserted-by": "crossref", "first-page": "457", "DOI": "10.2353/ajpath.2007.060554", "volume": "170", "author": "F Heller", "year": "2007", "unstructured": "Heller, F. et al. The contribution of B cells to renal interstitial inflammation. Am. J. Pathol. 170, 457\u2013468 (2007).", "journal-title": "Am. J. Pathol."}, {"key": "74_CR51", "doi-asserted-by": "crossref", "first-page": "1728", "DOI": "10.1093/ndt/gfu042", "volume": "29", "author": "Z Hruskova", "year": "2014", "unstructured": "Hruskova, Z. et al. Repeat protocol renal biopsy in ANCA-associated renal vasculitis. Nephrol. Dial. Transplant. 29, 1728\u20131732 (2014).", "journal-title": "Nephrol. Dial Transplant"}, {"key": "74_CR52", "doi-asserted-by": "crossref", "first-page": "221", "DOI": "10.1146/annurev-immunol-020711-074934", "volume": "30", "author": "C Mauri", "year": "2012", "unstructured": "Mauri, C. & Bosma, A. Immune regulatory function of B cells. Annu. Rev. Immunol. 30, 221\u2013241 (2012).", "journal-title": "Annu. Rev. Immunol."}, {"key": "74_CR53", "doi-asserted-by": "crossref", "first-page": "683", "DOI": "10.1016/j.immuni.2016.02.012", "volume": "44", "author": "M Menon", "year": "2016", "unstructured": "Menon, M., Blair, P. A., Isenberg, D. A. & Mauri, C. A. Regulatory feedback between plasmacytoid dendritic cells and regulatory B cells is aberrant in systemic lupus erythematosus. Immunity 44, 683\u2013697 (2016).", "journal-title": "Immunity"}, {"key": "74_CR54", "doi-asserted-by": "crossref", "first-page": "1334", "DOI": "10.1038/nm.3680", "volume": "20", "author": "EC Rosser", "year": "2014", "unstructured": "Rosser, E. C. et al. Regulatory B cells are induced by gut microbiota-driven interleukin-1\u03b2 and interleukin-6 production. Nat. Med. 20, 1334\u20131339 (2014).", "journal-title": "Nat. Med."}, {"key": "74_CR55", "doi-asserted-by": "crossref", "first-page": "264", "DOI": "10.1038/nature11501", "volume": "491", "author": "A Yoshizaki", "year": "2012", "unstructured": "Yoshizaki, A. et al. Regulatory B cells control T cell autoimmunity through IL-21-dependent cognate interactions. Nature 491, 264\u2013268 (2012).", "journal-title": "Nature"}, {"key": "74_CR56", "doi-asserted-by": "crossref", "first-page": "129", "DOI": "10.1016/j.immuni.2009.11.009", "volume": "32", "author": "PA Blair", "year": "2010", "unstructured": "Blair, P. A. et al. CD19+CD24hiCD38hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity 32, 129\u2013140 (2010). This study is the first characterization of human B\n                           reg\u00a0cells in PBMCs.", "journal-title": "Immunity"}, {"key": "74_CR57", "doi-asserted-by": "crossref", "first-page": "530", "DOI": "10.1182/blood-2010-07-294249", "volume": "117", "author": "Y Iwata", "year": "2011", "unstructured": "Iwata, Y. et al. Characterization of a rare IL-10-competent B cell subset in humans that parallels mouse regulatory B10 cells. Blood 117, 530\u2013541 (2011). This study is the first to identify the human equivalent of mouse B10 B\n                           reg cells.", "journal-title": "Blood"}, {"key": "74_CR58", "doi-asserted-by": "crossref", "first-page": "1040", "DOI": "10.1016/j.immuni.2014.10.016", "volume": "41", "author": "M Matsumoto", "year": "2014", "unstructured": "Matsumoto, M. et al. Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation. Immunity 41, 1040\u20131051 (2014). This is the first study to characterize B\n                           reg cells with a plasmablast phenotype.", "journal-title": "Immunity"}, {"key": "74_CR59", "doi-asserted-by": "crossref", "first-page": "944", "DOI": "10.1038/ni833", "volume": "3", "author": "S Fillatreau", "year": "2002", "unstructured": "Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D. & Anderton, S. M. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3, 944\u2013950 (2002).", "journal-title": "Nat. Immunol."}, {"key": "74_CR60", "doi-asserted-by": "crossref", "first-page": "2211", "DOI": "10.1172/JCI78085", "volume": "125", "author": "PR Burkett", "year": "2015", "unstructured": "Burkett, P. R., Meyer zu Horste, G. & Kuchroo, V. K. Pouring fuel on the fire: Th17 cells, the environment, and autoimmunity. J. Clin. Invest. 125, 2211\u20132219 (2015).", "journal-title": "J. Clin. Invest."}, {"key": "74_CR61", "doi-asserted-by": "crossref", "first-page": "703", "DOI": "10.1016/j.immuni.2011.03.016", "volume": "34", "author": "M Matsumoto", "year": "2011", "unstructured": "Matsumoto, M. et al. The calcium sensors STIM1 and STIM2 control B cell regulatory function through interleukin-10 production. Immunity 34, 703\u2013714 (2011).", "journal-title": "Immunity"}, {"key": "74_CR62", "doi-asserted-by": "crossref", "first-page": "489", "DOI": "10.1084/jem.20021293", "volume": "197", "author": "C Mauri", "year": "2003", "unstructured": "Mauri, C., Gray, D., Mushtaq, N. & Londei, M. Prevention of arthritis by interleukin 10-producing B cells. J. Exp. Med. 197, 489\u2013501 (2003).", "journal-title": "J. Exp. Med."}, {"key": "74_CR63", "doi-asserted-by": "crossref", "first-page": "219", "DOI": "10.1016/S1074-7613(02)00274-1", "volume": "16", "author": "A Mizoguchi", "year": "2002", "unstructured": "Mizoguchi, A., Mizoguchi, E., Takedatsu, H., Blumberg, R. S. & Bhan, A. K. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16, 219\u2013230 (2002). This study and references 59 and 62 are the first reports to demonstrate the importance of\u00a0IL-10-producing B cells in the suppression of immune responses.", "journal-title": "Immunity"}, {"key": "74_CR64", "doi-asserted-by": "crossref", "first-page": "3492", "DOI": "10.4049/jimmunol.0803052", "volume": "182", "author": "PA Blair", "year": "2009", "unstructured": "Blair, P. A. et al. Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice. J. Immunol. 182, 3492\u20133502 (2009).", "journal-title": "J. Immunol."}, {"key": "74_CR65", "doi-asserted-by": "crossref", "first-page": "2121", "DOI": "10.1002/eji.201344341", "volume": "44", "author": "BS Liu", "year": "2014", "unstructured": "Liu, B. S., Cao, Y., Huizinga, T. W., Hafler, D. A. & Toes, R. E. TLR-mediated STAT3 and ERK activation controls IL-10 secretion by human B cells. Eur. J. Immunol. 44, 2121\u20132129 (2014).", "journal-title": "Eur. J. Immunol."}, {"key": "74_CR66", "doi-asserted-by": "crossref", "first-page": "4763", "DOI": "10.4049/jimmunol.180.7.4763", "volume": "180", "author": "V Lampropoulou", "year": "2008", "unstructured": "Lampropoulou, V. et al. TLR-activated B cells suppress T cell-mediated autoimmunity. J. Immunol. 180, 4763\u20134773 (2008).", "journal-title": "J. Immunol."}, {"key": "74_CR67", "doi-asserted-by": "crossref", "first-page": "1081", "DOI": "10.4049/jimmunol.167.2.1081", "volume": "167", "author": "J Tian", "year": "2001", "unstructured": "Tian, J. et al. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J. Immunol. 167, 1081\u20131089 (2001).", "journal-title": "J. Immunol."}, {"key": "74_CR68", "doi-asserted-by": "crossref", "first-page": "5569", "DOI": "10.4049/jimmunol.1100284", "volume": "186", "author": "NA Carter", "year": "2011", "unstructured": "Carter, N. A. et al. Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J.\u00a0Immunol. 186, 5569\u20135579 (2011).", "journal-title": "J. Immunol."}, {"key": "74_CR69", "doi-asserted-by": "crossref", "first-page": "R32", "DOI": "10.1186/ar3736", "volume": "14", "author": "NA Carter", "year": "2012", "unstructured": "Carter, N. A., Rosser, E. C. & Mauri, C. Interleukin-10 produced by B cells is crucial for the suppression of Th17/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis. Arthritis Res. Ther. 14, R32 (2012).", "journal-title": "Arthritis Res. Ther."}, {"key": "74_CR70", "doi-asserted-by": "crossref", "first-page": "8278", "DOI": "10.4049/jimmunol.181.12.8278", "volume": "181", "author": "JB Sun", "year": "2008", "unstructured": "Sun, J. B., Flach, C. F., Czerkinsky, C. & Holmgren, J. B lymphocytes promote expansion of regulatory T cells in oral tolerance: powerful induction by antigen coupled to cholera toxin B subunit. J. Immunol. 181, 8278\u20138287 (2008).", "journal-title": "J. Immunol."}, {"key": "74_CR71", "doi-asserted-by": "crossref", "first-page": "609", "DOI": "10.1007/s00262-011-0972-z", "volume": "60", "author": "T Tadmor", "year": "2011", "unstructured": "Tadmor, T., Zhang, Y., Cho, H. M., Podack, E. R. & Rosenblatt, J. D. The absence of B lymphocytes reduces the number and function of T-regulatory cells and enhances the anti-tumor response in a murine tumor model. Cancer Immunol. Immunother. 60, 609\u2013619 (2011).", "journal-title": "Cancer Immunol. Immunother."}, {"key": "74_CR72", "doi-asserted-by": "crossref", "first-page": "366", "DOI": "10.1038/nature12979", "volume": "507", "author": "P Shen", "year": "2014", "unstructured": "Shen, P. et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature 507, 366\u2013370 (2014).", "journal-title": "Nature"}, {"key": "74_CR73", "doi-asserted-by": "crossref", "first-page": "633", "DOI": "10.1038/nm.3554", "volume": "20", "author": "RX Wang", "year": "2014", "unstructured": "Wang, R. X. et al. Interleukin-35 induces regulatory B cells that suppress autoimmune disease. Nat. Med. 20, 633\u2013641 (2014).", "journal-title": "Nat. Med."}, {"key": "74_CR74", "doi-asserted-by": "crossref", "first-page": "477", "DOI": "10.1016/j.immuni.2012.02.008", "volume": "36", "author": "A Bosma", "year": "2012", "unstructured": "Bosma, A., Abdel-Gadir, A., Isenberg, D. A., Jury, E. C. & Mauri, C. Lipid-antigen presentation by CD1d+ B cells is essential for the maintenance of invariant natural killer T cells. Immunity 36, 477\u2013490 (2012).", "journal-title": "Immunity"}, {"key": "74_CR75", "doi-asserted-by": "crossref", "first-page": "173ra23", "DOI": "10.1126/scitranslmed.3005407", "volume": "5", "author": "F Flores-Borja", "year": "2013", "unstructured": "Flores-Borja, F. et al. CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. Sci. Transl Med. 5, 173ra23 (2013).", "journal-title": "Sci. Transl. Med."}, {"key": "74_CR76", "doi-asserted-by": "crossref", "first-page": "80", "DOI": "10.1016/j.jneuroim.2011.08.019", "volume": "239", "author": "S Knippenberg", "year": "2011", "unstructured": "Knippenberg, S. et al. Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naive/memory Breg ratio during a relapse but not in remission. J. Neuroimmunol. 239, 80\u201386 (2011).", "journal-title": "J Neuroimmunol."}, {"key": "74_CR77", "doi-asserted-by": "crossref", "first-page": "93", "DOI": "10.1016/j.jdermsci.2015.11.003", "volume": "81", "author": "M Hayashi", "year": "2016", "unstructured": "Hayashi, M. et al. IL-10-producing regulatory B cells are decreased in patients with psoriasis. J. Dermatol. Sci. 81, 93\u2013100 (2016).", "journal-title": "J. Dermatol. Sci."}, {"key": "74_CR78", "doi-asserted-by": "crossref", "first-page": "772", "DOI": "10.1172/JCI85113", "volume": "127", "author": "C Mauri", "year": "2017", "unstructured": "Mauri, C. & Menon, M. Human regulatory B cells in health and disease: therapeutic potential. J. Clin. Invest. 127, 772\u2013779 (2017).", "journal-title": "J. Clin. Invest."}, {"key": "74_CR79", "author": "NS Barsotti", "volume": "11", "year": "2016", "unstructured": "Barsotti, N. S. et al. IL-10-producing regulatory B cells are decreased in patients with common variable immunodeficiency. PLOS ONE 11, e0151761 (2016).", "journal-title": "PLOS ONE", "DOI": "10.1371/journal.pone.0151761", "doi-asserted-by": "crossref"}, {"key": "74_CR80", "doi-asserted-by": "crossref", "first-page": "53", "DOI": "10.1016/j.jaut.2015.02.004", "volume": "59", "author": "A Nouel", "year": "2015", "unstructured": "Nouel, A. et al. B-cells induce regulatory T cells through TGF-\u03b2/IDO production in a CTLA-4 dependent manner. J. Autoimmun. 59, 53\u201360 (2015).", "journal-title": "J. Autoimmun"}, {"key": "74_CR81", "author": "AR Khan", "volume": "6", "year": "2015", "unstructured": "Khan, A. R. et al. PD-L1hi B cells are critical regulators of humoral immunity. Nat. Commun. 6, 5997 (2015).", "journal-title": "Nat. Commun."}, {"key": "74_CR82", "doi-asserted-by": "crossref", "first-page": "670", "DOI": "10.1016/j.autrev.2011.11.018", "volume": "11", "author": "A Kessel", "year": "2012", "unstructured": "Kessel, A. et al. Human CD19+CD25high B regulatory cells suppress proliferation of CD4+ T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells. Autoimmun. Rev. 11, 670\u2013677 (2012).", "journal-title": "Autoimmun Rev."}, {"key": "74_CR83", "doi-asserted-by": "crossref", "first-page": "1204", "DOI": "10.1016/j.jaci.2013.01.014", "volume": "131", "author": "W Veen van de", "year": "2013", "unstructured": "van de Veen, W. et al. IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses. J. Allergy Clin. Immunol. 131, 1204\u20131212 (2013).", "journal-title": "J. Allergy Clin. Immunol."}, {"key": "74_CR84", "doi-asserted-by": "crossref", "first-page": "2468", "DOI": "10.1158/0008-5472.CAN-12-3450", "volume": "73", "author": "S Lindner", "year": "2013", "unstructured": "Lindner, S. et al. Interleukin 21-induced granzyme B-expressing B cells infiltrate tumors and regulate T cells. Cancer Res. 73, 2468\u20132479 (2013).", "journal-title": "Cancer Res."}, {"key": "74_CR85", "doi-asserted-by": "crossref", "first-page": "1114", "DOI": "10.1016/j.jaci.2010.01.018", "volume": "125", "author": "S Amu", "year": "2010", "unstructured": "Amu, S. et al. Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model. J. Allergy Clin. Immunol. 125, 1114\u20131124.e8 (2010).", "journal-title": "J. Allergy Clin. Immunol."}, {"key": "74_CR86", "doi-asserted-by": "crossref", "first-page": "263", "DOI": "10.1016/j.cyto.2010.11.001", "volume": "53", "author": "J Novak", "year": "2011", "unstructured": "Novak, J. & Lehuen, A. Mechanism of regulation of autoimmunity by iNKT cells. Cytokine 53, 263\u2013270 (2011).", "journal-title": "Cytokine"}, {"key": "74_CR87", "author": "K Oleinika", "volume": "9", "year": "2018", "unstructured": "Oleinika, K. et al. CD1d-dependent immune suppression mediated by regulatory B cells through modulations of iNKT cells. Nat. Commun. 9, 684 (2018).", "journal-title": "Nat. Commun.", "DOI": "10.1038/s41467-018-02911-y", "doi-asserted-by": "crossref"}, {"key": "74_CR88", "doi-asserted-by": "crossref", "first-page": "332", "DOI": "10.2215/CJN.05000516", "volume": "12", "author": "M Vivarelli", "year": "2017", "unstructured": "Vivarelli, M., Massella, L., Ruggiero, B. & Emma, F. Minimal change disease. Clin. J. Am. Soc. Nephrol. 12, 332\u2013345 (2017).", "journal-title": "Clin. J. Am. Soc. Nephrol."}, {"key": "74_CR89", "doi-asserted-by": "crossref", "first-page": "465", "DOI": "10.3858/emm.2012.44.8.053", "volume": "44", "author": "KW Kim", "year": "2012", "unstructured": "Kim, K. W. et al. B cell-associated immune profiles in patients with end-stage renal disease (ESRD). Exp. Mol. Med. 44, 465\u2013472 (2012).", "journal-title": "Exp. Mol. Med."}, {"key": "74_CR90", "doi-asserted-by": "crossref", "first-page": "1836", "DOI": "10.1172/JCI39933", "volume": "120", "author": "KA Newell", "year": "2010", "unstructured": "Newell, K. A. et al. Identification of a B cell signature associated with renal transplant tolerance in humans. J. Clin. Invest. 120, 1836\u20131847 (2010).", "journal-title": "J. Clin. Invest."}, {"key": "74_CR91", "doi-asserted-by": "crossref", "first-page": "1848", "DOI": "10.1172/JCI39922", "volume": "120", "author": "P Sagoo", "year": "2010", "unstructured": "Sagoo, P. et al. Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J. Clin. Invest. 120, 1848\u20131861 (2010).", "journal-title": "J. Clin. Invest."}, {"key": "74_CR92", "doi-asserted-by": "crossref", "first-page": "497", "DOI": "10.3389/fimmu.2013.00497", "volume": "4", "author": "M Chesneau", "year": "2013", "unstructured": "Chesneau, M., Michel, L., Degauque, N. & Brouard, S. Regulatory B cells and tolerance in transplantation: from animal models to human. Front. Immunol. 4, 497 (2013).", "journal-title": "Front. Immunol."}, {"key": "74_CR93", "doi-asserted-by": "crossref", "first-page": "2588", "DOI": "10.1681/ASN.2014040404", "volume": "26", "author": "M Chesneau", "year": "2015", "unstructured": "Chesneau, M. et al. Tolerant kidney transplant patients produce B cells with regulatory properties. J. Am. Soc. Nephrol. 26, 2588\u20132598 (2015).", "journal-title": "J. Am. Soc. Nephrol."}, {"key": "74_CR94", "doi-asserted-by": "crossref", "first-page": "3443", "DOI": "10.1111/ajt.13932", "volume": "16", "author": "I Rebollo-Mesa", "year": "2016", "unstructured": "Rebollo-Mesa, I. et al. Biomarkers of tolerance in kidney transplantation: are we predicting tolerance or response to immunosuppressive treatment? Am. J. Transplant. 16, 3443\u20133457 (2016).", "journal-title": "Am. J. Transplant"}, {"key": "74_CR95", "doi-asserted-by": "crossref", "first-page": "1916", "DOI": "10.1111/j.1600-6143.2011.03638.x", "volume": "11", "author": "JJ Lozano", "year": "2011", "unstructured": "Lozano, J. J. et al. Comparison of transcriptional and blood cell-phenotypic markers between operationally tolerant liver and kidney recipients. Am. J. Transplant. 11, 1916\u20131926 (2011).", "journal-title": "Am. J. Transplant"}, {"key": "74_CR96", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/j.trim.2016.01.004", "volume": "35", "author": "I Latorre", "year": "2016", "unstructured": "Latorre, I. et al. Calcineurin and mTOR inhibitors have opposing effects on regulatory T cells while reducing regulatory B cell populations in kidney transplant recipients. Transpl. Immunol. 35, 1\u20136 (2016).", "journal-title": "Transpl. Immunol."}, {"key": "74_CR97", "doi-asserted-by": "crossref", "first-page": "1384", "DOI": "10.1111/ajt.13122", "volume": "15", "author": "S Shabir", "year": "2015", "unstructured": "Shabir, S. et al. Transitional B lymphocytes are associated with protection from kidney allograft rejection: a prospective study. Am. J. Transplant. 15, 1384\u20131391 (2015).", "journal-title": "Am. J. Transplant"}, {"key": "74_CR98", "author": "B Tebbe", "volume": "11", "year": "2016", "unstructured": "Tebbe, B. et al. Renal transplant recipients treated with calcineurin-inhibitors lack circulating immature transitional CD19+CD24hiCD38hi regulatory B-lymphocytes. PLOS ONE 11, e0153170 (2016).", "journal-title": "PLOS ONE", "DOI": "10.1371/journal.pone.0153170", "doi-asserted-by": "crossref"}, {"key": "74_CR99", "doi-asserted-by": "crossref", "first-page": "542", "DOI": "10.1111/ajt.14013", "volume": "17", "author": "HA Schlosser", "year": "2017", "unstructured": "Schlosser, H. A. et al. Prospective analyses of circulating B cell subsets in ABO-compatible and ABO-incompatible kidney transplant recipients. Am.\u00a0J.\u00a0Transplant. 17, 542\u2013550 (2017).", "journal-title": "Am. J. Transplant"}, {"key": "74_CR100", "doi-asserted-by": "crossref", "first-page": "1575", "DOI": "10.1681/ASN.2013080837", "volume": "25", "author": "A Cherukuri", "year": "2014", "unstructured": "Cherukuri, A. et al. Immunologic human renal allograft injury associates with an altered IL-10/TNF-\u03b1 expression ratio in regulatory B cells. J. Am. Soc. Nephrol. 25, 1575\u20131585 (2014). This study identified the cytokine profile of B\n                           reg cells as a potential biomarker of allograft function in renal transplantation.", "journal-title": "J. Am. Soc. Nephrol."}, {"key": "74_CR101", "doi-asserted-by": "crossref", "first-page": "919", "DOI": "10.1111/j.1600-6143.2011.03891.x", "volume": "12", "author": "A Cherukuri", "year": "2012", "unstructured": "Cherukuri, A. et al. An analysis of lymphocyte phenotype after steroid avoidance with either alemtuzumab or basiliximab induction in renal transplantation. Am. J. Transplant. 12, 919\u2013931 (2012).", "journal-title": "Am. J. Transplant"}, {"key": "74_CR102", "doi-asserted-by": "crossref", "first-page": "2683", "DOI": "10.1056/NEJMc0808481", "volume": "360", "author": "MR Clatworthy", "year": "2009", "unstructured": "Clatworthy, M. R. et al. B cell-depleting induction therapy and acute cellular rejection. N. Engl. J. Med. 360, 2683\u20132685 (2009).", "journal-title": "N. Engl. J. Med."}, {"key": "74_CR103", "doi-asserted-by": "crossref", "first-page": "563", "DOI": "10.1111/tri.12072", "volume": "26", "author": "AN Barnett", "year": "2013", "unstructured": "Barnett, A. N., Hadjianastassiou, V. G. & Mamode, N. Rituximab in renal transplantation. Transpl. Int. 26, 563\u2013575 (2013).", "journal-title": "Transpl. Int."}, {"key": "74_CR104", "doi-asserted-by": "crossref", "first-page": "1325", "DOI": "10.1097/TP.0b013e3181a235fd", "volume": "87", "author": "G Tyden", "year": "2009", "unstructured": "Tyden, G. et al. A randomized, doubleblind, placebo-controlled, study of single-dose rituximab as induction in renal transplantation. Transplantation 87, 1325\u20131329 (2009).", "journal-title": "Transplantation"}, {"key": "74_CR105", "doi-asserted-by": "crossref", "first-page": "i123", "DOI": "10.1093/ndt/gfv076", "volume": "30", "author": "JG McGregor", "year": "2015", "unstructured": "McGregor, J. G. et al. Rituximab as an immunosuppressant in antineutrophil cytoplasmic antibody-associated vasculitis. Nephrol. Dial. Transplant. 30 (Suppl. 1), i123\u2013i131 (2015).", "journal-title": "Nephrol. Dial Transplant"}, {"key": "74_CR106", "doi-asserted-by": "crossref", "first-page": "448", "DOI": "10.1038/ki.2008.191", "volume": "74", "author": "OM Steinmetz", "year": "2008", "unstructured": "Steinmetz, O. M. et al. Analysis and classification of B cell infiltrates in lupus and ANCA-associated nephritis. Kidney Int. 74, 448\u2013457 (2008).", "journal-title": "Kidney Int."}, {"key": "74_CR107", "doi-asserted-by": "crossref", "first-page": "3030", "DOI": "10.1093/ndt/gfn318", "volume": "23", "author": "AJ Ferraro", "year": "2008", "unstructured": "Ferraro, A. J., Smith, S. W., Neil, D. & Savage, C. O. Relapsed Wegener\u2019s granulomatosis after rituximab therapy \u2014 B cells are present in new pathological lesions despite persistent \u2018depletion\u2019 of peripheral blood. Nephrol. Dial. Transplant. 23, 3030\u20133032 (2008).", "journal-title": "Nephrol. Dial. Transplant."}, {"key": "74_CR108", "doi-asserted-by": "crossref", "first-page": "2086", "DOI": "10.3899/jrheum.100074", "volume": "37", "author": "P Eriksson", "year": "2010", "unstructured": "Eriksson, P., Sandell, C., Backteman, K. & Ernerudh, J. B cell abnormalities in Wegener\u2019s granulomatosis and microscopic polyangiitis: role of CD25+-expressing B cells. J. Rheumatol. 37, 2086\u20132095 (2010).", "journal-title": "J. Rheumatol."}, {"key": "74_CR109", "doi-asserted-by": "crossref", "first-page": "1683", "DOI": "10.1093/rheumatology/keu149", "volume": "53", "author": "N Lepse", "year": "2014", "unstructured": "Lepse, N. et al. Altered B cell balance, but unaffected B cell capacity to limit monocyte activation in anti-neutrophil cytoplasmic antibody-associated vasculitis in remission. Rheumatology 53, 1683\u20131692 (2014).", "journal-title": "Rheumatology"}, {"key": "74_CR110", "doi-asserted-by": "crossref", "first-page": "1693", "DOI": "10.1093/rheumatology/keu136", "volume": "53", "author": "SK Todd", "year": "2014", "unstructured": "Todd, S. K. et al. Regulatory B cells are numerically but not functionally deficient in anti-neutrophil cytoplasm antibody-associated vasculitis. Rheumatology (Oxford) 53, 1693\u20131703 (2014).", "journal-title": "Rheumatology (Oxford)"}, {"key": "74_CR111", "doi-asserted-by": "crossref", "first-page": "1416", "DOI": "10.1136/annrheumdis-2012-202986", "volume": "72", "author": "B Wilde", "year": "2013", "unstructured": "Wilde, B. et al. Regulatory B cells in ANCA-associated vasculitis. Ann. Rheum. Dis. 72, 1416\u20131419 (2013).", "journal-title": "Ann. Rheum. Dis."}, {"key": "74_CR112", "doi-asserted-by": "crossref", "first-page": "1066", "DOI": "10.1053/j.ajkd.2013.11.029", "volume": "63", "author": "B Wilde", "year": "2014", "unstructured": "Wilde, B., Witzke, O. & Cohen Tervaert, J. W. Rituximab and B cell return in ANCA-associated vasculitis. Am. J. Kidney Dis. 63, 1066 (2014).", "journal-title": "Am. J. Kidney Dis."}, {"key": "74_CR113", "doi-asserted-by": "crossref", "first-page": "4537", "DOI": "10.1182/blood-2002-05-1525", "volume": "100", "author": "H Gary-Gouy", "year": "2002", "unstructured": "Gary-Gouy, H. et al. Human CD5 promotes B cell survival through stimulation of autocrine IL-10 production. Blood 100, 4537\u20134543 (2002).", "journal-title": "Blood"}, {"key": "74_CR114", "doi-asserted-by": "crossref", "first-page": "382", "DOI": "10.2215/CJN.03950412", "volume": "8", "author": "DO Bunch", "year": "2013", "unstructured": "Bunch, D. O. et al. Decreased CD5+ B cells in active ANCA vasculitis and relapse after rituximab. Clin. J. Am. Soc. Nephrol. 8, 382\u2013391 (2013).", "journal-title": "Clin. J. Am. Soc. Nephrol."}, {"key": "74_CR115", "doi-asserted-by": "crossref", "first-page": "1784", "DOI": "10.1136/annrheumdis-2014-206756", "volume": "74", "author": "DO Bunch", "year": "2015", "unstructured": "Bunch, D. O. et al. Gleaning relapse risk from B cell phenotype: decreased CD5+ B cells portend a shorter time to relapse after B cell depletion in patients with ANCA-associated vasculitis. Ann. Rheum. Dis. 74, 1784\u20131786 (2015).", "journal-title": "Ann. Rheum. Dis."}, {"key": "74_CR116", "doi-asserted-by": "crossref", "first-page": "535", "DOI": "10.1002/art.38916", "volume": "67", "author": "S Unizony", "year": "2015", "unstructured": "Unizony, S. et al. Peripheral CD5+ B cells in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatol. 67, 535\u2013544 (2015).", "journal-title": "Arthritis Rheumatol."}, {"key": "74_CR117", "doi-asserted-by": "crossref", "first-page": "929", "DOI": "10.1056/NEJMra071297", "volume": "358", "author": "A Rahman", "year": "2008", "unstructured": "Rahman, A. & Isenberg, D. A. Systemic lupus erythematosus. N. Engl. J. Med. 358, 929\u2013939 (2008).", "journal-title": "N. Engl. J. Med."}, {"key": "74_CR118", "doi-asserted-by": "crossref", "first-page": "496", "DOI": "10.1002/art.40396", "volume": "70", "author": "S Karrar", "year": "2018", "unstructured": "Karrar, S. & Cunninghame Graham, D. S. Abnormal B cell development in systemic lupus erythematosus: what the genetics tell us. Arthritis Rheumatol. 70, 496\u2013507 (2018).", "journal-title": "Arthritis Rheumatol"}, {"key": "74_CR119", "doi-asserted-by": "crossref", "first-page": "222", "DOI": "10.1002/art.27233", "volume": "62", "author": "JT Merrill", "year": "2010", "unstructured": "Merrill, J. T. et al. Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial. Arthritis Rheum. 62, 222\u2013233 (2010).", "journal-title": "Arthritis Rheum."}, {"key": "74_CR120", "doi-asserted-by": "crossref", "first-page": "1215", "DOI": "10.1002/art.34359", "volume": "64", "author": "BH Rovin", "year": "2012", "unstructured": "Rovin, B. H. et al. Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study. Arthritis Rheum. 64, 1215\u20131226 (2012).", "journal-title": "Arthritis Rheum."}, {"key": "74_CR121", "doi-asserted-by": "crossref", "first-page": "S2", "DOI": "10.1186/ar3910", "volume": "15", "author": "V Reddy", "year": "2013", "unstructured": "Reddy, V., Jayne, D., Close, D. & Isenberg, D. B cell depletion in SLE: clinical and trial experience with rituximab and ocrelizumab and implications for study design. Arthritis Res. Ther. 15 (Suppl.1), S2 (2013).", "journal-title": "Arthritis Res. Ther."}, {"key": "74_CR122", "doi-asserted-by": "crossref", "first-page": "1833", "DOI": "10.1136/annrheumdis-2011-200831", "volume": "71", "author": "S Manzi", "year": "2012", "unstructured": "Manzi, S. et al. Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials. Ann. Rheum. Dis. 71, 1833\u20131838 (2012).", "journal-title": "Ann. Rheum. Dis."}, {"key": "74_CR123", "doi-asserted-by": "crossref", "first-page": "667", "DOI": "10.1080/1744666X.2017.1259068", "volume": "13", "author": "P Mota", "year": "2017", "unstructured": "Mota, P., Reddy, V. & Isenberg, D. Improving B cell depletion in systemic lupus erythematosus and rheumatoid arthritis. Expert Rev. Clin. Immunol. 13, 667\u2013676 (2017).", "journal-title": "Expert Rev. Clin. Immunol."}, {"key": "74_CR124", "doi-asserted-by": "crossref", "first-page": "312", "DOI": "10.3109/03009742.2015.1126346", "volume": "45", "author": "K Heinemann", "year": "2016", "unstructured": "Heinemann, K. et al. Decreased IL-10+ regulatory B cells (Bregs) in lupus nephritis patients. Scand. J.\u00a0Rheumatol. 45, 312\u2013316 (2016).", "journal-title": "Scand. J. Rheumatol"}, {"key": "74_CR125", "doi-asserted-by": "crossref", "first-page": "190", "DOI": "10.1186/s13075-015-0687-1", "volume": "17", "author": "JH Sim", "year": "2015", "unstructured": "Sim, J. H. et al. Autoregulatory function of interleukin-10-producing pre-naive B cells is defective in systemic lupus erythematosus. Arthritis Res. Ther. 17, 190 (2015).", "journal-title": "Arthritis Res. Ther."}, {"key": "74_CR126", "author": "S Wang", "volume": "9", "year": "2018", "unstructured": "Wang, S. et al. IL-21 drives expansion and plasma cell differentiation of autoreactive CD11chiT-bet+ B cells in SLE. Nat. Commun. 9, 1758 (2018).", "journal-title": "Nat. Commun."}, {"key": "74_CR127", "doi-asserted-by": "crossref", "first-page": "1127", "DOI": "10.1002/1529-0131(200105)44:5<1127::AID-ANR194>3.0.CO;2-W", "volume": "44", "author": "S Kojo", "year": "2001", "unstructured": "Kojo, S., Adachi, Y., Keino, H., Taniguchi, M. & Sumida, T. Dysfunction of T cell receptor AV24AJ18+, BV11+ double-negative regulatory natural killer T cells in autoimmune diseases. Arthritis Rheum. 44, 1127\u20131138 (2001).", "journal-title": "Arthritis Rheum."}, {"key": "74_CR128", "doi-asserted-by": "crossref", "first-page": "303", "DOI": "10.1002/art.22326", "volume": "56", "author": "MR Green", "year": "2007", "unstructured": "Green, M. R. et al. Natural killer T cells in families of patients with systemic lupus erythematosus: their possible role in regulation of IGG production. Arthritis Rheum. 56, 303\u2013310 (2007).", "journal-title": "Arthritis Rheum."}, {"key": "74_CR129", "doi-asserted-by": "crossref", "first-page": "1054", "DOI": "10.1093/rheumatology/keq457", "volume": "50", "author": "YN Cho", "year": "2011", "unstructured": "Cho, Y. N. et al. Numerical and functional deficiencies of natural killer T cells in systemic lupus erythematosus: their deficiency related to disease activity. Rheumatology 50, 1054\u20131063 (2011).", "journal-title": "Rheumatology"}, {"key": "74_CR130", "doi-asserted-by": "crossref", "first-page": "225", "DOI": "10.1016/S1074-7613(03)00208-5", "volume": "19", "author": "G Jego", "year": "2003", "unstructured": "Jego, G. et al. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 19, 225\u2013234 (2003).", "journal-title": "Immunity"}, {"key": "74_CR131", "doi-asserted-by": "crossref", "first-page": "3058", "DOI": "10.1182/blood-2003-08-2972", "volume": "103", "author": "H Poeck", "year": "2004", "unstructured": "Poeck, H. et al. Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T cell help. Blood 103, 3058\u20133064 (2004).", "journal-title": "Blood"}, {"key": "74_CR132", "doi-asserted-by": "crossref", "first-page": "185", "DOI": "10.1186/s13075-015-0686-2", "volume": "17", "author": "V Fleischer", "year": "2015", "unstructured": "Fleischer, V. et al. Epratuzumab inhibits the production of the proinflammatory cytokines IL-6 and TNF-alpha, but not the regulatory cytokine IL-10, by B cells from healthy donors and SLE patients. Arthritis Res. Ther. 17, 185 (2015).", "journal-title": "Arthritis Res. Ther."}, {"key": "74_CR133", "doi-asserted-by": "crossref", "first-page": "3044", "DOI": "10.1002/art.22810", "volume": "56", "author": "JH Anolik", "year": "2007", "unstructured": "Anolik, J. H. et al. Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy. Arthritis Rheum. 56, 3044\u20133056 (2007).", "journal-title": "Arthritis Rheum."}, {"key": "74_CR134", "doi-asserted-by": "crossref", "first-page": "1000", "DOI": "10.1093/rheumatology/kev438", "volume": "55", "author": "ZS Wallace", "year": "2016", "unstructured": "Wallace, Z. S. et al. Predictors of disease relapse in IgG4-related disease following rituximab. Rheumatology 55, 1000\u20131008 (2016).", "journal-title": "Rheumatology"}, {"key": "74_CR135", "doi-asserted-by": "crossref", "first-page": "1158", "DOI": "10.1053/j.ajkd.2008.07.011", "volume": "52", "author": "M Collins", "year": "2008", "unstructured": "Collins, M. et al. Rituximab treatment of fibrillary glomerulonephritis. Am. J. Kidney Dis. 52, 1158\u20131162 (2008).", "journal-title": "Am. J. Kidney Dis."}, {"key": "74_CR136", "doi-asserted-by": "crossref", "first-page": "109", "DOI": "10.1002/art.40339", "volume": "70", "author": "F Maritati", "year": "2018", "unstructured": "Maritati, F. et al. Brief Report: Rituximab for the treatment of adult-onset IgA Vasculitis (Henoch-Schonlein). Arthritis Rheumatol. 70, 109\u2013114 (2018).", "journal-title": "Arthritis Rheumatol"}, {"key": "74_CR137", "author": "E Comstock", "volume": "12", "year": "2017", "unstructured": "Comstock, E. et al. Transcriptional profiling of PBMCs unravels B cell mediated immunopathogenic imprints of HCV vasculitis. PLOS ONE 12, e0188314 (2017).", "journal-title": "PLOS ONE", "DOI": "10.1371/journal.pone.0188314", "doi-asserted-by": "crossref"}, {"key": "74_CR138", "doi-asserted-by": "crossref", "first-page": "2052", "DOI": "10.1053/j.gastro.2017.02.037", "volume": "152", "author": "C Comarmond", "year": "2017", "unstructured": "Comarmond, C. et al. Direct-acting antiviral therapy restores immune tolerance to patients with hepatitis C virus-induced cryoglobulinemia vasculitis. Gastroenterology 152, 2052\u20132062.e2 (2017).", "journal-title": "Gastroenterology"}, {"key": "74_CR139", "doi-asserted-by": "crossref", "first-page": "R118", "DOI": "10.1186/ar4571", "volume": "16", "author": "W Lin", "year": "2014", "unstructured": "Lin, W. et al. B cell subsets and dysfunction of regulatory B cells in IgG4-related diseases and primary Sjogren\u2019s syndrome: the similarities and differences. Arthritis Res. Ther. 16, R118 (2014).", "journal-title": "Arthritis Res. Ther."}, {"key": "74_CR140", "doi-asserted-by": "crossref", "first-page": "190", "DOI": "10.1136/annrheumdis-2014-205233", "volume": "74", "author": "ZS Wallace", "year": "2015", "unstructured": "Wallace, Z. S. et al. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann. Rheum. Dis. 74, 190\u2013195 (2015).", "journal-title": "Ann. Rheum. Dis."}, {"key": "74_CR141", "doi-asserted-by": "crossref", "first-page": "51", "DOI": "10.1111/sji.12128", "volume": "79", "author": "YY Wang", "year": "2014", "unstructured": "Wang, Y. Y. et al. Functional implications of regulatory B cells in human IgA nephropathy. Scand. J. Immunol. 79, 51\u201360 (2014).", "journal-title": "Scand. J. Immunol."}, {"key": "74_CR142", "doi-asserted-by": "crossref", "first-page": "1306", "DOI": "10.1681/ASN.2016060640", "volume": "28", "author": "RA Lafayette", "year": "2017", "unstructured": "Lafayette, R. A. et al. A randomized, controlled trial of rituximab in IgA nephropathy with proteinuria and renal dysfunction. J. Am. Soc. Nephrol. 28, 1306\u20131313 (2017).", "journal-title": "J. Am. Soc. Nephrol."}, {"key": "74_CR143", "doi-asserted-by": "crossref", "first-page": "348", "DOI": "10.1681/ASN.2016040449", "volume": "28", "author": "K Dahan", "year": "2017", "unstructured": "Dahan, K. et al. Rituximab for severe membranous nephropathy: a 6-month trial with extended follow-up. J. Am. Soc. Nephrol. 28, 348\u2013358 (2017).", "journal-title": "J. Am. Soc. Nephrol."}, {"key": "74_CR144", "doi-asserted-by": "crossref", "first-page": "227", "DOI": "10.1016/j.kint.2017.01.012", "volume": "92", "author": "M Rosenzwajg", "year": "2017", "unstructured": "Rosenzwajg, M. et al. B- and T-cell subpopulations in patients with severe idiopathic membranous nephropathy may predict an early response to rituximab. Kidney Int. 92, 227\u2013237 (2017).", "journal-title": "Kidney Int."}, {"key": "74_CR145", "doi-asserted-by": "crossref", "first-page": "2729", "DOI": "10.1681/ASN.2016091022", "volume": "28", "author": "J Brand van den", "year": "2017", "unstructured": "van den Brand, J. et al. Safety of rituximab compared with steroids and cyclophosphamide for idiopathic membranous nephropathy. J. Am. Soc. Nephrol. 28, 2729\u20132737 (2017).", "journal-title": "J. Am. Soc. Nephrol."}, {"key": "74_CR146", "doi-asserted-by": "crossref", "first-page": "1811", "DOI": "10.1681/ASN.2015050523", "volume": "27", "author": "M Colucci", "year": "2016", "unstructured": "Colucci, M. et al. B cell reconstitution after rituximab treatment in idiopathic nephrotic syndrome. J. Am. Soc. Nephrol. 27, 1811\u20131822 (2016).", "journal-title": "J. Am. Soc. Nephrol."}, {"key": "74_CR147", "doi-asserted-by": "crossref", "first-page": "81836", "DOI": "10.1172/jci.insight.81836", "volume": "2", "author": "AH Kim", "year": "2017", "unstructured": "Kim, A. H. et al. B cell-derived IL-4 acts on podocytes to induce proteinuria and foot process effacement. JCI\u00a0Insight 2, 81836 (2017).", "journal-title": "JCI Insight"}, {"key": "74_CR148", "doi-asserted-by": "crossref", "first-page": "199", "DOI": "10.1007/s004670050592", "volume": "13", "author": "BS Cho", "year": "1999", "unstructured": "Cho, B. S., Yoon, S. R., Jang, J. Y., Pyun, K. H. & Lee, C. E. Up-regulation of interleukin-4 and CD23/Fc\u03b5RII in minimal change nephrotic syndrome. Pediatr. Nephrol. 13, 199\u2013204 (1999).", "journal-title": "Pediatr. Nephrol."}, {"key": "74_CR149", "doi-asserted-by": "crossref", "first-page": "2572", "DOI": "10.1056/NEJMoa032534", "volume": "350", "author": "JC Edwards", "year": "2004", "unstructured": "Edwards, J. C. et al. Efficacy of B cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N. Engl. J. Med. 350, 2572\u20132581 (2004).", "journal-title": "N. Engl. J. Med."}, {"key": "74_CR150", "doi-asserted-by": "crossref", "first-page": "115", "DOI": "10.1053/j.seminhematol.2010.01.011", "volume": "47", "author": "GJ Weiner", "year": "2010", "unstructured": "Weiner, G. J. Rituximab: mechanism of action. Semin. Hematol. 47, 115\u2013123 (2010).", "journal-title": "Semin. Hematol."}, {"key": "74_CR151", "doi-asserted-by": "crossref", "first-page": "1287", "DOI": "10.1517/14712598.7.9.1287", "volume": "7", "author": "T Dorner", "year": "2007", "unstructured": "Dorner, T. & Lipsky, P. E. B cell targeting: a novel approach to immune intervention today and tomorrow. Expert Opin. Biol. Ther. 7, 1287\u20131299 (2007).", "journal-title": "Expert Opin. Biol. Ther."}, {"key": "74_CR152", "doi-asserted-by": "crossref", "first-page": "426", "DOI": "10.1111/j.1365-2141.2011.08857.x", "volume": "155", "author": "E Ward", "year": "2011", "unstructured": "Ward, E. et al. A glycoengineered anti-CD19 antibody with potent antibody-dependent cellular cytotoxicity activity in vitro and lymphoma growth inhibition in vivo. Br. J. Haematol. 155, 426\u2013437 (2011).", "journal-title": "Br. J. Haematol."}, {"key": "74_CR153", "unstructured": "US National Library of Medicine. ClinicalTrials.gov \n                    https://clinicaltrials.gov/ct2/show/NCT02260934\n                    \n                   (2018)."}, {"key": "74_CR154", "unstructured": "US National Library of Medicine. ClinicalTrials.gov \n                    https://clinicaltrials.gov/ct2/show/NCT02284984\n                    \n                   (2018)."}, {"key": "74_CR155", "unstructured": "US National Library of Medicine. ClinicalTrials.gov \n                    https://clinicaltrials.gov/ct2/show/NCT03312907\n                    \n                   (2018)."}, {"key": "74_CR156", "unstructured": "US National Library of Medicine. ClinicalTrials.gov \n                    https://clinicaltrials.gov/ct2/show/NCT02284984\n                    \n                   (2017)."}, {"key": "74_CR157", "doi-asserted-by": "crossref", "first-page": "2229", "DOI": "10.1136/ard.2011.153890", "volume": "70", "author": "NJ Holden", "year": "2011", "unstructured": "Holden, N. J. et al. ANCA-stimulated neutrophils release BLyS and promote B cell survival: a clinically relevant cellular process. Ann. Rheum. Dis. 70, 2229\u20132233 (2011).", "journal-title": "Ann. Rheum. Dis."}, {"key": "74_CR158", "doi-asserted-by": "crossref", "first-page": "432", "DOI": "10.1172/JCI65689", "volume": "123", "author": "M Mahevas", "year": "2013", "unstructured": "Mahevas, M. et al. B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells. J. Clin. Invest. 123, 432\u2013442 (2013).", "journal-title": "J. Clin. Invest."}, {"key": "74_CR159", "doi-asserted-by": "crossref", "first-page": "1049", "DOI": "10.1517/14712598.2013.787064", "volume": "13", "author": "EM Vital", "year": "2013", "unstructured": "Vital, E. M., Kay, J. & Emery, P. Rituximab biosimilars. Expert Opin. Biol. Ther. 13, 1049\u20131062 (2013).", "journal-title": "Expert Opin. Biol. Ther."}, {"key": "74_CR160", "doi-asserted-by": "crossref", "first-page": "1541", "DOI": "10.4049/jimmunol.1501376", "volume": "196", "author": "D Chen", "year": "2016", "unstructured": "Chen, D. et al. Autoreactive CD19+CD20\u2013 plasma cells contribute to disease severity of experimental autoimmune encephalomyelitis. J. Immunol. 196, 1541\u20131549 (2016).", "journal-title": "J. Immunol."}, {"key": "74_CR161", "doi-asserted-by": "crossref", "first-page": "591", "DOI": "10.1681/ASN.2017070818", "volume": "29", "author": "F Eskandary", "year": "2018", "unstructured": "Eskandary, F. et al. A randomized trial of bortezomib in late antibody-mediated kidney transplant rejection. J. Am. Soc. Nephrol. 29, 591\u2013605 (2018).", "journal-title": "J. Am. Soc. Nephrol."}, {"key": "74_CR162", "unstructured": "US National Library of Medicine. ClinicalTrials.gov \n                    https://clinicaltrials.gov/ct2/show/NCT02102594\n                    \n                   (2018)."}, {"key": "74_CR163", "doi-asserted-by": "crossref", "first-page": "31", "DOI": "10.1182/bloodadvances.2016001412", "volume": "1", "author": "S Ratnasingam", "year": "2016", "unstructured": "Ratnasingam, S. et al. Bortezomib-based antibody depletion for refractory autoimmune hematological diseases. Blood Adv. 1, 31\u201335 (2016).", "journal-title": "Blood Adv."}, {"key": "74_CR164", "doi-asserted-by": "crossref", "first-page": "101", "DOI": "10.1016/j.blre.2015.08.004", "volume": "30", "author": "T Jelinek", "year": "2016", "unstructured": "Jelinek, T. & Hajek, R. Monoclonal antibodies \u2014 a new era in the treatment of multiple myeloma. Blood Rev. 30, 101\u2013110 (2016).", "journal-title": "Blood Rev."}, {"key": "74_CR165", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1080/13543784.2018.1492549", "volume": "27", "author": "MP Watkins", "year": "2018", "unstructured": "Watkins, M. P. & Bartlett, N. L. CD19-targeted immunotherapies for treatment of patients with non-Hodgkin B cell lymphomas. Expert Opin. Investig. Drugs. 27, 1\u201311 (2018).", "journal-title": "Expert Opin. Investig. Drugs."}, {"key": "74_CR166", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/j.clim.2017.04.011", "volume": "184", "author": "K Amrouche", "year": "2017", "unstructured": "Amrouche, K. & Jamin, C. Influence of drug molecules on regulatory B cells. Clin. Immunol. 184, 1\u201310 (2017).", "journal-title": "Clin. Immunol."}, {"key": "74_CR167", "doi-asserted-by": "crossref", "first-page": "2666", "DOI": "10.1182/blood-2014-07-585976", "volume": "124", "author": "EF Wallin", "year": "2014", "unstructured": "Wallin, E. F. et al. Human T-follicular helper and T-follicular regulatory cell maintenance is independent of germinal centers. Blood 124, 2666\u20132674 (2014).", "journal-title": "Blood"}, {"key": "74_CR168", "doi-asserted-by": "crossref", "first-page": "6624", "DOI": "10.4049/jimmunol.178.10.6624", "volume": "178", "author": "C Wei", "year": "2007", "unstructured": "Wei, C. et al. A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus\u00a0erythematosus. J. Immunol. 178, 6624\u20136633 (2007).", "journal-title": "J. Immunol."}, {"key": "74_CR169", "doi-asserted-by": "crossref", "first-page": "1079", "DOI": "10.1016/j.autrev.2015.07.013", "volume": "14", "author": "T Dorner", "year": "2015", "unstructured": "Dorner, T., Shock, A., Goldenberg, D. M. & Lipsky, P. E. The mechanistic impact of CD22 engagement with epratuzumab on B cell function: Implications for the treatment of systemic lupus erythematosus. Autoimmun. Rev. 14, 1079\u20131086 (2015).", "journal-title": "Autoimmun. Rev."}, {"key": "74_CR170", "doi-asserted-by": "crossref", "first-page": "370", "DOI": "10.1016/j.jhep.2017.03.021", "volume": "67", "author": "European Association for the Study of the Liver", "year": "2017", "unstructured": "European Association for the Study of the Liver et al. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J. Hepatol. 67, 370\u2013398 (2017).", "journal-title": "J. Hepatol."}, {"key": "74_CR171", "doi-asserted-by": "crossref", "first-page": "3043", "DOI": "10.1002/art.34468", "volume": "64", "author": "ES Molloy", "year": "2012", "unstructured": "Molloy, E. S. & Calabrese, L. H. Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: evolving role of biologic therapies. Arthritis Rheum. 64, 3043\u20133051 (2012).", "journal-title": "Arthritis Rheum."}, {"key": "74_CR172", "doi-asserted-by": "crossref", "first-page": "101", "DOI": "10.1186/s13075-017-1306-0", "volume": "19", "author": "J Thiel", "year": "2017", "unstructured": "Thiel, J. et al. B cell repopulation kinetics after rituximab treatment in ANCA-associated vasculitides compared to rheumatoid arthritis, and connective tissue diseases: a longitudinal observational study on 120 patients. Arthritis Res. Ther. 19, 101 (2017).", "journal-title": "Arthritis Res. Ther."}, {"key": "74_CR173", "doi-asserted-by": "crossref", "first-page": "60", "DOI": "10.1016/j.jaut.2014.11.009", "volume": "57", "author": "DM Roberts", "year": "2015", "unstructured": "Roberts, D. M. et al. Rituximab-associated hypogammaglobulinemia: incidence, predictors and outcomes in patients with multi-system autoimmune disease. J. Autoimmun. 57, 60\u201365 (2015).", "journal-title": "J. Autoimmun"}, {"key": "74_CR174", "doi-asserted-by": "crossref", "first-page": "3364", "DOI": "10.1002/art.34564", "volume": "64", "author": "JT Merrill", "year": "2012", "unstructured": "Merrill, J. T. et al. Long-term safety profile of belimumab plus standard therapy in patients with systemic lupus erythematosus. Arthritis Rheum. 64, 3364\u20133373 (2012).", "journal-title": "Arthritis Rheum."}, {"key": "74_CR175", "doi-asserted-by": "crossref", "first-page": "87", "DOI": "10.2147/DDDT.S41645", "volume": "8", "author": "CC Mok", "year": "2013", "unstructured": "Mok, C. C. Rituximab for the treatment of rheumatoid arthritis: an update. Drug Des. Devel. Ther. 8, 87\u2013100 (2013).", "journal-title": "Drug Des. Devel. Ther."}, {"key": "74_CR176", "doi-asserted-by": "crossref", "first-page": "9", "DOI": "10.1182/blood-2013-02-482406", "volume": "122", "author": "Z Saze", "year": "2013", "unstructured": "Saze, Z. et al. Adenosine production by human B cells and B cell-mediated suppression of activated T cells. Blood 122, 9\u201318 (2013).", "journal-title": "Blood"}, {"key": "74_CR177", "doi-asserted-by": "crossref", "first-page": "401", "DOI": "10.3109/08916934.2014.914174", "volume": "47", "author": "N Venhoff", "year": "2014", "unstructured": "Venhoff, N. et al. Reconstitution of the peripheral B\u00a0lymphocyte compartment in patients with ANCA-associated vasculitides treated with rituximab for relapsing or refractory disease. Autoimmunity 47, 401\u2013408 (2014).", "journal-title": "Autoimmunity"}, {"key": "74_CR178", "unstructured": "von Borstel, A. et al. Increased CD38hiCD27+ plasmablast frequency in remission predicts relapsing disease in granulomatosis with polyangiitis patients. Arthritis Rheumatol. 69 (suppl. 10) (2017).", "DOI": "10.3389/fimmu.2019.02221", "doi-asserted-by": "crossref"}, {"key": "74_CR179", "doi-asserted-by": "crossref", "first-page": "53", "DOI": "10.1016/j.trim.2010.04.004", "volume": "23", "author": "E Morelon", "year": "2010", "unstructured": "Morelon, E. et al. Preferential increase in memory and regulatory subsets during T-lymphocyte immune reconstitution after Thymoglobulin induction therapy with maintenance sirolimus versus cyclosporine. Transpl. Immunol. 23, 53\u201358 (2010).", "journal-title": "Transpl. Immunol."}, {"key": "74_CR180", "doi-asserted-by": "crossref", "first-page": "90", "DOI": "10.1016/j.intimp.2016.05.014", "volume": "38", "author": "J Song", "year": "2016", "unstructured": "Song, J. et al. The role of regulatory B cells (Bregs) in the Tregs-amplifying effect of Sirolimus. Int. Immunopharmacol. 38, 90\u201396 (2016).", "journal-title": "Int. Immunopharmacol."}, {"key": "74_CR181", "doi-asserted-by": "crossref", "first-page": "1784", "DOI": "10.1111/j.1600-6143.2012.04012.x", "volume": "12", "author": "S Heidt", "year": "2012", "unstructured": "Heidt, S., Hester, J., Shankar, S., Friend, P. J. & Wood, K. J. B cell repopulation after alemtuzumab induction-transient increase in transitional B cells and long-term dominance of naive B cells. Am. J. Transplant. 12, 1784\u20131792 (2012).", "journal-title": "Am. J. Transplant"}, {"key": "74_CR182", "doi-asserted-by": "crossref", "first-page": "630", "DOI": "10.1111/cei.12367", "volume": "177", "author": "A Picchianti Diamanti", "year": "2014", "unstructured": "Picchianti Diamanti, A. et al. Abatacept (cytotoxic T\u00a0lymphocyte antigen 4-immunoglobulin) improves B cell function and regulatory T cell inhibitory capacity in rheumatoid arthritis patients non-responding to anti-tumour necrosis factor-\u03b1 agents. Clin. Exp. Immunol. 177, 630\u2013640 (2014).", "journal-title": "Clin. Exp. Immunol."}], "container-title": ["Nature Reviews Nephrology"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/s41581-018-0074-7", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/s41581-018-0074-7.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/s41581-018-0074-7.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 15]], "date-time": "2019-11-15T00:15:46Z", "timestamp": 1573776946000}, "score": 26.62389, "issued": {"date-parts": [[2018, 11, 15]]}, "references-count": 182, "journal-issue": {"published-print": {"date-parts": [[2019, 1]]}, "issue": "1"}, "alternative-id": ["74"], "URL": "http://dx.doi.org/10.1038/s41581-018-0074-7", "relation": {"cites": []}, "ISSN": ["1759-5061", "1759-507X"], "issn-type": [{"value": "1759-5061", "type": "print"}, {"value": "1759-507X", "type": "electronic"}], "subject": ["Nephrology"], "assertion": [{"value": "15 November 2018", "order": 1, "name": "first_online", "label": "First Online", "group": {"name": "ArticleHistory", "label": "Article History"}}, {"value": "The authors declare no competing interests.", "order": 1, "name": "Ethics", "group": {"name": "EthicsHeading", "label": "Competing interests"}}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T23:05:10Z", "timestamp": 1575327910567}, "reference-count": 0, "publisher": "BMJ Publishing Group Ltd", "content-domain": {"domain": ["bmj.com"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2018, 6]]}, "DOI": "10.1136/esmoopen-2018-eacr25.893", "type": "proceedings-article", "created": {"date-parts": [[2018, 6, 30]], "date-time": "2018-06-30T06:03:58Z", "timestamp": 1530338638000}, "update-policy": "http://dx.doi.org/10.1136/crossmarkpolicy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["PO-386\u2005Dissecting the role of regulatory T cells in metastatic breast cancer"], "prefix": "10.1136", "author": [{"given": "K", "family": "Kos", "sequence": "first", "affiliation": []}, {"given": "M", "family": "Wellenstein", "sequence": "additional", "affiliation": []}, {"given": "K", "family": "Vrijland", "sequence": "additional", "affiliation": []}, {"given": "CS", "family": "Hau", "sequence": "additional", "affiliation": []}, {"given": "K", "family": "De Visser", "sequence": "additional", "affiliation": []}], "member": "239", "event": {"name": "Abstracts of the 25th Biennial Congress of the European Association for Cancer Research, Amsterdam, The Netherlands, 30 June \u2013 3 July 2018"}, "container-title": ["Tumour Immunology"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1136/esmoopen-2018-EACR25.893", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 6, 30]], "date-time": "2018-06-30T06:09:52Z", "timestamp": 1530338992000}, "score": 24.783276, "issued": {"date-parts": [[2018, 6]]}, "references-count": 0, "alternative-id": ["10.1136/esmoopen-2018-EACR25.893"], "URL": "http://dx.doi.org/10.1136/esmoopen-2018-eacr25.893"}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T23:05:10Z", "timestamp": 1575327910936}, "reference-count": 0, "publisher": "BMJ Publishing Group Ltd", "content-domain": {"domain": ["bmj.com"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2018, 6]]}, "DOI": "10.1136/esmoopen-2018-eacr25.898", "type": "proceedings-article", "created": {"date-parts": [[2018, 6, 30]], "date-time": "2018-06-30T06:03:58Z", "timestamp": 1530338638000}, "update-policy": "http://dx.doi.org/10.1136/crossmarkpolicy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["PO-386\u2005Dissecting the role of regulatory T cells in metastatic breast cancer"], "prefix": "10.1136", "author": [{"given": "K", "family": "Kos", "sequence": "first", "affiliation": []}, {"given": "M", "family": "Wellenstein", "sequence": "additional", "affiliation": []}, {"given": "K", "family": "Vrijland", "sequence": "additional", "affiliation": []}, {"given": "CS", "family": "Hau", "sequence": "additional", "affiliation": []}, {"given": "K", "family": "De Visser", "sequence": "additional", "affiliation": []}], "member": "239", "event": {"name": "Abstracts of the 25th Biennial Congress of the European Association for Cancer Research, Amsterdam, The Netherlands, 30 June \u2013 3 July 2018"}, "container-title": ["Tumour Immunology"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1136/esmoopen-2018-EACR25.898", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 6, 30]], "date-time": "2018-06-30T06:09:58Z", "timestamp": 1530338998000}, "score": 24.783276, "issued": {"date-parts": [[2018, 6]]}, "references-count": 0, "alternative-id": ["10.1136/esmoopen-2018-EACR25.898"], "URL": "http://dx.doi.org/10.1136/esmoopen-2018-eacr25.898"}, {"institution": {"name": "US Dept of the Army", "place": ["-", "-"], "department": ["Funding", "Performing"], "acronym": ["USAMRMC", "-"]}, "indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T02:33:24Z", "timestamp": 1574822004156}, "publisher-location": "Fort Belvoir, VA", "reference-count": 0, "publisher": "Defense Technical Information Center", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2004, 12, 1]]}, "DOI": "10.21236/ada433876", "type": "report", "created": {"date-parts": [[2017, 8, 11]], "date-time": "2017-08-11T18:53:16Z", "timestamp": 1502477596000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Role of PSMA in Aberrant Cell Cycle Progression in Prostate Cancer"], "prefix": "10.21236", "author": [{"given": "Ayyappan K.", "family": "Rajasekaran", "sequence": "first", "affiliation": []}], "member": "9879", "original-title": [""], "deposited": {"date-parts": [[2017, 8, 11]], "date-time": "2017-08-11T18:53:17Z", "timestamp": 1502477597000}, "score": 23.89458, "subtitle": [""], "issued": {"date-parts": [[2004, 12, 1]]}, "references-count": 0, "URL": "http://dx.doi.org/10.21236/ada433876"}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T17:23:46Z", "timestamp": 1574443426869}, "reference-count": 30, "publisher": "Springer Science and Business Media LLC", "issue": "2", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2012, 1, 12]], "date-time": "2012-01-12T00:00:00Z", "timestamp": 1326326400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Immunol Immunother"], "published-print": {"date-parts": [[2012, 2]]}, "DOI": "10.1007/s00262-011-1181-5", "type": "journal-article", "created": {"date-parts": [[2012, 1, 11]], "date-time": "2012-01-11T11:12:00Z", "timestamp": 1326280320000}, "page": "289-293", "source": "Crossref", "is-referenced-by-count": 53, "title": ["Immune suppression in the tumor microenvironment: a role for dendritic cell-mediated tolerization of T cells"], "prefix": "10.1007", "volume": "61", "author": [{"given": "Arthur A.", "family": "Hurwitz", "sequence": "first", "affiliation": []}, {"given": "Stephanie K.", "family": "Watkins", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2012, 1, 12]]}, "reference": [{"key": "1181_CR1", "doi-asserted-by": "crossref", "first-page": "1555", "DOI": "10.1084/jem.187.10.1555", "volume": "187", "author": "AJ Adler", "year": "1998", "unstructured": "Adler AJ, Marsh DW, Yochum GS, Guzzo JL, Nigam A, Nelson WG, Pardoll DM (1998) CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells. J Exp Med 187:1555\u20131564", "journal-title": "J Exp Med"}, {"key": "1181_CR2", "doi-asserted-by": "crossref", "first-page": "1365", "DOI": "10.1189/jlb.0307166", "volume": "82", "author": "N Cools", "year": "2007", "unstructured": "Cools N, Ponsaerts P, Van TV, Berneman ZN (2007) Balancing between immunity and tolerance: an interplay between dendritic cells, regulatory T cells, and effector T cells. J Leukoc Biol 82:1365\u20131374", "journal-title": "J Leukoc Biol"}, {"key": "1181_CR3", "doi-asserted-by": "crossref", "first-page": "715", "DOI": "10.1038/ni.2060", "volume": "12", "author": "Y Ben-Neriah", "year": "2011", "unstructured": "Ben-Neriah Y, Karin M (2011) Inflammation meets cancer, with NF-kappaB as the matchmaker. Nat Immunol 12:715\u2013723", "journal-title": "Nat Immunol"}, {"key": "1181_CR4", "doi-asserted-by": "crossref", "first-page": "646", "DOI": "10.1016/j.cell.2011.02.013", "volume": "144", "author": "D Hanahan", "year": "2011", "unstructured": "Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646\u2013674", "journal-title": "Cell"}, {"key": "1181_CR5", "doi-asserted-by": "crossref", "first-page": "5194", "DOI": "10.4049/jimmunol.181.8.5194", "volume": "181", "author": "ML Belladonna", "year": "2008", "unstructured": "Belladonna ML, Volpi C, Bianchi R et al (2008) Cutting edge: autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells. J Immunol 181:5194\u20135198", "journal-title": "J Immunol"}, {"key": "1181_CR6", "doi-asserted-by": "crossref", "first-page": "690", "DOI": "10.1111/j.1582-4934.2007.00084.x", "volume": "12", "author": "N Cools", "year": "2008", "unstructured": "Cools N, Van TV, Smits EL, Lenjou M, Nijs G, Van Bockstaele DR, Berneman ZN, Ponsaerts P (2008) Immunosuppression induced by immature dendritic cells is mediated by TGF-beta/IL-10 double-positive CD4+ regulatory T cells. J Cell Mol Med 12:690\u2013700", "journal-title": "J Cell Mol Med"}, {"key": "1181_CR7", "doi-asserted-by": "crossref", "first-page": "206", "DOI": "10.1111/j.1600-065X.2008.00610.x", "volume": "222", "author": "JB Katz", "year": "2008", "unstructured": "Katz JB, Muller AJ, Prendergast GC (2008) Indoleamine 2, 3-dioxygenase in T-cell tolerance and tumoral immune escape. Immunol Rev 222:206\u2013221", "journal-title": "Immunol Rev"}, {"key": "1181_CR8", "first-page": "4673", "volume": "58", "author": "R Ganss", "year": "1998", "unstructured": "Ganss R, Hanahan D (1998) Tumor microenvironment can restrict the effectiveness of activated antitumor lymphocytes. Cancer Res 58:4673\u20134681", "journal-title": "Cancer Res"}, {"key": "1181_CR9", "doi-asserted-by": "crossref", "first-page": "1268", "DOI": "10.4049/jimmunol.178.3.1268", "volume": "178", "author": "MJ Anderson", "year": "2007", "unstructured": "Anderson MJ, Shafer-Weaver K, Greenberg NM, Hurwitz AA (2007) Tolerization of tumor-specific T cells despite efficient initial priming in a primary murine model of prostate cancer. J Immunol 178:1268\u20131276", "journal-title": "J Immunol"}, {"key": "1181_CR10", "unstructured": "Hurwitz AA, Foster BA, Allison JP, Greenberg NM, Kwon ED (2001) The TRAMP mouse as a model for prostate cancer. Curr.Protoc.Immunol (Chapter 20)", "DOI": "10.1002/0471142735.im2005s45", "doi-asserted-by": "crossref"}, {"key": "1181_CR11", "doi-asserted-by": "crossref", "first-page": "4848", "DOI": "10.4049/jimmunol.0900848", "volume": "183", "author": "KA Shafer-Weaver", "year": "2009", "unstructured": "Shafer-Weaver KA, Anderson MJ, Stagliano K, Malyguine A, Greenberg NM, Hurwitz AA (2009) Cutting edge: tumor-specific CD8+ T cells infiltrating prostatic tumors are induced to become suppressor cells. J Immunol 183:4848\u20134852", "journal-title": "J Immunol"}, {"key": "1181_CR12", "doi-asserted-by": "crossref", "first-page": "6256", "DOI": "10.1158/0008-5472.CAN-08-4516", "volume": "69", "author": "KA Shafer-Weaver", "year": "2009", "unstructured": "Shafer-Weaver KA, Watkins SK, Anderson MJ, Draper LJ, Malyguine A, Alvord WG, Greenberg NM, Hurwitz AA (2009) Immunity to murine prostatic tumors: continuous provision of T-cell help prevents CD8 T-cell tolerance and activates tumor-infiltrating dendritic cells. Cancer Res 69:6256\u20136264", "journal-title": "Cancer Res"}, {"key": "1181_CR13", "doi-asserted-by": "crossref", "first-page": "1361", "DOI": "10.1172/JCI44325", "volume": "121", "author": "SK Watkins", "year": "2011", "unstructured": "Watkins SK, Zhu Z, Riboldi E, Shafer-Weaver KA, Stagliano KE, Sklavos MM, Ambs S, Yagita H, Hurwitz AA (2011) FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer. J Clin Invest 121:1361\u20131372", "journal-title": "J Clin Invest"}, {"key": "1181_CR14", "doi-asserted-by": "crossref", "first-page": "1051", "DOI": "10.1084/jem.20040942", "volume": "200", "author": "F Fallarino", "year": "2004", "unstructured": "Fallarino F, Bianchi R, Orabona C, Vacca C, Belladonna ML, Fioretti MC, Serreze DV, Grohmann U, Puccetti P (2004) CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice. J Exp Med 200:1051\u20131062", "journal-title": "J Exp Med"}, {"key": "1181_CR15", "doi-asserted-by": "crossref", "first-page": "203", "DOI": "10.1016/j.immuni.2004.06.016", "volume": "21", "author": "L Lin", "year": "2004", "unstructured": "Lin L, Hron JD, Peng SL (2004) Regulation of NF-kappaB, Th activation, and autoinflammation by the forkhead transcription factor Foxo3a. Immunity 21:203\u2013213", "journal-title": "Immunity"}, {"key": "1181_CR16", "doi-asserted-by": "crossref", "first-page": "459", "DOI": "10.1080/08820130600803429", "volume": "35", "author": "I Fricke", "year": "2006", "unstructured": "Fricke I, Gabrilovich DI (2006) Dendritic cells and tumor microenvironment: a dangerous liaison. Immunol Invest 35:459\u2013483", "journal-title": "Immunol Invest"}, {"key": "1181_CR17", "doi-asserted-by": "crossref", "first-page": "605", "DOI": "10.1158/0008-5472.CAN-05-4005", "volume": "66", "author": "CE Lewis", "year": "2006", "unstructured": "Lewis CE, Pollard JW (2006) Distinct role of macrophages in different tumor microenvironments. Cancer Res 66:605\u2013612", "journal-title": "Cancer Res"}, {"key": "1181_CR18", "doi-asserted-by": "crossref", "first-page": "68", "DOI": "10.1002/1097-0045(200101)46:1<68::AID-PROS1010>3.0.CO;2-2", "volume": "46", "author": "M Aalamian", "year": "2001", "unstructured": "Aalamian M, Pirtskhalaishvili G, Nunez A, Esche C, Shurin GV, Huland E, Huland H, Shurin MR (2001) Human prostate cancer regulates generation and maturation of monocyte-derived dendritic cells. Prostate 46:68\u201375", "journal-title": "Prostate"}, {"key": "1181_CR19", "doi-asserted-by": "crossref", "first-page": "504", "DOI": "10.1038/ni.1729", "volume": "10", "author": "AS Dejean", "year": "2009", "unstructured": "Dejean AS, Beisner DR, Ch\u2019en IL, Kerdiles YM, Babour A, Arden KC, Castrillon DH, DePinho RA, Hedrick SM (2009) Transcription factor Foxo3 controls the magnitude of T cell immune responses by modulating the function of dendritic cells. Nat Immunol 10:504\u2013513", "journal-title": "Nat Immunol"}, {"key": "1181_CR20", "doi-asserted-by": "crossref", "first-page": "467", "DOI": "10.1016/j.immuni.2011.09.006", "volume": "35", "author": "A Kuraishy", "year": "2011", "unstructured": "Kuraishy A, Karin M, Grivennikov SI (2011) Tumor promotion via injury- and death-induced inflammation. Immunity 35:467\u2013477", "journal-title": "Immunity"}, {"key": "1181_CR21", "doi-asserted-by": "crossref", "first-page": "121", "DOI": "10.1126/science.1140485", "volume": "317", "author": "WE Naugler", "year": "2007", "unstructured": "Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, Karin M (2007) Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317:121\u2013124", "journal-title": "Science"}, {"key": "1181_CR22", "doi-asserted-by": "crossref", "first-page": "1023", "DOI": "10.1002/hep.23746", "volume": "52", "author": "S Kurinna", "year": "2010", "unstructured": "Kurinna S, Stratton SA, Tsai WW, Akdemir KC, Gu W, Singh P, Goode T, Darlington GJ, Barton MC (2010) Direct activation of forkhead box O3 by tumor suppressors p53 and p73 is disrupted during liver regeneration in mice. Hepatology 52:1023\u20131032", "journal-title": "Hepatology"}, {"key": "1181_CR23", "doi-asserted-by": "crossref", "first-page": "45", "DOI": "10.1007/s10555-011-9286-z", "volume": "30", "author": "K Khazaie", "year": "2011", "unstructured": "Khazaie K, Blatner NR, Khan MW et al (2011) The significant role of mast cells in cancer. Cancer Metastasis Rev 30:45\u201360", "journal-title": "Cancer Metastasis Rev"}, {"key": "1181_CR24", "doi-asserted-by": "crossref", "first-page": "5987", "DOI": "10.1158/0008-5472.CAN-11-1637", "volume": "71", "author": "P Pittoni", "year": "2011", "unstructured": "Pittoni P, Tripodo C, Piconese S, Mauri G, Parenza M, Rigoni A, Sangaletti S, Colombo MP (2011) Mast cell targeting hampers prostate adenocarcinoma development but promotes the occurrence of highly malignant neuroendocrine cancers. Cancer Res 71:5987\u20135997", "journal-title": "Cancer Res"}, {"key": "1181_CR25", "unstructured": "Yang Z, Zhang B, Li D, Lv M, Huang C, Shen GX, Huang B (2010) Mast cells mobilize myeloid-derived suppressor cells and Treg cells in tumor microenvironment via IL-17 pathway in murine hepatocarcinoma model. PLoS One 5:e8922.2", "DOI": "10.1371/journal.pone.0008922", "doi-asserted-by": "crossref"}, {"key": "1181_CR26", "doi-asserted-by": "crossref", "first-page": "643", "DOI": "10.1016/j.coi.2010.08.015", "volume": "22", "author": "VC Vries de", "year": "2010", "unstructured": "de Vries VC, Noelle RJ (2010) Mast cell mediators in tolerance. Curr Opin Immunol 22:643\u2013648", "journal-title": "Curr Opin Immunol"}, {"key": "1181_CR27", "doi-asserted-by": "crossref", "first-page": "478", "DOI": "10.1038/nri2327", "volume": "8", "author": "SJ Galli", "year": "2008", "unstructured": "Galli SJ, Grimbaldeston M, Tsai M (2008) Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol 8:478\u2013486", "journal-title": "Nat Rev Immunol"}, {"key": "1181_CR28", "doi-asserted-by": "crossref", "first-page": "83", "DOI": "10.1196/annals.1443.023", "volume": "1143", "author": "KN Rao", "year": "2008", "unstructured": "Rao KN, Brown MA (2008) Mast cells: multifaceted immune cells with diverse roles in health and disease. Ann N Y Acad Sci 1143:83\u2013104", "journal-title": "Ann N Y Acad Sci"}, {"key": "1181_CR29", "unstructured": "Watkins SK, Zhu Z, Riboldi E, Shafer-Weaver KA, Stagliano KER, Sklavos MM, Ambs S, Yagita H, Hurwitz AA (2011) Foxo3a programs tumor associated dendritic cells to become tolerogenic in human and murine prostate cancer. J Clin Investig 121"}, {"key": "1181_CR30", "doi-asserted-by": "crossref", "first-page": "3089", "DOI": "10.1200/JCO.2005.04.5252", "volume": "24", "author": "EJ Small", "year": "2006", "unstructured": "Small EJ, Schellhammer PF, Higano CS, Redfern CH, Nemunaitis JJ, Valone FH, Verjee SS, Jones LA, Hershberg RM (2006) Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer. J Clin Oncol 24:3089\u20133094", "journal-title": "J Clin Oncol"}], "container-title": ["Cancer Immunology, Immunotherapy"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s00262-011-1181-5.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s00262-011-1181-5/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s00262-011-1181-5", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 22]], "date-time": "2019-06-22T10:02:59Z", "timestamp": 1561197779000}, "score": 23.031572, "issued": {"date-parts": [[2012, 1, 12]]}, "references-count": 30, "journal-issue": {"published-print": {"date-parts": [[2012, 2]]}, "issue": "2"}, "alternative-id": ["1181"], "URL": "http://dx.doi.org/10.1007/s00262-011-1181-5", "relation": {"cites": []}, "ISSN": ["0340-7004", "1432-0851"], "issn-type": [{"value": "0340-7004", "type": "print"}, {"value": "1432-0851", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T04:22:39Z", "timestamp": 1575433359411}, "publisher-location": "Hoboken, NJ", "reference-count": 43, "publisher": "John Wiley & Sons", "isbn-type": [{"value": "9781118356166", "type": "print"}, {"value": "9781118356203", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1002/9781118356203.ch22", "type": "book-chapter", "created": {"date-parts": [[2014, 2, 1]], "date-time": "2014-02-01T04:52:36Z", "timestamp": 1391230356000}, "page": "287-294", "source": "Crossref", "is-referenced-by-count": 0, "title": ["A Perspective on Breast Cancer Malignant Progression"], "prefix": "10.1002", "author": [{"given": "Pasquale", "family": "Sansone", "sequence": "first", "affiliation": []}, {"given": "Vinagolu K.", "family": "Rajasekhar", "sequence": "additional", "affiliation": []}, {"given": "Jacqueline", "family": "Bromberg", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2014, 1, 31]]}, "reference": [{"key": "10.1002/9781118356203.ch22-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "356", "DOI": "10.1016/j.ygyno.2011.04.039", "article-title": "Comparison of estrogen and progesterone receptor status of circulating tumor cells and the primary tumor in metastatic breast cancer patients", "volume": "122", "author": "Aktas", "year": "2011", "journal-title": "Gynecologic oncology"}, {"key": "10.1002/9781118356203.ch22-BIB2|cit2", "doi-asserted-by": "crossref", "first-page": "3983", "DOI": "10.1073/pnas.0530291100", "article-title": "Prospective identification of tumorigenic breast cancer cells", "volume": "100", "author": "Al-Hajj", "year": "2003", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "10.1002/9781118356203.ch22-BIB3|cit3", "doi-asserted-by": "crossref", "first-page": "7950", "DOI": "10.1073/pnas.1102454108", "article-title": "Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state", "volume": "108", "author": "Chaffer", "year": "2011", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "10.1002/9781118356203.ch22-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "1101", "DOI": "10.4161/cbt.12.12.18703", "article-title": "Pyruvate kinase expression (PKM1 and PKM2) in cancer-associated fibroblasts drives stromal nutrient production and tumor growth", "volume": "12", "author": "Chiavarina", "year": "2011", "journal-title": "Cancer Biol Ther"}, {"key": "10.1002/9781118356203.ch22-BIB5|cit5", "doi-asserted-by": "crossref", "first-page": "2784", "DOI": "10.1073/pnas.1018866109", "article-title": "Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia", "volume": "109", "author": "Conley", "year": "2012", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "10.1002/9781118356203.ch22-BIB6|cit6", "doi-asserted-by": "crossref", "first-page": "13820", "DOI": "10.1073/pnas.0905718106", "article-title": "Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features", "volume": "106", "author": "Creighton", "year": "2009", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "10.1002/9781118356203.ch22-BIB7|cit7", "doi-asserted-by": "crossref", "first-page": "300", "DOI": "10.1186/1476-4598-9-300", "article-title": "Epigenetic control of the basal-like gene expression profile via Interleukin-6 in breast cancer cells", "volume": "9", "author": "D'Anello", "year": "2010", "journal-title": "Molecular cancer"}, {"key": "10.1002/9781118356203.ch22-BIB8|cit8", "doi-asserted-by": "crossref", "first-page": "e10240", "DOI": "10.1371/journal.pone.0010240", "article-title": "Malignant precursor cells pre-exist in human breast DCIS and require autophagy for survival", "volume": "5", "author": "Espina", "year": "2010", "journal-title": "PLoS One"}, {"key": "10.1002/9781118356203.ch22-BIB9|cit9", "doi-asserted-by": "crossref", "first-page": "R76", "DOI": "10.1186/bcr2143", "article-title": "ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients", "volume": "10", "author": "Fehm", "year": "2008", "journal-title": "Breast Cancer Res"}, {"key": "10.1002/9781118356203.ch22-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "509", "DOI": "10.1007/s10549-013-2470-9", "article-title": "The HER2 status of disseminated tumor cells in the bone marrow of early breast cancer patients is independent from primary tumor and predicts higher risk of relapse", "volume": "138", "author": "Hartkopf", "year": "2013", "journal-title": "Breast Cancer Res Treat"}, {"key": "10.1002/9781118356203.ch22-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "79", "DOI": "10.3389/fonc.2013.00079", "article-title": "Expression of the Pluripotency Transcription Factor OCT4 in the Normal and Aberrant Mammary Gland", "volume": "3", "author": "Hassiotou", "year": "2013", "journal-title": "Front Oncol"}, {"key": "10.1002/9781118356203.ch22-BIB12|cit12", "doi-asserted-by": "crossref", "first-page": "313", "DOI": "10.1016/j.stem.2007.06.002", "article-title": "Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer", "volume": "1", "author": "Hermann", "year": "2007", "journal-title": "Cell Stem Cell"}, {"key": "10.1002/9781118356203.ch22-BIB13|cit13", "doi-asserted-by": "crossref", "first-page": "3296", "DOI": "10.1172/JCI41490", "article-title": "Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status", "volume": "120", "author": "Jiang", "year": "2010", "journal-title": "J Clin Invest"}, {"key": "10.1002/9781118356203.ch22-BIB14|cit14", "doi-asserted-by": "crossref", "first-page": "R15", "DOI": "10.1186/bcr3099", "article-title": "Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells", "volume": "14", "author": "Kasimir-Bauer", "year": "2012", "journal-title": "Breast Cancer Res"}, {"key": "10.1002/9781118356203.ch22-BIB15|cit15", "doi-asserted-by": "crossref", "first-page": "6120", "DOI": "10.1038/onc.2008.207", "article-title": "HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion", "volume": "27", "author": "Korkaya", "year": "2008", "journal-title": "Oncogene"}, {"key": "10.1002/9781118356203.ch22-BIB16|cit16", "doi-asserted-by": "crossref", "first-page": "1730", "DOI": "10.1038/bjc.2011.159", "article-title": "An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer", "volume": "104", "author": "Lee", "year": "2011", "journal-title": "Br J Cancer"}, {"key": "10.1002/9781118356203.ch22-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "1354", "DOI": "10.1038/onc.2011.338", "article-title": "Sox2 expression in breast tumours and activation in breast cancer stem cells", "volume": "31", "author": "Leis", "year": "2012", "journal-title": "Oncogene"}, {"key": "10.1002/9781118356203.ch22-BIB18|cit18", "doi-asserted-by": "crossref", "first-page": "2545", "DOI": "10.1038/onc.2011.433", "article-title": "Heterogeneity in MYC-induced mammary tumors contributes to escape from oncogene dependence", "volume": "31", "author": "Leung", "year": "2012", "journal-title": "Oncogene"}, {"key": "10.1002/9781118356203.ch22-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "5875", "DOI": "10.1007/s11033-011-1398-6", "article-title": "Co-expression of Oct-4 and Nestin in human breast cancers", "volume": "39", "author": "Liu", "year": "2012", "journal-title": "Molecular biology reports"}, {"key": "10.1002/9781118356203.ch22-BIB20|cit20", "doi-asserted-by": "crossref", "first-page": "1165", "DOI": "10.1097/SLA.0b013e318214c54e", "article-title": "Clinical implications of stem cell gene Oct-4 expression in breast cancer", "volume": "253", "author": "Liu", "year": "2011a", "journal-title": "Annals of surgery"}, {"key": "10.1002/9781118356203.ch22-BIB21|cit21", "doi-asserted-by": "crossref", "first-page": "18115", "DOI": "10.1073/pnas.1006732107", "article-title": "Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models", "volume": "107", "author": "Liu", "year": "2010", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "10.1002/9781118356203.ch22-BIB22|cit22", "doi-asserted-by": "crossref", "first-page": "614", "DOI": "10.1158/0008-5472.CAN-10-0538", "article-title": "Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks", "volume": "71", "author": "Liu", "year": "2011b", "journal-title": "Cancer Res"}, {"key": "10.1002/9781118356203.ch22-BIB23|cit23", "doi-asserted-by": "crossref", "first-page": "135039", "DOI": "10.1155/2011/135039", "article-title": "Phenotypic heterogeneity of breast cancer stem cells", "volume": "2011", "author": "Lorico", "year": "2011", "journal-title": "Journal of oncology"}, {"key": "10.1002/9781118356203.ch22-BIB24|cit24", "doi-asserted-by": "crossref", "first-page": "85", "DOI": "10.1038/nature10694", "article-title": "Interactions between cancer stem cells and their niche govern metastatic colonization", "volume": "481", "author": "Malanchi", "year": "2012", "journal-title": "Nature"}, {"key": "10.1002/9781118356203.ch22-BIB25|cit25", "doi-asserted-by": "crossref", "first-page": "704", "DOI": "10.1016/j.cell.2008.03.027", "article-title": "The epithelial-mesenchymal transition generates cells with properties of stem cells", "volume": "133", "author": "Mani", "year": "2008", "journal-title": "Cell"}, {"key": "10.1002/9781118356203.ch22-BIB26|cit26", "doi-asserted-by": "crossref", "first-page": "32", "DOI": "10.1002/stem.563", "article-title": "Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis", "volume": "29", "author": "Marcato", "year": "2011", "journal-title": "Stem Cells"}, {"key": "10.1002/9781118356203.ch22-BIB27|cit27", "doi-asserted-by": "crossref", "first-page": "4624", "DOI": "10.1158/0008-5472.CAN-09-3619", "article-title": "CD44posCD49fhiCD133/2hi defines xenograft-initiating cells in estrogen receptor-negative breast cancer", "volume": "70", "author": "Meyer", "year": "2010", "journal-title": "Cancer Res"}, {"key": "10.1002/9781118356203.ch22-BIB28|cit28", "doi-asserted-by": "crossref", "first-page": "22745", "DOI": "10.1073/pnas.1017001108", "article-title": "Inactivation of p53 in breast cancers correlates with stem cell transcriptional signatures", "volume": "107", "author": "Mizuno", "year": "2010", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "10.1002/9781118356203.ch22-BIB29|cit29", "doi-asserted-by": "crossref", "first-page": "1656", "DOI": "10.1200/JCO.2005.03.2755", "article-title": "Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers", "volume": "24", "author": "Oh", "year": "2006", "journal-title": "J Clin Oncol"}, {"key": "10.1002/9781118356203.ch22-BIB30|cit30", "doi-asserted-by": "crossref", "first-page": "4020", "DOI": "10.4161/cc.22225", "article-title": "Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin)", "volume": "11", "author": "Oliveras-Ferraros", "year": "2012", "journal-title": "Cell Cycle"}, {"key": "10.1002/9781118356203.ch22-BIB31|cit31", "doi-asserted-by": "crossref", "first-page": "747", "DOI": "10.1038/35021093", "article-title": "Molecular portraits of human breast tumours", "volume": "406", "author": "Perou", "year": "2000", "journal-title": "Nature"}, {"key": "10.1002/9781118356203.ch22-BIB32|cit32", "doi-asserted-by": "crossref", "first-page": "3155", "DOI": "10.1172/JCI33295", "article-title": "Breast cancer: origins and evolution", "volume": "117", "author": "Polyak", "year": "2007", "journal-title": "J Clin Invest"}, {"key": "10.1002/9781118356203.ch22-BIB33|cit33", "doi-asserted-by": "crossref", "first-page": "782", "DOI": "10.1016/S0140-6736(12)62038-8", "article-title": "Extended adjuvant tamoxifen for breast cancer-a new era?", "volume": "381", "author": "Powles", "year": "2013", "journal-title": "Lancet"}, {"key": "10.1002/9781118356203.ch22-BIB34|cit34", "doi-asserted-by": "crossref", "first-page": "2498", "DOI": "10.1634/stemcells.2006-0608", "article-title": "Concise review: roles of polycomb group proteins in development and disease: a stem cell perspective", "volume": "25", "author": "Rajasekhar", "year": "2007", "journal-title": "Stem Cells"}, {"key": "10.1002/9781118356203.ch22-BIB35|cit35", "doi-asserted-by": "crossref", "first-page": "162", "DOI": "10.1038/ncomms1159", "article-title": "Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-kappaB signalling", "volume": "2", "author": "Rajasekhar", "year": "2011", "journal-title": "Nature communications"}, {"key": "10.1002/9781118356203.ch22-BIB36|cit36", "doi-asserted-by": "crossref", "first-page": "8058", "DOI": "10.1158/0008-5472.CAN-09-0834", "article-title": "Immunoselection of breast and ovarian cancer cells with trastuzumab and natural killer cells: selective escape of CD44high/CD24low/HER2low breast cancer stem cells", "volume": "69", "author": "Reim", "year": "2009", "journal-title": "Cancer Res"}, {"key": "10.1002/9781118356203.ch22-BIB37|cit37", "doi-asserted-by": "crossref", "first-page": "964", "DOI": "10.1093/carcin/bgr029", "article-title": "Activation of autophagy in mesenchymal stem cells provides tumor stromal support", "volume": "32", "author": "Sanchez", "year": "2011", "journal-title": "Carcinogenesis"}, {"key": "10.1002/9781118356203.ch22-BIB38|cit38", "doi-asserted-by": "crossref", "first-page": "807", "DOI": "10.1634/stemcells.2006-0442", "article-title": "p66Shc/Notch-3 interplay controls self-renewal and hypoxia survival in human stem/progenitor cells of the mammary gland expanded in vitro as mammospheres", "volume": "25", "author": "Sansone", "year": "2007a", "journal-title": "Stem Cells"}, {"key": "10.1002/9781118356203.ch22-BIB39|cit39", "doi-asserted-by": "crossref", "first-page": "3988", "DOI": "10.1172/JCI32533", "article-title": "IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland", "volume": "117", "author": "Sansone", "year": "2007b", "journal-title": "J Clin Invest"}, {"key": "10.1002/9781118356203.ch22-BIB40|cit40", "doi-asserted-by": "crossref", "first-page": "755", "DOI": "10.1038/nrc2499", "article-title": "Cancer stem cells in solid tumours: accumulating evidence and unresolved questions", "volume": "8", "author": "Visvader", "year": "2008", "journal-title": "Nat Rev Cancer"}, {"key": "10.1002/9781118356203.ch22-BIB41|cit41", "doi-asserted-by": "crossref", "first-page": "503", "DOI": "10.1007/s10549-012-2382-0", "article-title": "The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer", "volume": "137", "author": "Wallwiener", "year": "2013", "journal-title": "Breast Cancer Res Treat"}, {"key": "10.1002/9781118356203.ch22-BIB42|cit42", "doi-asserted-by": "crossref", "first-page": "R10", "DOI": "10.1186/bcr1855", "article-title": "Brca1 breast tumors contain distinct CD44+/CD24\u2212 and CD133+ cells with cancer stem cell characteristics", "volume": "10", "author": "Wright", "year": "2008", "journal-title": "Breast Cancer Res"}, {"key": "10.1002/9781118356203.ch22-BIB43|cit43", "doi-asserted-by": "crossref", "first-page": "4674", "DOI": "10.1158/0008-5472.CAN-07-6353", "article-title": "Identification of tumor-initiating cells in a p53-null mouse model of breast cancer", "volume": "68", "author": "Zhang", "year": "2008", "journal-title": "Cancer Res"}], "container-title": ["Cancer Stem Cells"], "link": [{"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/9781118356203.ch22", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 5]], "date-time": "2018-08-05T20:09:05Z", "timestamp": 1533499745000}, "score": 22.836952, "subtitle": ["From Cancer Stem Cell Intra Tumor Heterogeneity to Metastasis-Initiating Cells"], "issued": {"date-parts": [[2014, 1, 31]]}, "ISBN": ["9781118356203", "9781118356166"], "references-count": 43, "URL": "http://dx.doi.org/10.1002/9781118356203.ch22", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T14:07:04Z", "timestamp": 1575295624338}, "reference-count": 108, "publisher": "Informa UK Limited", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Research and Regulatory Affairs"], "published-print": {"date-parts": [[2008, 1]]}, "DOI": "10.1080/10601330802208291", "type": "journal-article", "created": {"date-parts": [[2008, 8, 6]], "date-time": "2008-08-06T12:35:48Z", "timestamp": 1218026148000}, "page": "139-155", "source": "Crossref", "is-referenced-by-count": 1, "title": ["The Role of Inflammation in Tumor Progression: Targeting Tumor-Associated Macrophages"], "prefix": "10.1080", "volume": "25", "author": [{"given": "Michelle L.", "family": "Varney", "sequence": "first", "affiliation": []}, {"given": "Rakesh K.", "family": "Singh", "sequence": "additional", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2008, 10, 20]]}, "reference": [{"key": "CIT0001", "DOI": "10.1016/S0140-6736(00)04046-0", "doi-asserted-by": "publisher"}, {"key": "CIT0002", "author": "Fidler IJ", "volume": "10", "first-page": "257", "year": "2001", "journal-title": "Surg Oncol Clin N Am.", "DOI": "10.1016/S1055-3207(18)30064-4", "doi-asserted-by": "crossref"}, {"key": "CIT0003", "DOI": "10.1007/s004280050053", "doi-asserted-by": "publisher"}, {"key": "CIT0004", "author": "Seljelid R", "volume": "19", "first-page": "4809", "year": "1999", "journal-title": "Anticancer Res."}, {"key": "CIT0005", "DOI": "10.1158/0008-5472.CAN-06-3149", "doi-asserted-by": "publisher"}, {"key": "CIT0006", "DOI": "10.1002/(SICI)1097-0142(19960401)77:7<1303::AIDCNCR12>3.0.CO;2-5", "doi-asserted-by": "publisher"}, {"key": "CIT0007", "author": "Menard S", "volume": "3", "first-page": "817", "year": "1997", "journal-title": "Clin Cancer Res."}, {"key": "CIT0008", "author": "Mihm MC", "volume": "74", "first-page": "43", "year": "1996", "journal-title": "Lab Invest."}, {"key": "CIT0009", "DOI": "10.1002/(SICI)1096-9896(199707)182:3<318::AID-PATH862>3.0.CO;2-6", "doi-asserted-by": "publisher"}, {"key": "CIT0010", "DOI": "10.1038/bjc.1996.434", "doi-asserted-by": "publisher"}, {"key": "CIT0011", "DOI": "10.1038/nri1936", "doi-asserted-by": "publisher"}, {"key": "CIT0012", "DOI": "10.1038/25292", "doi-asserted-by": "publisher"}, {"key": "CIT0013", "DOI": "10.1056/NEJM198809013190901", "doi-asserted-by": "publisher"}, {"key": "CIT0014", "DOI": "10.1084/jem.193.6.F23", "doi-asserted-by": "publisher"}, {"key": "CIT0015", "DOI": "10.1038/nature01322", "doi-asserted-by": "publisher"}, {"key": "CIT0016", "DOI": "10.1016/S0065-230X(02)84008-8", "doi-asserted-by": "publisher"}, {"key": "CIT0017", "DOI": "10.1054/bjoc.2001.1943", "doi-asserted-by": "publisher"}, {"key": "CIT0018", "DOI": "10.1191/096228098675091404", "doi-asserted-by": "publisher"}, {"key": "CIT0019", "DOI": "10.3109/07357909909032849", "doi-asserted-by": "publisher"}, {"key": "CIT0020", "DOI": "10.1016/S1567-5769(01)00172-2", "doi-asserted-by": "publisher"}, {"key": "CIT0021", "DOI": "10.1136/thorax.55.9.731", "doi-asserted-by": "publisher"}, {"key": "CIT0022", "author": "Shacter E", "volume": "16", "first-page": "217", "year": "2002", "journal-title": "Oncology (Huntingt)"}, {"key": "CIT0023", "DOI": "10.1046/j.1365-2796.2000.00742.x", "doi-asserted-by": "publisher"}, {"key": "CIT0024", "DOI": "10.3322/canjclin.56.2.69", "doi-asserted-by": "publisher"}, {"key": "CIT0025", "DOI": "10.1016/j.coi.2007.01.001", "doi-asserted-by": "publisher"}, {"key": "CIT0026", "DOI": "10.1007/BF02899679", "doi-asserted-by": "publisher"}, {"key": "CIT0027", "DOI": "10.1016/S1383-5742(00)00028-4", "doi-asserted-by": "publisher"}, {"key": "CIT0028", "DOI": "10.1111/j.1469-7580.2006.00626.x", "doi-asserted-by": "publisher"}, {"key": "CIT0029", "DOI": "10.1111/j.1600-065X.1997.tb00994.x", "doi-asserted-by": "publisher"}, {"key": "CIT0030", "author": "He X", "volume": "27", "first-page": "589", "year": "2000", "journal-title": "J Rheumatol."}, {"key": "CIT0031", "DOI": "10.4049/jimmunol.165.11.6590", "doi-asserted-by": "publisher"}, {"key": "CIT0032", "DOI": "10.1016/S1081-1206(10)62005-4", "doi-asserted-by": "publisher"}, {"key": "CIT0033", "DOI": "10.1097/00062752-200001000-00007", "doi-asserted-by": "publisher"}, {"key": "CIT0034", "DOI": "10.1038/nature01321", "doi-asserted-by": "publisher"}, {"key": "CIT0035", "DOI": "10.1038/nature01320", "doi-asserted-by": "publisher"}, {"key": "CIT0036", "DOI": "10.1046/j.1365-2567.1998.00473.x", "doi-asserted-by": "publisher"}, {"key": "CIT0037", "author": "Mukaida N", "volume": "72", "first-page": "391", "year": "2000", "journal-title": "Int J Hematol."}, {"key": "CIT0038", "DOI": "10.1016/0006-291X(89)92366-8", "doi-asserted-by": "publisher"}, {"key": "CIT0039", "DOI": "10.1016/0006-2952(91)90528-D", "doi-asserted-by": "publisher"}, {"key": "CIT0040", "DOI": "10.1021/bi00411a039", "doi-asserted-by": "publisher"}, {"key": "CIT0041", "author": "Crowther M", "volume": "70", "first-page": "478", "year": "2001", "journal-title": "J Leukoc Biol."}, {"key": "CIT0042", "author": "Elgert KD", "volume": "64", "first-page": "275", "year": "1998", "journal-title": "J Leukoc Biol.", "DOI": "10.1002/jlb.64.3.275", "doi-asserted-by": "crossref"}, {"key": "CIT0043", "DOI": "10.1016/0167-5699(92)90008-U", "doi-asserted-by": "publisher"}, {"key": "CIT0044", "author": "Mantovani A", "volume": "71", "first-page": "5", "year": "1994", "journal-title": "Lab Invest"}, {"key": "CIT0045", "author": "Polverini PJ", "volume": "51", "first-page": "635", "year": "1984", "journal-title": "Lab Invest."}, {"key": "CIT0046", "DOI": "10.1038/35077241", "doi-asserted-by": "publisher"}, {"key": "CIT0047", "DOI": "10.1159/000163654", "doi-asserted-by": "publisher"}, {"key": "CIT0048", "DOI": "10.1002/path.1027", "doi-asserted-by": "publisher"}, {"key": "CIT0049", "DOI": "10.1189/jlb.0905495", "doi-asserted-by": "publisher"}, {"key": "CIT0050", "DOI": "10.1016/S0002-9440(10)62038-X", "doi-asserted-by": "publisher"}, {"key": "CIT0051", "author": "Komori A", "volume": "53", "first-page": "1982", "year": "1993", "journal-title": "Cancer Res."}, {"key": "CIT0052", "DOI": "10.1016/0027-5107(94)90245-3", "doi-asserted-by": "publisher"}, {"key": "CIT0053", "DOI": "10.1016/S0960-7404(02)00015-4", "doi-asserted-by": "publisher"}, {"key": "CIT0054", "DOI": "10.1073/pnas.012511599", "doi-asserted-by": "publisher"}, {"key": "CIT0055", "author": "Couturier J", "volume": "65", "first-page": "4534", "year": "1991", "journal-title": "J Virol."}, {"key": "CIT0056", "DOI": "10.1054/mehy.2001.1326", "doi-asserted-by": "publisher"}, {"key": "CIT0057", "DOI": "10.3201/eid0403.980339", "doi-asserted-by": "publisher"}, {"key": "CIT0058", "DOI": "10.1016/S1470-2045(03)01220-8", "doi-asserted-by": "publisher"}, {"key": "CIT0059", "DOI": "10.1038/ncponc0140", "doi-asserted-by": "publisher"}, {"issue": "49", "key": "CIT0060", "first-page": "15", "volume": "24", "author": "Crofford LJ", "year": "1997", "journal-title": "J Rheumatol."}, {"key": "CIT0061", "DOI": "10.1016/S1567-5769(01)00102-3", "doi-asserted-by": "publisher"}, {"key": "CIT0062", "author": "Leek RD", "volume": "56", "first-page": "423", "year": "1994", "journal-title": "J Leukoc Biol.", "DOI": "10.1002/jlb.56.4.423", "doi-asserted-by": "crossref"}, {"key": "CIT0063", "DOI": "10.1006/scbi.2001.0419", "doi-asserted-by": "publisher"}, {"key": "CIT0064", "DOI": "10.1056/NEJM198612253152606", "doi-asserted-by": "publisher"}, {"key": "CIT0065", "DOI": "10.1081/CNV-120003548", "doi-asserted-by": "publisher"}, {"key": "CIT0066", "author": "Shih IM", "volume": "8", "first-page": "113", "year": "1994", "journal-title": "In Vivo"}, {"key": "CIT0067", "author": "Singh RK", "volume": "15", "first-page": "843", "year": "2000", "journal-title": "Histol Histopathol."}, {"key": "CIT0068", "author": "Herlyn M", "volume": "61", "first-page": "4642", "year": "2001", "journal-title": "Cancer Res."}, {"key": "CIT0069", "author": "Luan J", "volume": "62", "first-page": "588", "year": "1997", "journal-title": "J Leukoc Biol.", "DOI": "10.1002/jlb.62.5.588", "doi-asserted-by": "crossref"}, {"key": "CIT0070", "DOI": "10.1172/JCI117933", "doi-asserted-by": "publisher"}, {"key": "CIT0071", "DOI": "10.1007/978-1-4615-2952-1_6", "doi-asserted-by": "publisher"}, {"key": "CIT0072", "author": "Al Sarireh B", "volume": "45", "first-page": "1", "year": "2000", "journal-title": "JR Coll Surg Edinb."}, {"key": "CIT0073", "DOI": "10.1007/s002800051101", "doi-asserted-by": "publisher"}, {"key": "CIT0074", "author": "Lewis CE", "volume": "57", "first-page": "747", "year": "1995", "journal-title": "J Leukoc Biol.", "DOI": "10.1002/jlb.57.5.747", "doi-asserted-by": "crossref"}, {"key": "CIT0075", "DOI": "10.1038/269804a0", "doi-asserted-by": "publisher"}, {"key": "CIT0076", "DOI": "10.1158/0008-5472.CAN-05-2714", "doi-asserted-by": "publisher"}, {"key": "CIT0077", "DOI": "10.1158/0008-5472.CAN-05-4005", "doi-asserted-by": "publisher"}, {"key": "CIT0078", "DOI": "10.1007/s10555-006-9001-7", "doi-asserted-by": "publisher"}, {"key": "CIT0079", "author": "Shimura S", "volume": "60", "first-page": "5857", "year": "2000", "journal-title": "Cancer Res."}, {"key": "CIT0080", "DOI": "10.1002/(SICI)1097-0215(19990219)84:1<74::AID-IJC14>3.0.CO;2-I", "doi-asserted-by": "publisher"}, {"key": "CIT0081", "DOI": "10.1007/BF01525986", "doi-asserted-by": "publisher"}, {"key": "CIT0082", "DOI": "10.1046/j.1442-2042.2000.00190.x", "doi-asserted-by": "publisher"}, {"key": "CIT0083", "DOI": "10.1038/bjc.1998.280", "doi-asserted-by": "publisher"}, {"key": "CIT0084", "author": "Nishie A", "volume": "5", "first-page": "1107", "year": "1999", "journal-title": "Clin Cancer Res."}, {"key": "CIT0085", "DOI": "10.1002/(SICI)1097-0215(19991022)84:5<538::AID-IJC17>3.0.CO;2-B", "doi-asserted-by": "publisher"}, {"key": "CIT0086", "DOI": "10.1097/00008390-200510000-00010", "doi-asserted-by": "publisher"}, {"key": "CIT0087", "author": "Singh RK", "volume": "59", "first-page": "3107", "year": "1999", "journal-title": "Cancer Res."}, {"key": "CIT0088", "DOI": "10.1158/1078-0432.CCR-05-1346", "doi-asserted-by": "publisher"}, {"key": "CIT0089", "author": "Sunderkotter C", "volume": "55", "first-page": "410", "year": "1994", "journal-title": "J Leukoc Biol.", "DOI": "10.1002/jlb.55.3.410", "doi-asserted-by": "crossref"}, {"key": "CIT0090", "DOI": "10.1056/NEJM197108122850711", "doi-asserted-by": "publisher"}, {"key": "CIT0091", "DOI": "10.1002/(SICI)1097-0215(20000115)85:2%3C182::AID-IJC6%3E3.0.CO;2-M", "doi-asserted-by": "publisher"}, {"key": "CIT0092", "author": "Ueno T", "volume": "6", "first-page": "3282", "year": "2000", "journal-title": "Clin. Cancer Res."}, {"key": "CIT0093", "DOI": "10.1159/000012021", "doi-asserted-by": "publisher"}, {"key": "CIT0094", "DOI": "10.1089/jir.2005.25.674", "doi-asserted-by": "publisher"}, {"key": "CIT0095", "DOI": "10.1038/bjc.1977.89", "doi-asserted-by": "publisher"}, {"key": "CIT0096", "DOI": "10.1089/cbr.1994.9.163", "doi-asserted-by": "publisher"}, {"key": "CIT0097", "DOI": "10.1146/annurev.med.49.1.407", "doi-asserted-by": "publisher"}, {"key": "CIT0098", "DOI": "10.1007/BF00052607", "doi-asserted-by": "publisher"}, {"key": "CIT0099", "DOI": "10.1038/nm0295-149", "doi-asserted-by": "publisher"}, {"key": "CIT0100", "DOI": "10.1096/fj.01-0813com", "doi-asserted-by": "publisher"}, {"key": "CIT0101", "author": "Guba M", "volume": "61", "first-page": "5575", "year": "2001", "journal-title": "Cancer Res."}, {"key": "CIT0102", "DOI": "10.1016/S0065-230X(08)60469-8", "doi-asserted-by": "publisher"}, {"key": "CIT0103", "author": "Bayer-Garner IB", "volume": "12", "first-page": "770", "year": "1999", "journal-title": "Mod Pathol."}, {"key": "CIT0104", "author": "Graham CH", "volume": "145", "first-page": "510", "year": "1994", "journal-title": "Am J Pathol."}, {"key": "CIT0105", "DOI": "10.1007/s004280100480", "doi-asserted-by": "publisher"}, {"key": "CIT0106", "author": "Singh RK", "volume": "12", "first-page": "285", "year": "1993", "journal-title": "Lymphokine Cytokine Res."}, {"key": "CIT0107", "DOI": "10.1007/s00262-002-0309-z", "doi-asserted-by": "publisher"}, {"key": "CIT0108", "DOI": "10.1615/JEnvironPatholToxicolOncol.v21.i2.130", "doi-asserted-by": "publisher"}], "container-title": ["Clinical Research and Regulatory Affairs"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.1080/10601330802208291", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 13]], "date-time": "2019-05-13T04:35:08Z", "timestamp": 1557722108000}, "score": 22.172438, "issued": {"date-parts": [[2008, 1]]}, "references-count": 108, "journal-issue": {"published-online": {"date-parts": [[2008, 10, 20]]}, "published-print": {"date-parts": [[2008, 1]]}, "issue": "3"}, "alternative-id": ["10.1080/10601330802208291"], "URL": "http://dx.doi.org/10.1080/10601330802208291", "relation": {"cites": []}, "ISSN": ["1060-1333", "1532-2521"], "issn-type": [{"value": "1060-1333", "type": "print"}, {"value": "1532-2521", "type": "electronic"}], "subject": ["Pharmacology (medical)", "Pharmacology", "Pharmaceutical Science"]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T00:27:23Z", "timestamp": 1574728043650}, "reference-count": 144, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "https://www.elsevier.com/open-access/userlicense/1.0/", "start": {"date-parts": [[2016, 9, 15]], "date-time": "2016-09-15T00:00:00Z", "timestamp": 1473897600000}, "delay-in-days": 380, "content-version": "vor"}], "content-domain": {"domain": ["cell.com", "elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Immunity"], "published-print": {"date-parts": [[2015, 9]]}, "DOI": "10.1016/j.immuni.2015.09.001", "type": "journal-article", "created": {"date-parts": [[2015, 9, 15]], "date-time": "2015-09-15T15:46:30Z", "timestamp": 1442331990000}, "page": "435-449", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 117, "title": ["Metabolic Reprogramming of Immune Cells in Cancer Progression"], "prefix": "10.1016", "volume": "43", "author": [{"given": "Subhra\u00a0K.", "family": "Biswas", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Immunity"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1074761315003611?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1074761315003611?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 8, 30]], "date-time": "2019-08-30T15:49:24Z", "timestamp": 1567180164000}, "score": 22.10305, "issued": {"date-parts": [[2015, 9]]}, "references-count": 144, "journal-issue": {"published-print": {"date-parts": [[2015, 9]]}, "issue": "3"}, "alternative-id": ["S1074761315003611"], "URL": "http://dx.doi.org/10.1016/j.immuni.2015.09.001", "ISSN": ["1074-7613"], "issn-type": [{"value": "1074-7613", "type": "print"}], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Metabolic Reprogramming of Immune Cells in Cancer Progression", "name": "articletitle", "label": "Article Title"}, {"value": "Immunity", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.immuni.2015.09.001", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "Copyright \u00a9 2015 Elsevier Inc. All rights reserved.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T05:29:56Z", "timestamp": 1574486996776}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2009, 12, 15]]}, "DOI": "10.1158/0008-5472.sabcs-09-4132", "type": "proceedings-article", "created": {"date-parts": [[2010, 12, 30]], "date-time": "2010-12-30T23:32:01Z", "timestamp": 1293751921000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Peri-Operative Suppression of Immune-Regulatory Blood Cells Predicts Wound Complications in Breast Cancer Patients."], "prefix": "10.1158", "author": [{"given": "B.", "family": "Hogan", "sequence": "first", "affiliation": []}, {"given": "M.", "family": "Peter", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Thorpe", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Achuthan", "sequence": "additional", "affiliation": []}, {"given": "C.", "family": "Carter", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Horgan", "sequence": "additional", "affiliation": []}, {"given": "T.", "family": "Hughes", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2014, 11, 5]]}, "event": {"name": "Abstracts: Thirty-Second Annual CTRC\u2010AACR San Antonio Breast Cancer Symposium\u2010\u2010 Dec 10\u201013, 2009; San Antonio, TX"}, "container-title": ["Poster Session Abstracts"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/0008-5472.SABCS-09-4132", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 18]], "date-time": "2019-05-18T22:18:05Z", "timestamp": 1558217885000}, "score": 22.100632, "issued": {"date-parts": [[2009, 12, 15]]}, "references-count": 0, "alternative-id": ["10.1158/0008-5472.SABCS-09-4132"], "URL": "http://dx.doi.org/10.1158/0008-5472.sabcs-09-4132"}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T16:52:33Z", "timestamp": 1574527953315}, "reference-count": 0, "publisher": "InTech", "isbn-type": [{"value": "9789535109327", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.5772/52751", "type": "book-chapter", "created": {"date-parts": [[2013, 1, 17]], "date-time": "2013-01-17T12:58:11Z", "timestamp": 1358427491000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["The Role of E-Cadherin-Catenin Complex in Prostate Cancer Progression"], "prefix": "10.5772", "author": [{"given": "Anuradha", "family": "K.", "sequence": "first", "affiliation": []}, {"given": "James", "family": "S.", "sequence": "additional", "affiliation": []}], "member": "3774", "published-online": {"date-parts": [[2013, 1, 16]]}, "container-title": ["Advances in Prostate Cancer"], "link": [{"URL": "http://www.intechopen.com/download/pdf/41843", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 29]], "date-time": "2016-12-29T10:47:26Z", "timestamp": 1483008446000}, "score": 22.089363, "issued": {"date-parts": [[2013, 1, 16]]}, "ISBN": ["9789535109327"], "references-count": 0, "URL": "http://dx.doi.org/10.5772/52751"}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T00:35:00Z", "timestamp": 1574296500021}, "publisher-location": "Totowa, NJ", "reference-count": 247, "publisher": "Humana Press", "isbn-type": [{"value": "9781603279321", "type": "print"}, {"value": "9781603279338", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2009]]}, "DOI": "10.1007/978-1-60327-933-8_23", "type": "book-chapter", "created": {"date-parts": [[2009, 4, 18]], "date-time": "2009-04-18T17:10:08Z", "timestamp": 1240074608000}, "page": "287-308", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Critical Roles of Tumorigenic and Migrating Cancer Stem/Progenitor Cells in Cancer Progression and their Therapeutic Implications"], "prefix": "10.1007", "author": [{"given": "Murielle", "family": "Mimeault", "sequence": "first", "affiliation": []}, {"given": "Surinder K.", "family": "Batra", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2009, 3, 9]]}, "reference": [{"key": "23_CR1_23", "doi-asserted-by": "publisher", "first-page": "7274", "DOI": "10.1038/sj.onc.1207947", "volume": "23", "author": "M Al-Hajj", "year": "2004", "unstructured": "1. Al-Hajj M, Clarke MF. Self-renewal and solid tumor stem cells. Oncogene 2004;23:7274\u201382.", "journal-title": "Oncogene"}, {"key": "23_CR2_23", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1016/j.critrevonc.2004.04.007", "volume": "51", "author": "S Sell", "year": "2004", "unstructured": "2. Sell S. Stem cell origin of cancer and differentiation therapy. Crit Rev Oncol Hematol 2004;51:1\u201328.", "journal-title": "Crit Rev Oncol Hematol"}, {"key": "23_CR3_23", "doi-asserted-by": "publisher", "first-page": "324", "DOI": "10.1038/nature03100", "volume": "432", "author": "PA Beachy", "year": "2004", "unstructured": "3. Beachy PA, Karhadkar SS, Berman DM. Tissue repair and stem cell renewal in carcinogenesis. Nature 2004;432:324\u201331.", "journal-title": "Nature"}, {"key": "23_CR4_23", "doi-asserted-by": "crossref", "first-page": "3025", "DOI": "10.1158/0008-5472.CAN-04-3931", "volume": "65", "author": "SA Bapat", "year": "2005", "unstructured": "4. Bapat SA, Mali AM, Koppikar CB, Kurrey NK. Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res 2005;65:3025\u20139.", "journal-title": "Cancer Res"}, {"key": "23_CR5_23", "doi-asserted-by": "publisher", "first-page": "744", "DOI": "10.1038/nrc1694", "volume": "5", "author": "T Brabletz", "year": "2005", "unstructured": "5. Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T. Opinion: migrating cancer stem cells \u2013 an integrated concept of malignant tumour progression. Nat Rev Cancer 2005;5:744\u20139.", "journal-title": "Nat Rev Cancer"}, {"key": "23_CR6_23", "doi-asserted-by": "publisher", "first-page": "4553", "DOI": "10.1158/0008-5472.CAN-05-3986", "volume": "66", "author": "L Li", "year": "2006", "unstructured": "6. Li L, Neaves WB. Normal stem cells and cancer stem cells: the niche matters. Cancer Res 2006;66:4553\u20137.", "journal-title": "Cancer Res"}, {"key": "23_CR7_23", "doi-asserted-by": "publisher", "first-page": "425", "DOI": "10.1038/nrc1889", "volume": "6", "author": "AL Vescovi", "year": "2006", "unstructured": "7. Vescovi AL, Galli R, Reynolds BA. Brain tumour stem cells. Nat Rev Cancer 2006;6:425\u201336.", "journal-title": "Nat Rev Cancer"}, {"key": "23_CR8_23", "doi-asserted-by": "publisher", "first-page": "607", "DOI": "10.1158/1541-7786.MCR-06-0005", "volume": "4", "author": "CL Tso", "year": "2006", "unstructured": "8. Tso CL, Shintaku P, Chen J et al. Primary glioblastomas express mesenchymal stem-like properties. Mol Cancer Res 2006;4:607\u201319.", "journal-title": "Mol Cancer Res"}, {"key": "23_CR9_23", "doi-asserted-by": "publisher", "first-page": "6063", "DOI": "10.1158/0008-5472.CAN-06-0054", "volume": "66", "author": "S Liu", "year": "2006", "unstructured": "9. Liu S, Dontu G, Mantle ID et al. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 2006;66:6063\u201371.", "journal-title": "Cancer Res"}, {"key": "23_CR10_23", "doi-asserted-by": "publisher", "first-page": "217", "DOI": "10.1016/j.nbd.2006.08.022", "volume": "25", "author": "SK Nicolis", "year": "2007", "unstructured": "10. Nicolis SK. Cancer stem cells and \u201cstemness\u201d genes in neuro-oncology. Neurobiol Dis 2007;25:217\u201329.", "journal-title": "Neurobiol Dis"}, {"key": "23_CR11_23", "doi-asserted-by": "publisher", "first-page": "673", "DOI": "10.1038/sj.clpt.6100296", "volume": "83", "author": "M Mimeault", "year": "2008", "unstructured": "11. Mimeault M, Hauke R, Batra SK. Recent advances on the molecular mechanisms involved in drug-resistance of cancer cells and novel targeting therapies. Clin Pharmacol Ther 2008;83:673\u201391.", "journal-title": "Clin Pharmacol Ther"}, {"key": "23_CR12_23", "doi-asserted-by": "publisher", "first-page": "981", "DOI": "10.1111/j.1582-4934.2007.00088.x", "volume": "11", "author": "M Mimeault", "year": "2007", "unstructured": "12. Mimeault M, Hauke R, Mehta PP, Batra SK. Recent advances on cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers. J Mol Cell Med 2007;11:981\u20131011.", "journal-title": "J Mol Cell Med"}, {"key": "23_CR13_23", "doi-asserted-by": "publisher", "first-page": "252", "DOI": "10.1038/sj.clpt.6100301", "volume": "82", "author": "M Mimeault", "year": "2007", "unstructured": "13. Mimeault M, Hauke R, Batra SK. Stem cells \u2013 A revolution in therapeutics\u2013Recent advances on the stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies. Clin Pharmacol Ther 2007;82:252\u201364.", "journal-title": "Clin Pharmacol Ther"}, {"key": "23_CR14_23", "unstructured": "14. Mimeault M, Batra SK. Stem cell applications in disease research: Recent advances on stem cell and cancer stem cell biology and their therapeutic implications. In: Allen V. Faraday and Jonathon T. Dyer, eds. Progress in stem cell applications, NOVA Publisher 2008;57\u201398.", "DOI": "10.1007/s12015-008-9008-2", "doi-asserted-by": "publisher"}, {"key": "23_CR15_23", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1093/carcin/bgi229", "volume": "27", "author": "M Mimeault", "year": "2006", "unstructured": "15. Mimeault M, Batra SK. Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies. Carcinogenesis 2006;27:1\u201322.", "journal-title": "Carcinogenesis"}, {"key": "23_CR16_23", "doi-asserted-by": "publisher", "first-page": "2319", "DOI": "10.1634/stemcells.2006-0066", "volume": "24", "author": "M Mimeault", "year": "2006", "unstructured": "16. Mimeault M, Batra SK. Recent advances on the significance of stem cells in tissue regeneration and cancer therapies. Stem Cells 2006; 24:2319\u201345.", "journal-title": "Stem Cells"}, {"key": "23_CR17_23", "doi-asserted-by": "publisher", "first-page": "234", "DOI": "10.1210/er.2007-0040", "volume": "29", "author": "M Mimeault", "year": "2008", "unstructured": "17. Mimeault M, Mehta PP, Hauke R, Batra SK. Functions of normal and malignant prostatic stem/progenitor cells in tissue regeneration and cancer progression and novel targeting therapies against advanced prostate cancers. Endocr Rev 2008;29:234\u201352.", "journal-title": "Endocr Rev"}, {"key": "23_CR18_23", "doi-asserted-by": "publisher", "first-page": "1605", "DOI": "10.1093/annonc/mdm070", "volume": "18", "author": "M Mimeault", "year": "2007", "unstructured": "18. Mimeault M, Batra SK. Interplay of distinct growth factors during epithelial-mesenchymal transition of cancer progenitor cells and molecular targeting as novel cancer therapies. Ann Oncol 2007;18:1605\u201319.", "journal-title": "Ann Oncol"}, {"key": "23_CR19_23", "doi-asserted-by": "publisher", "first-page": "203", "DOI": "10.1007/s10555-007-9052-4", "volume": "26", "author": "M Mimeault", "year": "2007", "unstructured": "19. Mimeault M, Batra SK. Functions of tumorigenic and migrating cancer progenitor cells in cancer progression and metastasis and their therapeutic implications. Cancer Metastasis Rev 2007;26:203\u201314.", "journal-title": "Cancer Metastasis Rev"}, {"key": "23_CR20_23", "doi-asserted-by": "publisher", "first-page": "27", "DOI": "10.1007/s12015-008-9008-2", "volume": "4", "author": "M Mimeault", "year": "2008", "unstructured": "20. Mimeault M, Batra SK. Recent progress on tissue-resident adult stem cell biology and their therapeutic implications. Stem Cell Rev 2008;4:27\u201349.", "journal-title": "Stem Cell Rev"}, {"key": "23_CR21_23", "doi-asserted-by": "publisher", "first-page": "313", "DOI": "10.1016/j.stem.2007.06.002", "volume": "1", "author": "PC Hermann", "year": "2007", "unstructured": "21. Hermann PC, Huber SL, Herrler T et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cells 2007;1:313\u201323.", "journal-title": "Cell Stem Cells"}, {"key": "23_CR22_23", "doi-asserted-by": "publisher", "first-page": "279", "DOI": "10.1007/s11154-007-9037-1", "volume": "8", "author": "ES Radisky", "year": "2007", "unstructured": "22. Radisky ES, Radisky DC. Stromal induction of breast cancer: inflammation and invasion. Rev Endocr Metab Disord 2007;8:279\u2013287.", "journal-title": "Rev Endocr Metab Disord"}, {"key": "23_CR23_23", "doi-asserted-by": "publisher", "first-page": "699", "DOI": "10.1002/ijc.22871", "volume": "121", "author": "J Kleeff", "year": "2007", "unstructured": "23. Kleeff J, Beckhove P, Esposito I et al. Pancreatic cancer microenvironment. Int J Cancer 2007;121:699\u2013705.", "journal-title": "Int J Cancer"}, {"key": "23_CR24_23", "doi-asserted-by": "publisher", "first-page": "9392", "DOI": "10.1038/sj.onc.1208311", "volume": "23", "author": "X Yuan", "year": "2004", "unstructured": "24. Yuan X, Curtin J, Xiong Y et al. Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 2004;23:9392\u2013400.", "journal-title": "Oncogene"}, {"key": "23_CR25_23", "doi-asserted-by": "publisher", "first-page": "7011", "DOI": "10.1158/0008-5472.CAN-04-1364", "volume": "64", "author": "R Galli", "year": "2004", "unstructured": "25. Galli R, Binda E, Orfanelli U et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 2004;64:7011\u201321.", "journal-title": "Cancer Res"}, {"key": "23_CR26_23", "doi-asserted-by": "publisher", "first-page": "67", "DOI": "10.1186/1476-4598-5-67", "volume": "5", "author": "G Liu", "year": "2006", "unstructured": "26. Liu G, Yuan X, Zeng Z et al. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 2006;5:67.", "journal-title": "Mol Cancer"}, {"key": "23_CR27_23", "doi-asserted-by": "publisher", "first-page": "756", "DOI": "10.1038/nature05236", "volume": "444", "author": "S Bao", "year": "2006", "unstructured": "27. Bao S, Wu Q, McLendon RE et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006;444:756\u201360.", "journal-title": "Nature"}, {"key": "23_CR28_23", "doi-asserted-by": "publisher", "first-page": "506", "DOI": "10.1634/stemcells.2005-0282", "volume": "24", "author": "N Haraguchi", "year": "2006", "unstructured": "28. Haraguchi N, Utsunomiya T, Inoue H et al. Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells 2006;24:506\u201313.", "journal-title": "Stem Cells"}, {"key": "23_CR29_23", "doi-asserted-by": "publisher", "first-page": "327", "DOI": "10.1097/01.JTO.0000263718.69320.4c", "volume": "2", "author": "M Sato", "year": "2007", "unstructured": "29. Sato M, Shames DS, Gazdar AF, Minna JD. A translational view of the molecular pathogenesis of lung cancer. J Thorac Oncol 2007;2:327\u201343.", "journal-title": "J Thorac Oncol"}, {"key": "23_CR30_23", "doi-asserted-by": "publisher", "first-page": "7443", "DOI": "10.1038/sj.onc.1209091", "volume": "24", "author": "L Larue", "year": "2005", "unstructured": "30. Larue L, Bellacosa A. Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3\u2032 kinase/AKT pathways. Oncogene 2005;24:7443\u201354.", "journal-title": "Oncogene"}, {"key": "23_CR31_23", "doi-asserted-by": "publisher", "first-page": "442", "DOI": "10.1038/nrc822", "volume": "2", "author": "JP Thiery", "year": "2002", "unstructured": "31. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002;2:442\u201354.", "journal-title": "Nat Rev Cancer"}, {"key": "23_CR32_23", "doi-asserted-by": "publisher", "first-page": "9", "DOI": "10.1016/S1383-5742(03)00033-4", "volume": "566", "author": "J Gotzmann", "year": "2004", "unstructured": "32. Gotzmann J, Mikula M, Eger A et al. Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis. Mutat Res 2004;566:9\u201320.", "journal-title": "Mutat Res"}, {"key": "23_CR33_23", "doi-asserted-by": "publisher", "first-page": "11254", "DOI": "10.1158/0008-5472.CAN-07-2253", "volume": "67", "author": "AM Eastham", "year": "2007", "unstructured": "33. Eastham AM, Spencer H, Soncin F et al. Epithelial-mesenchymal transition events during human embryonic stem cell differentiation. Cancer Res 2007;67:11254\u201362.", "journal-title": "Cancer Res"}, {"key": "23_CR34_23", "doi-asserted-by": "publisher", "first-page": "805", "DOI": "10.1634/stemcells.2004-0234", "volume": "23", "author": "R Behr", "year": "2005", "unstructured": "34. Behr R, Heneweer C, Viebahn C, Denker HW, Thie M. Epithelial-mesenchymal transition in colonies of rhesus monkey embryonic stem cells: a model for processes involved in gastrulation. Stem Cells 2005;23:805\u201316.", "journal-title": "Stem Cells"}, {"key": "23_CR35_23", "doi-asserted-by": "publisher", "first-page": "1535", "DOI": "10.1002/dvdy.20482", "volume": "233", "author": "KM Barrow", "year": "2005", "unstructured": "35. Barrow KM, Ward CM, Rutter J, Ali S, Stern PL. Embryonic expression of murine 5T4 oncofoetal antigen is associated with morphogenetic events at implantation and in developing epithelia. Dev Dyn 2005;233:1535\u201345.", "journal-title": "Dev Dyn"}, {"key": "23_CR36_23", "doi-asserted-by": "publisher", "first-page": "21", "DOI": "10.1093/molehr/gal091", "volume": "13", "author": "U Ullmann", "year": "2007", "unstructured": "36. Ullmann U, In\u2019t VP, Gilles C et al. Epithelial-mesenchymal transition process in human embryonic stem cells cultured in feeder-free conditions. Mol Hum Reprod 2007;13:21\u201332.", "journal-title": "Mol Hum Reprod"}, {"key": "23_CR37_23", "doi-asserted-by": "publisher", "first-page": "463", "DOI": "10.1387/ijdb.041793ld", "volume": "48", "author": "LD Derycke", "year": "2004", "unstructured": "37. Derycke LD, Bracke ME. N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling. Int J Dev Biol 2004;48:463\u201376.", "journal-title": "Int J Dev Biol"}, {"key": "23_CR38_23", "doi-asserted-by": "publisher", "first-page": "973", "DOI": "10.1083/jcb.200601018", "volume": "172", "author": "JM Lee", "year": "2006", "unstructured": "38. Lee JM, Dedhar S, Kalluri R, Thompson EW. The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 2006;172:973\u201381.", "journal-title": "J Cell Biol"}, {"key": "23_CR39_23", "doi-asserted-by": "publisher", "first-page": "657", "DOI": "10.1038/nrm1175", "volume": "4", "author": "S Grunert", "year": "2003", "unstructured": "39. Grunert S, Jechlinger M, Beug H. Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat Rev Mol Cell Biol 2003;4:657\u201365.", "journal-title": "Nat Rev Mol Cell Biol"}, {"key": "23_CR40_23", "doi-asserted-by": "publisher", "first-page": "118", "DOI": "10.1038/nrc1276", "volume": "4", "author": "U Cavallaro", "year": "2004", "unstructured": "40. Cavallaro U, Christofori G. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 2004;4:118\u201332.", "journal-title": "Nat Rev Cancer"}, {"key": "23_CR41_23", "doi-asserted-by": "publisher", "first-page": "58", "DOI": "10.1196/annals.1294.006", "volume": "1014", "author": "U Cavallaro", "year": "2004", "unstructured": "41. Cavallaro U, Christofori G. Multitasking in tumor progression: signaling functions of cell adhesion molecules. Ann N Y Acad Sci 2004;1014:58\u201366.", "journal-title": "Ann N Y Acad Sci"}, {"key": "23_CR42_23", "doi-asserted-by": "publisher", "first-page": "740", "DOI": "10.1016/j.ceb.2003.10.006", "volume": "15", "author": "JP Thiery", "year": "2003", "unstructured": "42. Thiery JP. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2003;15:740\u20136.", "journal-title": "Curr Opin Cell Biol"}, {"issue": "2", "key": "23_CR43_23", "doi-asserted-by": "publisher", "first-page": "133", "DOI": "10.1038/nrc725", "volume": "2", "author": "E Sahai", "year": "2002", "unstructured": "43. Sahai E, Marshall CJ. RHO-GTPases and cancer. Nat Rev Cancer 2002;2(2):133\u2013142.", "journal-title": "Nat Rev Cancer"}, {"key": "23_CR44_23", "doi-asserted-by": "publisher", "first-page": "5532", "DOI": "10.1038/sj.onc.1207718", "volume": "23", "author": "B Seidel", "year": "2004", "unstructured": "44. Seidel B, Braeg S, Adler G, Wedlich D, Menke A. E- and N-cadherin differ with respect to their associated p120ctn isoforms and their ability to suppress invasive growth in pancreatic cancer cells. Oncogene 2004;23:5532\u201342.", "journal-title": "Oncogene"}, {"key": "23_CR45_23", "doi-asserted-by": "publisher", "first-page": "365", "DOI": "10.4161/cbt.4.4.1655", "volume": "4", "author": "RC Bates", "year": "2005", "unstructured": "45. Bates RC, Mercurio AM. The epithelial-mesenchymal transition (EMT) and colorectal cancer progression. Cancer Biol Ther 2005;4:365\u201370.", "journal-title": "Cancer Biol Ther"}, {"key": "23_CR46_23", "doi-asserted-by": "publisher", "first-page": "3272", "DOI": "10.1038/sj.onc.1207439", "volume": "23", "author": "D Sarrio", "year": "2004", "unstructured": "46. Sarrio D, Perez-Mies B, Hardisson D et al. Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions. Oncogene 2004;23:3272\u201383.", "journal-title": "Oncogene"}, {"key": "23_CR47_23", "doi-asserted-by": "publisher", "first-page": "912", "DOI": "10.1002/bies.1132", "volume": "23", "author": "P Savagner", "year": "2001", "unstructured": "47. Savagner P. Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays 2001;23:912\u201323.", "journal-title": "Bioessays"}, {"key": "23_CR48_23", "doi-asserted-by": "publisher", "first-page": "46", "DOI": "10.1038/35094059", "volume": "1", "author": "MJ Bissell", "year": "2001", "unstructured": "48. Bissell MJ, Radisky D. Putting tumours in context. Nat Rev Cancer 2001;1:46\u201354.", "journal-title": "Nat Rev Cancer"}, {"key": "23_CR49_23", "doi-asserted-by": "publisher", "first-page": "548", "DOI": "10.1016/j.ceb.2005.08.001", "volume": "17", "author": "MA Huber", "year": "2005", "unstructured": "49. Huber MA, Kraut N, Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 2005;17:548\u201358.", "journal-title": "Curr Opin Cell Biol"}, {"key": "23_CR50_23", "doi-asserted-by": "publisher", "first-page": "1155", "DOI": "10.1038/sj.emboj.7600069", "volume": "23", "author": "J Zavadil", "year": "2004", "unstructured": "50. Zavadil J, Cermak L, Soto-Nieves N, Bottinger EP. Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J 2004;23:1155\u201365.", "journal-title": "EMBO J"}, {"key": "23_CR51_23", "doi-asserted-by": "publisher", "first-page": "1059", "DOI": "10.4161/cbt.5.9.3151", "volume": "5", "author": "M Katoh", "year": "2006", "unstructured": "51. Katoh M, Katoh M. Cross-talk of WNT and FGF signaling pathways at GSK3beta to regulate beta-catenin and SNAIL signaling cascades. Cancer Biol Ther 2006;5:1059\u201364.", "journal-title": "Cancer Biol Ther"}, {"key": "23_CR52_23", "doi-asserted-by": "publisher", "first-page": "918", "DOI": "10.1002/jcb.20458", "volume": "95", "author": "M Davies", "year": "2005", "unstructured": "52. Davies M, Robinson M, Smith E, Huntley S, Prime S, Paterson I. Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-beta1 involves MAPK, Smad and AP-1 signalling pathways. J Cell Biochem 2005;95:918\u201331.", "journal-title": "J Cell Biochem"}, {"key": "23_CR53_23", "doi-asserted-by": "publisher", "first-page": "4227", "DOI": "10.1242/jcs.00091", "volume": "115", "author": "M Grande", "year": "2002", "unstructured": "53. Grande M, Franzen A, Karlsson JO, Ericson LE, Heldin NE, Nilsson M. Transforming growth factor-beta and epidermal growth factor synergistically stimulate epithelial to mesenchymal transition (EMT) through a MEK-dependent mechanism in primary cultured pig thyrocytes. J Cell Sci 2002;115:4227\u201336.", "journal-title": "J Cell Sci"}, {"key": "23_CR54_23", "doi-asserted-by": "publisher", "first-page": "457", "DOI": "10.1111/j.0022-202X.2004.23590.x", "volume": "124", "author": "RL Bigelow", "year": "2005", "unstructured": "54. Bigelow RL, Jen EY, Delehedde M, Chari NS, McDonnell TJ. Sonic hedgehog induces epidermal growth factor dependent matrix infiltration in HaCaT keratinocytes. J Invest Dermatol 2005;124:457\u201365.", "journal-title": "J Invest Dermatol"}, {"key": "23_CR55_23", "doi-asserted-by": "publisher", "first-page": "6283", "DOI": "10.1128/MCB.02317-05", "volume": "26", "author": "M Kasper", "year": "2006", "unstructured": "55. Kasper M, Schnidar H, Neill GW et al. Selective modulation of hedgehog/GLI target gene expression by epidermal growth factor signaling in human keratinocytes. Mol Cell Biol 2006;26:6283\u201398.", "journal-title": "Mol Cell Biol"}, {"key": "23_CR56_23", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1158/0008-5472.CAN-05-4478", "volume": "66", "author": "N Oku", "year": "2006", "unstructured": "56. Oku N, Sasabe E, Ueta E, Yamamoto T, Osaki T. Tight junction protein claudin-1 enhances the invasive activity of oral squamous cell carcinoma cells by promoting cleavage of laminin-5 gamma2 chain via matrix metalloproteinase (MMP)-2 and membrane-type MMP-1. Cancer Res 2006;66:1\u20135257.", "journal-title": "Cancer Res"}, {"key": "23_CR57_23", "doi-asserted-by": "publisher", "first-page": "255", "DOI": "10.1002/gcc.10083", "volume": "34", "author": "KM Hajra", "year": "2002", "unstructured": "57. Hajra KM, Fearon ER. Cadherin and catenin alterations in human cancer. Genes Chromosomes Cancer 2002;34:255\u201368.", "journal-title": "Genes Chromosomes Cancer"}, {"key": "23_CR58_23", "doi-asserted-by": "publisher", "first-page": "301", "DOI": "10.1097/01.mpa.0000175893.04660.1b", "volume": "31", "author": "M Mimeault", "year": "2005", "unstructured": "58. Mimeault M, Brand RE, Sasson AA, Batra SK. Recent advances on the molecular mechanisms involved in pancreatic cancer progression and therapies. Pancreas 2005;31:301\u201316.", "journal-title": "Pancreas"}, {"key": "23_CR59_23", "doi-asserted-by": "publisher", "first-page": "843", "DOI": "10.1038/nature03319", "volume": "434", "author": "T Reya", "year": "2005", "unstructured": "59. Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature 2005;434:843\u201350.", "journal-title": "Nature"}, {"key": "23_CR60_23", "doi-asserted-by": "publisher", "first-page": "3585", "DOI": "10.1242/jcs.02532", "volume": "118", "author": "WA Woodward", "year": "2005", "unstructured": "60. Woodward WA, Chen MS, Behbod F, Rosen JM. On mammary stem cells. J Cell Sci 2005;118:3585\u201394.", "journal-title": "J Cell Sci"}, {"key": "23_CR61_23", "doi-asserted-by": "publisher", "first-page": "444", "DOI": "10.1038/nrc1096", "volume": "3", "author": "DM Owens", "year": "2003", "unstructured": "61. Owens DM, Watt FM. Contribution of stem cells and differentiated cells to epidermal tumours. Nat Rev Cancer 2003;3:444\u201351.", "journal-title": "Nat Rev Cancer"}, {"key": "23_CR62_23", "doi-asserted-by": "publisher", "first-page": "1022", "DOI": "10.1002/ijc.21440", "volume": "118", "author": "M Mimeault", "year": "2006", "unstructured": "62. Mimeault M, Moore E, Moniaux N et al. Cytotoxic effects induced by a combination of cyclopamine and gefitinib, the selective hedgehog and epidermal growth factor receptor signaling inhibitors, in prostate cancer cells. Int J Cancer 2006;118:1022\u2013031.", "journal-title": "Int J Cancer"}, {"key": "23_CR63_23", "doi-asserted-by": "publisher", "first-page": "6156", "DOI": "10.1038/sj.onc.1207818", "volume": "23", "author": "G Rao", "year": "2004", "unstructured": "63. Rao G, Pedone CA, Valle LD, Reiss K, Holland EC, Fults DW. Sonic hedgehog and insulin-like growth factor signaling synergize to induce medulloblastoma formation from nestin-expressing neural progenitors in mice. Oncogene 2004;23:6156\u201362.", "journal-title": "Oncogene"}, {"key": "23_CR64_23", "doi-asserted-by": "publisher", "first-page": "117", "DOI": "10.1038/ng1001-117", "volume": "29", "author": "R Derynck", "year": "2001", "unstructured": "64. Derynck R, Akhurst RJ, Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 2001;29:117\u201329.", "journal-title": "Nat Genet"}, {"key": "23_CR65_23", "doi-asserted-by": "crossref", "first-page": "1561", "DOI": "10.1172/JCI24652", "volume": "116", "author": "M Jechlinger", "year": "2006", "unstructured": "65. Jechlinger M, Sommer A, Moriggl R et al. Autocrine PDGFR signaling promotes mammary cancer metastasis. J metastasis. J metastasis. J Clin Invest 2006;116:1561\u201370.", "journal-title": "J metastasis. J metastasis. J Clin Invest"}, {"key": "23_CR66_23", "doi-asserted-by": "publisher", "first-page": "227", "DOI": "10.1016/j.ccr.2006.07.020", "volume": "10", "author": "T Waerner", "year": "2006", "unstructured": "66. Waerner T, Alacakaptan M, Tamir I et al. ILEI: a cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cells. Cancer Cell 2006;10:227\u201339.", "journal-title": "Cancer Cell"}, {"key": "23_CR67_23", "first-page": "3", "volume": "50", "author": "M Mimeault", "year": "2008", "unstructured": "67. Mimeault M, Batra SK. Targeting of cancer stem/progenitor cells plus stem cell-based therapies:an ultimate hope for treating and curing the aggressive and recurrent cancers. Panminerva Medica 2008;50:3\u201318.", "journal-title": "Panminerva Medica"}, {"key": "23_CR68_23", "doi-asserted-by": "publisher", "first-page": "826", "DOI": "10.1038/nrc925", "volume": "2", "author": "S Rafii", "year": "2002", "unstructured": "68. Rafii S, Lyden D, Benezra R, Hattori K, Heissig B. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? Nat Rev Cancer 2002;2:826\u201335.", "journal-title": "Nat Rev Cancer"}, {"key": "23_CR69_23", "doi-asserted-by": "publisher", "first-page": "1597", "DOI": "10.4161/cc.5.15.3112", "volume": "5", "author": "A Orimo", "year": "2006", "unstructured": "69. Orimo A, Weinberg RA. Stromal fibroblasts in cancer: A novel tumor-promoting cell type. Cell Cycle 2006;5:1597\u2013601.", "journal-title": "Cell Cycle"}, {"key": "23_CR70_23", "doi-asserted-by": "publisher", "first-page": "857", "DOI": "10.1111/j.1582-4934.2006.tb00530.x", "volume": "10", "author": "R Ganss", "year": "2006", "unstructured": "70. Ganss R. Tumor stroma fosters neovascularization by recruitment of progenitor cells into the tumor bed. J Cell Mol Med 2006;10:857\u201365.", "journal-title": "J Cell Mol Med"}, {"key": "23_CR71_23", "doi-asserted-by": "publisher", "first-page": "820", "DOI": "10.1038/nature04186", "volume": "438", "author": "RN Kaplan", "year": "2005", "unstructured": "71. Kaplan RN, Riba RD, Zacharoulis S et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005;438:820\u20137.", "journal-title": "Nature"}, {"key": "23_CR72_23", "doi-asserted-by": "publisher", "first-page": "2223", "DOI": "10.2353/ajpath.2006.060498", "volume": "169", "author": "S Bruno", "year": "2006", "unstructured": "72. Bruno S, Bussolati B, Grange C et al. CD133+ renal progenitor cells contribute to tumor angiogenesis. Am J Pathol 2006;169:2223\u201335.", "journal-title": "Am J Pathol"}, {"key": "23_CR73_23", "doi-asserted-by": "publisher", "first-page": "127", "DOI": "10.1186/1471-2164-7-127", "volume": "7", "author": "T Sorlie", "year": "2006", "unstructured": "73. Sorlie T, Wang Y, Xiao C et al. Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms. BMC Genomics 2006;7:127.", "journal-title": "BMC Genomics"}, {"key": "23_CR74_23", "doi-asserted-by": "publisher", "first-page": "3983", "DOI": "10.1073/pnas.0530291100", "volume": "100", "author": "M Al-Hajj", "year": "2003", "unstructured": "74. Al-Hajj M, Wicha MS, ito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003;100:3983\u20138.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "23_CR75_23", "doi-asserted-by": "publisher", "first-page": "193", "DOI": "10.1016/j.tem.2004.05.011", "volume": "15", "author": "G Dontu", "year": "2004", "unstructured": "75. Dontu G, El-Ashry D, Wicha MS. Breast cancer, stem/progenitor cells and the estrogen receptor. Trends Endocrinol Metab 2004;15:193\u20137.", "journal-title": "Trends Endocrinol Metab"}, {"key": "23_CR76_23", "doi-asserted-by": "publisher", "first-page": "86", "DOI": "10.1186/bcr1021", "volume": "7", "author": "S Liu", "year": "2005", "unstructured": "76. Liu S, Dontu G, Wicha MS. Mammary stem cells, self-renewal pathways, and carcinogenesis. Breast Cancer Res 2005;7:86\u201395.", "journal-title": "Breast Cancer Res"}, {"key": "23_CR77_23", "doi-asserted-by": "publisher", "first-page": "5506", "DOI": "10.1158/0008-5472.CAN-05-0626", "volume": "65", "author": "D Ponti", "year": "2005", "unstructured": "77. Ponti D, Costa A, Zaffaroni N et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 2005;65:5506\u201311.", "journal-title": "Cancer Res"}, {"key": "23_CR78_23", "doi-asserted-by": "publisher", "first-page": "267", "DOI": "10.1242/dev.01583", "volume": "132", "author": "J Teuliere", "year": "2005", "unstructured": "78. Teuliere J, Faraldo MM, Deugnier MA et al. Targeted activation of beta-catenin signaling in basal mammary epithelial cells affects mammary development and leads to hyperplasia. Development 2005;132:267\u201377.", "journal-title": "Development"}, {"key": "23_CR79_23", "doi-asserted-by": "publisher", "first-page": "443", "DOI": "10.1016/j.ydbio.2004.07.044", "volume": "277", "author": "RB Clarke", "year": "2005", "unstructured": "79. Clarke RB, Spence K, Anderson E, Howell A, Okano H, Potten CS. A putative human breast stem cell population is enriched for steroid receptor-positive cells. Dev Biol 2005;277:443\u201356.", "journal-title": "Dev Biol"}, {"key": "23_CR80_23", "doi-asserted-by": "publisher", "first-page": "17396", "DOI": "10.1073/pnas.0608607103", "volume": "103", "author": "Z Du", "year": "2006", "unstructured": "80. Du Z, Podsypanina K, Huang S et al. Introduction of oncogenes into mammary glands in vivo with an avian retroviral vector initiates and promotes carcinogenesis in mouse models. Proc Natl Acad Sci USA 2006;103:17396\u2013401.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "23_CR81_23", "first-page": "137", "volume": "36", "author": "P Tang", "year": "2006", "unstructured": "81. Tang P, Wang X, Schiffhauer L et al. Expression patterns of ER-alpha, PR, HER-2/neu, and EGFR in different cell origin subtypes of high grade and non-high grade ductal carcinoma in situ. Ann Clin Lab Sci 2006;36:137\u201343.", "journal-title": "Ann Clin Lab Sci"}, {"key": "23_CR82_23", "doi-asserted-by": "publisher", "first-page": "150", "DOI": "10.1016/j.ceb.2007.02.007", "volume": "19", "author": "R Fodde", "year": "2007", "unstructured": "82. Fodde R, Brabletz T. Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol 2007;19:150\u20138.", "journal-title": "Curr Opin Cell Biol"}, {"issue": "6", "key": "23_CR83_23", "doi-asserted-by": "publisher", "first-page": "1231", "DOI": "10.1242/dev.02797", "volume": "134", "author": "RC Moraes", "year": "2007", "unstructured": "83. Moraes RC, Zhang X, Harrington N et al. Constitutive activation of smoothened (SMO) in mammary glands of transgenic mice leads to increased proliferation, altered differentiation and ductal dysplasia. Development 2007;134(6):1231\u20131242.", "journal-title": "Development"}, {"key": "23_CR84_23", "doi-asserted-by": "publisher", "first-page": "10", "DOI": "10.1097/01.ju.0000141582.15218.10", "volume": "173", "author": "LW Chung", "year": "2005", "unstructured": "84. Chung LW, Baseman A, Assikis V, Zhau HE. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. J Urol 2005;173:10\u201320.", "journal-title": "J Urol"}, {"key": "23_CR85_23", "doi-asserted-by": "publisher", "first-page": "297", "DOI": "10.1210/er.2006-0027", "volume": "28", "author": "RR Langley", "year": "2007", "unstructured": "85. Langley RR, Fidler IJ. Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. Endocr Rev 2007;28:297\u2013321.", "journal-title": "Endocr Rev"}, {"key": "23_CR86_23", "doi-asserted-by": "publisher", "first-page": "5305", "DOI": "10.1158/1078-0432.CCR-06-0482", "volume": "12", "author": "BS Carver", "year": "2006", "unstructured": "86. Carver BS, Pandolfi PP. Mouse modeling in oncologic preclinical and translational research. Clin Cancer Res 2006;12:5305\u201311.", "journal-title": "Clin Cancer Res"}, {"key": "23_CR87_23", "doi-asserted-by": "publisher", "first-page": "5683", "DOI": "10.1158/0008-5472.CAN-07-0768", "volume": "67", "author": "Z Zhou", "year": "2007", "unstructured": "87. Zhou Z, Flesken-Nikitin A, Nikitin AY. Prostate cancer associated with p53 and Rb deficiency arises from the stem/progenitor cell-enriched proximal region of prostatic ducts. Cancer Res 2007;67:5683\u201390.", "journal-title": "Cancer Res"}, {"key": "23_CR88_23", "doi-asserted-by": "publisher", "first-page": "725", "DOI": "10.1038/nature03918", "volume": "436", "author": "Z Chen", "year": "2005", "unstructured": "88. Chen Z, Trotman LC, Shaffer D et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 2005;436:725\u201330.", "journal-title": "Nature"}, {"key": "23_CR89_23", "doi-asserted-by": "publisher", "first-page": "209", "DOI": "10.1016/S1535-6108(03)00215-0", "volume": "4", "author": "S Wang", "year": "2003", "unstructured": "89. Wang S, Gao J, Lei Q et al. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell 2003;4:209\u201321.", "journal-title": "Cancer Cell"}, {"key": "23_CR90_23", "doi-asserted-by": "publisher", "first-page": "1480", "DOI": "10.1073/pnas.0510652103", "volume": "103", "author": "S Wang", "year": "2006", "unstructured": "90. Wang S, Garcia AJ, Wu M, Lawson DA, Witte ON, Wu H. Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation. Proc Natl Acad Sci USA 2006;103:1480\u20135.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "23_CR91_23", "doi-asserted-by": "publisher", "first-page": "2490", "DOI": "10.1158/0008-5472.CAN-06-3028", "volume": "67", "author": "KJ Bruxvoort", "year": "2007", "unstructured": "91. Bruxvoort KJ, Charbonneau HM, Giambernardi TA et al. Inactivation of Apc in the mouse prostate causes prostate carcinoma. Cancer Res 2007;67:2490\u20136.", "journal-title": "Cancer Res"}, {"key": "23_CR92_23", "first-page": "1043", "volume": "22", "author": "AY Nikitin", "year": "2007", "unstructured": "92. Nikitin AY, Matoso A, Roy-Burman P. Prostate stem cells and cancer. Histol Histopathol 2007;22:1043\u20139.", "journal-title": "Histol Histopathol"}, {"key": "23_CR93_23", "doi-asserted-by": "publisher", "first-page": "1171", "DOI": "10.1158/1541-7786.MCR-07-0024", "volume": "5", "author": "T Reiner", "year": "2007", "unstructured": "93. Reiner T, de Las PA, Parrondo R, Perez-Stable C. Progression of prostate cancer from a subset of p63-positive basal epithelial cells in FG/Tag transgenic mice. Mol Cancer Res 2007;5:1171\u20139.", "journal-title": "Mol Cancer Res"}, {"key": "23_CR94_23", "doi-asserted-by": "publisher", "first-page": "392", "DOI": "10.1038/nrc1877", "volume": "6", "author": "R Kalluri", "year": "2006", "unstructured": "94. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006;6:392\u2013401.", "journal-title": "Nat Rev Cancer"}, {"key": "23_CR95_23", "doi-asserted-by": "publisher", "first-page": "4185", "DOI": "10.1158/1078-0432.CCR-06-0353", "volume": "12", "author": "M Laakso", "year": "2006", "unstructured": "95. Laakso M, Tanner M, Nilsson J et al. Basoluminal carcinoma: a new biologically and prognostically distinct entity between basal and luminal breast cancer. Clin Cancer Res 2006;12:4185\u201391.", "journal-title": "Clin Cancer Res"}, {"key": "23_CR96_23", "doi-asserted-by": "publisher", "first-page": "1169", "DOI": "10.1093/jnci/djj364", "volume": "98", "author": "R Simon", "year": "2006", "unstructured": "96. Simon R. Development and evaluation of therapeutically relevant predictive classifiers using gene expression profiling. J Natl Cancer Inst 2006;98:1169\u201371.", "journal-title": "J Natl Cancer Inst"}, {"key": "23_CR97_23", "doi-asserted-by": "publisher", "first-page": "906", "DOI": "10.1093/jnci/djh164", "volume": "96", "author": "GD Leonard", "year": "2004", "unstructured": "97. Leonard GD, Swain SM. Ductal carcinoma in situ, complexities and challenges. J Natl Cancer Inst 2004;96:906\u201320.", "journal-title": "J Natl Cancer Inst"}, {"key": "23_CR98_23", "doi-asserted-by": "publisher", "first-page": "1183", "DOI": "10.1093/jnci/djj329", "volume": "98", "author": "M Buyse", "year": "2006", "unstructured": "98. Buyse M, Loi S, van\u2019t VL et al. Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. J Natl Cancer Inst 2006;98:1183\u201392.", "journal-title": "J Natl Cancer Inst"}, {"key": "23_CR99_23", "doi-asserted-by": "publisher", "first-page": "948", "DOI": "10.1093/jnci/djj295", "volume": "98", "author": "WF Anderson", "year": "2006", "unstructured": "99. Anderson WF, Matsuno R. Breast cancer heterogeneity: a mixture of at least two main types? J Natl Cancer Inst 2006;98:948\u201351.", "journal-title": "J Natl Cancer Inst"}, {"key": "23_CR100_23", "doi-asserted-by": "publisher", "first-page": "1011", "DOI": "10.1093/jnci/djj267", "volume": "98", "author": "ML Asselin-Labat", "year": "2006", "unstructured": "100. Asselin-Labat ML, Shackleton M, Stingl J et al. Steroid hormone receptor status of mouse mammary stem cells. J Natl Cancer Inst 2006;98:1011\u20134.", "journal-title": "J Natl Cancer Inst"}, {"key": "23_CR101_23", "doi-asserted-by": "publisher", "first-page": "14228", "DOI": "10.1073/pnas.0400067101", "volume": "101", "author": "C Hirschmann-Jax", "year": "2004", "unstructured": "101. Hirschmann-Jax C, Foster AE, Wulf GG et al. A distinct \u201cside population\u201d of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci USA 2004;101:14228\u201333.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "23_CR102_23", "doi-asserted-by": "publisher", "first-page": "275", "DOI": "10.1038/nrc1590", "volume": "5", "author": "M Dean", "year": "2005", "unstructured": "102. Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer 2005;5:275\u201384.", "journal-title": "Nat Rev Cancer"}, {"key": "23_CR103_23", "doi-asserted-by": "publisher", "first-page": "S78", "DOI": "10.1053/j.seminoncol.2005.04.028", "volume": "32", "author": "L Milas", "year": "2005", "unstructured": "103. Milas L, Raju U, Liao Z, Ajani J. Targeting molecular determinants of tumor chemo-radioresistance. Semin Oncol 2005;32:S78\u2013S81.", "journal-title": "Semin Oncol"}, {"key": "23_CR104_23", "doi-asserted-by": "publisher", "first-page": "15178", "DOI": "10.1073/pnas.2036535100", "volume": "100", "author": "HD Hemmati", "year": "2003", "unstructured": "104. Hemmati HD, Nakano I, Lazareff JA et al. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 2003;100:15178\u201383.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "23_CR105_23", "doi-asserted-by": "publisher", "first-page": "396", "DOI": "10.1038/nature03128", "volume": "432", "author": "SK Singh", "year": "2004", "unstructured": "105. Singh SK, Hawkins C, Clarke ID et al. Identification of human brain tumour initiating cells. Nature 2004;432:396\u2013401.", "journal-title": "Nature"}, {"key": "23_CR106_23", "doi-asserted-by": "publisher", "first-page": "10946", "DOI": "10.1158/0008-5472.CAN-05-2018", "volume": "65", "author": "AT Collins", "year": "2005", "unstructured": "106. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005;65:10946\u201351.", "journal-title": "Cancer Res"}, {"key": "23_CR107_23", "doi-asserted-by": "publisher", "first-page": "1696", "DOI": "10.1038/sj.onc.1209327", "volume": "25", "author": "L Patrawala", "year": "2006", "unstructured": "107. Patrawala L, Calhoun T, Schneider-Broussard R et al. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 2006;25:1696\u2013708.", "journal-title": "Oncogene"}, {"key": "23_CR108_23", "doi-asserted-by": "publisher", "first-page": "1030", "DOI": "10.1158/0008-5472.CAN-06-2030", "volume": "67", "author": "C Li", "year": "2007", "unstructured": "108. Li C, Heidt DG, Dalerba P et al. Identification of pancreatic cancer stem cells. Cancer Res 2007;67:1030\u20137.", "journal-title": "Cancer Res"}, {"key": "23_CR109_23", "doi-asserted-by": "publisher", "first-page": "111", "DOI": "10.1038/nature05384", "volume": "445", "author": "L Ricci-Vitiani", "year": "2007", "unstructured": "109. Ricci-Vitiani L, Lombardi DG, Pilozzi E et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007;445:111\u20135.", "journal-title": "Nature"}, {"key": "23_CR110_23", "doi-asserted-by": "publisher", "first-page": "973", "DOI": "10.1073/pnas.0610117104", "volume": "104", "author": "ME Prince", "year": "2007", "unstructured": "110. Prince ME, Sivanandan R, Kaczorowski A et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 2007;104:973\u20138.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "23_CR111_23", "doi-asserted-by": "publisher", "first-page": "323", "DOI": "10.1016/j.ccr.2005.09.001", "volume": "8", "author": "MD Taylor", "year": "2005", "unstructured": "111. Taylor MD, Poppleton H, Fuller C et al. Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 2005;8:323\u201335.", "journal-title": "Cancer Cell"}, {"key": "23_CR112_23", "doi-asserted-by": "publisher", "first-page": "9328", "DOI": "10.1158/0008-5472.CAN-05-1343", "volume": "65", "author": "D Fang", "year": "2005", "unstructured": "112. Fang D, Nguyen TK, Leishear K et al. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 2005;65:9328\u201337.", "journal-title": "Cancer Res"}, {"key": "23_CR113_23", "doi-asserted-by": "publisher", "first-page": "6207", "DOI": "10.1158/0008-5472.CAN-05-0592", "volume": "65", "author": "L Patrawala", "year": "2005", "unstructured": "113. Patrawala L, Calhoun T, Schneider-Broussard R, Zhou J, Claypool K, Tang DG. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Res 2005;65:6207\u201319.", "journal-title": "Cancer Res"}, {"key": "23_CR114_23", "doi-asserted-by": "publisher", "first-page": "495", "DOI": "10.1093/carcin/bgh321", "volume": "26", "author": "MH Tai", "year": "2005", "unstructured": "114. Tai MH, Chang CC, Kiupel M, Webster JD, Olson LK, Trosko JE. Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis 2005;26:495\u2013502.", "journal-title": "Carcinogenesis"}, {"key": "23_CR115_23", "doi-asserted-by": "publisher", "first-page": "4827", "DOI": "10.1158/0008-5472.CAN-06-3557", "volume": "67", "author": "MM Ho", "year": "2007", "unstructured": "115. Ho MM, Ng AV, Lam S, Hung JY. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res 2007;67:4827\u201333.", "journal-title": "Cancer Res"}, {"key": "23_CR116_23", "doi-asserted-by": "publisher", "first-page": "3701", "DOI": "10.1016/j.yexcr.2006.08.030", "volume": "312", "author": "A Hadnagy", "year": "2006", "unstructured": "116. Hadnagy A, Gaboury L, Beaulieu R, Balicki D. SP analysis may be used to identify cancer stem cell populations. Exp Cell Res 2006;312:3701\u201310.", "journal-title": "Exp Cell Res"}, {"key": "23_CR117_23", "doi-asserted-by": "publisher", "first-page": "102", "DOI": "10.1038/modpathol.3800720", "volume": "20", "author": "WM Klein", "year": "2007", "unstructured": "117. Klein WM, Wu BP, Zhao S, Wu H, Klein-Szanto AJ, Tahan SR. Increased expression of stem cell markers in malignant melanoma. Mod Pathol 2007;20:102\u20137.", "journal-title": "Mod Pathol"}, {"key": "23_CR118_23", "doi-asserted-by": "publisher", "first-page": "48", "DOI": "10.1186/1471-2407-8-48", "volume": "8", "author": "H Immervoll", "year": "2008", "unstructured": "118. Immervoll H, Hoem D, Sakariassen PO, Steffensen OJ, Molven A. Expression of the \u201cstem cell marker\u201d CD133 in pancreas and pancreatic ductal adenocarcinomas. BMC Cancer 2008;8:48.", "journal-title": "BMC Cancer"}, {"key": "23_CR119_23", "doi-asserted-by": "publisher", "first-page": "R10", "DOI": "10.1186/bcr1855", "volume": "10", "author": "MH Wright", "year": "2008", "unstructured": "119. Wright MH, Calcagno AM, Salcido CD, Carlson MD, Ambudkar SV, Varticovski L. Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics. Breast Cancer Res 2008;10:R10.", "journal-title": "Breast Cancer Res"}, {"key": "23_CR120_23", "doi-asserted-by": "publisher", "first-page": "504", "DOI": "10.1038/sj.cdd.4402283", "volume": "15", "author": "A Eramo", "year": "2008", "unstructured": "120. Eramo A, Lotti F, Sette G et al. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 2008;15:504\u201314.", "journal-title": "Cell Death Differ"}, {"key": "23_CR121_23", "doi-asserted-by": "publisher", "first-page": "153", "DOI": "10.1016/j.ccr.2008.01.013", "volume": "13", "author": "ZF Yang", "year": "2008", "unstructured": "121. Yang ZF, Ho DW, Ng MN et al. Significance of CD90(+) cancer stem cells in human liver cancer. Cancer Cell 2008;13:153\u201366.", "journal-title": "Cancer Cell"}, {"key": "23_CR122_23", "doi-asserted-by": "publisher", "first-page": "67", "DOI": "10.1111/j.1582-4934.2007.00170.x", "volume": "12", "author": "JX Gao", "year": "2008", "unstructured": "122. Gao JX. Cancer stem cells: the lessons from precancerous stem cells. J Cell Mol Med 2008;12:67\u201396.", "journal-title": "J Cell Mol Med"}, {"key": "23_CR123_23", "doi-asserted-by": "publisher", "first-page": "1379", "DOI": "10.1093/carcin/bgm052", "volume": "28", "author": "C Blanco-Aparicio", "year": "2007", "unstructured": "123. Blanco-Aparicio C, Renner O, Leal JF, Carnero A. PTEN, more than the AKT pathway. Carcinogenesis 2007;28:1379\u201386.", "journal-title": "Carcinogenesis"}, {"key": "23_CR124_23", "doi-asserted-by": "publisher", "first-page": "192", "DOI": "10.1016/j.molmed.2007.03.002", "volume": "13", "author": "JJ Fuster", "year": "2007", "unstructured": "124. Fuster JJ, Sanz-Gonzalez SM, Moll UM, Andres V. Classic and novel roles of p53: prospects for anticancer therapy. Trends Mol Med 2007;13:192\u20139.", "journal-title": "Trends Mol Med"}, {"key": "23_CR125_23", "doi-asserted-by": "publisher", "first-page": "214", "DOI": "10.1016/j.critrevonc.2007.02.003", "volume": "62", "author": "SD de Jonge-Peeters", "year": "2007", "unstructured": "125. de Jonge-Peeters SD, Kuipers F, de Vries EG, Vellenga E. ABC transporter expression in hematopoietic stem cells and the role in AML drug resistance. Crit Rev Oncol Hematol 2007;62:214\u201326.", "journal-title": "Crit Rev Oncol Hematol"}, {"key": "23_CR126_23", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1080/0897719031000094921", "volume": "21", "author": "M Mimeault", "year": "2003", "unstructured": "126. Mimeault M, Pommery N, Henichart JP. New advances on prostate carcinogenesis and therapies: involvement of EGF-EGFR transduction system. Growth Factors 2003;21:1\u201314.", "journal-title": "Growth Factors"}, {"key": "23_CR127_23", "doi-asserted-by": "publisher", "first-page": "153", "DOI": "10.1159/000078818", "volume": "17", "author": "M Mimeault", "year": "2004", "unstructured": "127. Mimeault M, Bonenfant D, Batra SK. New advances on the functions of epidermal growth factor receptor and ceramides in skin cell differentiation, disorders and cancers. Skin Pharmacol Physiol 2004;17:153\u201366.", "journal-title": "Skin Pharmacol Physiol"}, {"key": "23_CR128_23", "doi-asserted-by": "publisher", "first-page": "1084", "DOI": "10.1016/j.bbrc.2007.04.091", "volume": "357", "author": "BY Chen", "year": "2007", "unstructured": "128. Chen BY, Liu JY, Chang HH et al. Hedgehog is involved in prostate basal cell hyperplasia formation and its progressing towards tumorigenesis. Biochem Biophys Res Commun 2007;357:1084\u20139.", "journal-title": "Biochem Biophys Res Commun"}, {"key": "23_CR129_23", "doi-asserted-by": "publisher", "first-page": "1620", "DOI": "10.1093/annonc/mdl074", "volume": "17", "author": "C Massard", "year": "2006", "unstructured": "129. Massard C, Deutsch E, Soria JC. Tumour stem cell-targeted treatment: elimination or differentiation. Ann Oncol 2006;17:1620\u20134.", "journal-title": "Ann Oncol"}, {"key": "23_CR130_23", "first-page": "2591", "volume": "115", "author": "N Edme", "year": "2002", "unstructured": "130. Edme N, Downward J, Thiery JP, Boyer B. Ras induces NBT-II epithelial cell scattering through the coordinate activities of Rac and MAPK pathways. J Cell Sci 2002;115:2591\u2013601.", "journal-title": "J Cell Sci"}, {"key": "23_CR131_23", "doi-asserted-by": "publisher", "first-page": "40355", "DOI": "10.1074/jbc.M506692200", "volume": "280", "author": "T Yin", "year": "2005", "unstructured": "131. Yin T, Getsios S, Caldelari R et al. Mechanisms of plakoglobin-dependent adhesion: desmosome-specific functions in assembly and regulation by epidermal growth factor receptor. J Biol Chem 2005;280:40355\u201363.", "journal-title": "J Biol Chem"}, {"key": "23_CR132_23", "doi-asserted-by": "publisher", "first-page": "37191", "DOI": "10.1074/jbc.M405123200", "volume": "279", "author": "JH Lorch", "year": "2004", "unstructured": "132. Lorch JH, Klessner J, Park JK et al. Epidermal growth factor receptor inhibition promotes desmosome assembly and strengthens intercellular adhesion in squamous cell carcinoma cells. J Biol Chem 2004;279:37191\u2013200.", "journal-title": "J Biol Chem"}, {"key": "23_CR133_23", "doi-asserted-by": "publisher", "first-page": "6566", "DOI": "10.1093/nar/gki965", "volume": "33", "author": "C Vandewalle", "year": "2005", "unstructured": "133. Vandewalle C, Comijn J, De CB et al. SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucleic Acids Res 2005;33:6566\u201378.", "journal-title": "Nucleic Acids Res"}, {"key": "23_CR134_23", "doi-asserted-by": "publisher", "first-page": "6237", "DOI": "10.1158/0008-5472.CAN-04-3545", "volume": "65", "author": "B De Craene", "year": "2005", "unstructured": "134. De Craene B, Gilbert B, Stove C, Bruyneel E, van RF, Berx G. The transcription factor snail induces tumor cell invasion through modulation of the epithelial cell differentiation program. Cancer Res 2005;65:6237\u201344.", "journal-title": "Cancer Res"}, {"key": "23_CR135_23", "doi-asserted-by": "publisher", "first-page": "45", "DOI": "10.1159/000092965", "volume": "13", "author": "JE Trosko", "year": "2006", "unstructured": "135. Trosko JE, Tai MH. Adult stem cell theory of the multi-stage, multi-mechanism theory of carcinogenesis: role of inflammation on the promotion of initiated stem cells. Contrib Microbiol 2006;13:45\u201365.", "journal-title": "Contrib Microbiol"}, {"key": "23_CR136_23", "doi-asserted-by": "publisher", "first-page": "449", "DOI": "10.1007/s00018-005-5296-8", "volume": "63", "author": "L Kopfstein", "year": "2006", "unstructured": "136. Kopfstein L, Christofori G. Metastasis: cell-autonomous mechanisms versus contributions by the tumor microenvironment. Cell Mol Life Sci 2006;63:449\u201368.", "journal-title": "Cell Mol Life Sci"}, {"key": "23_CR137_23", "doi-asserted-by": "publisher", "first-page": "1964", "DOI": "10.1091/mbc.E02-08-0469", "volume": "14", "author": "M Cozzolino", "year": "2003", "unstructured": "137. Cozzolino M, Stagni V, Spinardi L et al. p120 Catenin is required for growth factor-dependent cell motility and scattering in epithelial cells. Mol Biol Cell 2003;14:1964\u201377.", "journal-title": "Mol Biol Cell"}, {"key": "23_CR138_23", "doi-asserted-by": "publisher", "first-page": "103", "DOI": "10.1016/j.yexcr.2004.08.037", "volume": "301", "author": "YG Man", "year": "2004", "unstructured": "138. Man YG, Sang QX. The significance of focal myoepithelial cell layer disruptions in human breast tumor invasion: a paradigm shift from the \u201cprotease-centered\u201d hypothesis. Exp Cell Res 2004;301:103\u201318.", "journal-title": "Exp Cell Res"}, {"key": "23_CR139_23", "doi-asserted-by": "publisher", "first-page": "564", "DOI": "10.1038/sj.bjc.6601990", "volume": "91", "author": "R Hildenbrand", "year": "2004", "unstructured": "139. Hildenbrand R, Arens N. Protein and mRNA expression of uPAR and PAI-1 in myoepithelial cells of early breast cancer lesions and normal breast tissue. Br J Cancer 2004;91:564\u201371.", "journal-title": "Br J Cancer"}, {"key": "23_CR140_23", "doi-asserted-by": "publisher", "first-page": "155", "DOI": "10.1038/nrm757", "volume": "3", "author": "MA Nieto", "year": "2002", "unstructured": "140. Nieto MA. The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 2002;3:155\u201366.", "journal-title": "Nat Rev Mol Cell Biol"}, {"key": "23_CR141_23", "doi-asserted-by": "publisher", "first-page": "3151", "DOI": "10.1242/dev.01907", "volume": "132", "author": "A Barrallo-Gimeno", "year": "2005", "unstructured": "141. Barrallo-Gimeno A, Nieto MA. The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 2005;132:3151\u201361.", "journal-title": "Development"}, {"key": "23_CR142_23", "doi-asserted-by": "publisher", "first-page": "261", "DOI": "10.1016/j.ccr.2006.03.010", "volume": "9", "author": "A Wicki", "year": "2006", "unstructured": "142. Wicki A, Lehembre F, Wick N, Hantusch B, Kerjaschki D, Christofori G. Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell 2006;9:261\u201372.", "journal-title": "Cancer Cell"}, {"key": "23_CR143_23", "doi-asserted-by": "publisher", "first-page": "8319", "DOI": "10.1158/0008-5472.CAN-06-0410", "volume": "66", "author": "JJ Christiansen", "year": "2006", "unstructured": "143. Christiansen JJ, Rajasekaran AK. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res 2006;66:8319\u201326.", "journal-title": "Cancer Res"}, {"key": "23_CR144_23", "doi-asserted-by": "publisher", "first-page": "R668", "DOI": "10.1186/bcr930", "volume": "6", "author": "I Mikaelian", "year": "2004", "unstructured": "144. Mikaelian I, Blades N, Churchill GA et al. Proteotypic classification of spontaneous and transgenic mammary neoplasms. Breast Cancer Res 2004;6:R668\u201379.", "journal-title": "Breast Cancer Res"}, {"key": "23_CR145_23", "doi-asserted-by": "publisher", "first-page": "179", "DOI": "10.1016/j.critrevonc.2003.10.008", "volume": "49", "author": "M Polette", "year": "2004", "unstructured": "145. Polette M, Nawrocki-Raby B, Gilles C, Clavel C, Birembaut P. Tumour invasion and matrix metalloproteinases. Crit Rev Oncol Hematol 2004;49:179\u201386.", "journal-title": "Crit Rev Oncol Hematol"}, {"key": "23_CR146_23", "doi-asserted-by": "publisher", "first-page": "45", "DOI": "10.1016/j.gde.2005.12.011", "volume": "16", "author": "DC Radisky", "year": "2006", "unstructured": "146. Radisky DC, Bissell MJ. Matrix metalloproteinase-induced genomic instability. Curr Opin Genet Dev 2006;16:45\u201350.", "journal-title": "Curr Opin Genet Dev"}, {"key": "23_CR147_23", "doi-asserted-by": "publisher", "first-page": "120", "DOI": "10.1016/S0959-437X(99)00043-X", "volume": "10", "author": "G Bergers", "year": "2000", "unstructured": "147. Bergers G, Coussens LM. Extrinsic regulators of epithelial tumor progression: metalloproteinases. Curr Opin Genet Dev 2000;10:120\u20137.", "journal-title": "Curr Opin Genet Dev"}, {"key": "23_CR148_23", "doi-asserted-by": "publisher", "first-page": "985", "DOI": "10.1016/j.pharmthera.2006.02.009", "volume": "111", "author": "K Reiss", "year": "2006", "unstructured": "148. Reiss K, Ludwig A, Saftig P. Breaking up the tie: Disintegrin-like metalloproteinases as regulators of cell migration in inflammation and invasion. Pharmacol Ther 2006;111:985\u20131006.", "journal-title": "Pharmacol Ther"}, {"key": "23_CR149_23", "doi-asserted-by": "publisher", "first-page": "4549", "DOI": "10.1158/0008-5472.CAN-05-3850", "volume": "66", "author": "J Yang", "year": "2006", "unstructured": "149. Yang J, Mani SA, Weinberg RA. Exploring a new twist on tumor metastasis. Cancer Res 2006;66:4549\u201352.", "journal-title": "Cancer Res"}, {"key": "23_CR150_23", "doi-asserted-by": "publisher", "first-page": "9066", "DOI": "10.1158/0008-5472.CAN-07-0575", "volume": "67", "author": "HW Lo", "year": "2007", "unstructured": "150. Lo HW, Hsu SC, Xia W et al. Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res 2007;67:9066\u201376.", "journal-title": "Cancer Res"}, {"key": "23_CR151_23", "doi-asserted-by": "publisher", "first-page": "7559", "DOI": "10.1128/MCB.24.17.7559-7566.2004", "volume": "24", "author": "M Kajita", "year": "2004", "unstructured": "151. Kajita M, McClinic KN, Wade PA. Aberrant expression of the transcription factors snail and slug alters the response to genotoxic stress. Mol Cell Biol 2004;24:7559\u201366.", "journal-title": "Mol Cell Biol"}, {"key": "23_CR152_23", "doi-asserted-by": "publisher", "first-page": "1131", "DOI": "10.1101/gad.294104", "volume": "18", "author": "S Vega", "year": "2004", "unstructured": "152. Vega S, Morales AV, Ocana OH, Valdes F, Fabregat I, Nieto MA. Snail blocks the cell cycle and confers resistance to cell death. Genes Dev 2004;18:1131\u201343.", "journal-title": "Genes Dev"}, {"key": "23_CR153_23", "first-page": "1133", "volume": "29", "author": "T Onoue", "year": "2006", "unstructured": "153. Onoue T, Uchida D, Begum NM, Tomizuka Y, Yoshida H, Sato M. Epithelial-mesenchymal transition induced by the stromal cell-derived factor-1/CXCR4 system in oral squamous cell carcinoma cells. Int J Oncol 2006;29:1133\u20138.", "journal-title": "Int J Oncol"}, {"key": "23_CR154_23", "doi-asserted-by": "publisher", "first-page": "277", "DOI": "10.1016/j.cell.2004.07.011", "volume": "118", "author": "Y Kang", "year": "2004", "unstructured": "154. Kang Y, Massague J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 2004;118:277\u20139.", "journal-title": "Cell"}, {"key": "23_CR155_23", "unstructured": "155. Croker AK, Allan AL. Cancer Stem Cells: Implications for the progression and treatment of metastatic disease. J Cell Mol Med 2007."}, {"key": "23_CR156_23", "doi-asserted-by": "crossref", "first-page": "20", "DOI": "10.1177/153537020623100103", "volume": "231", "author": "M Ii", "year": "2006", "unstructured": "156 Ii M, Yamamoto H, Adachi Y, Maruyama Y, Shinomura Y. Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp Biol Med (Maywood) 2006;231:20\u201327.", "journal-title": "Exp Biol Med (Maywood)"}, {"key": "23_CR157_23", "doi-asserted-by": "publisher", "first-page": "603", "DOI": "10.1083/jcb.200306090", "volume": "164", "author": "H Liu", "year": "2004", "unstructured": "157. Liu H, Radisky DC, Wang F, Bissell MJ. Polarity and proliferation are controlled by distinct signaling pathways downstream of PI3-kinase in breast epithelial tumor cells. J Cell Biol 2004;164:603\u201312.", "journal-title": "J Cell Biol"}, {"key": "23_CR158_23", "doi-asserted-by": "crossref", "first-page": "964", "DOI": "10.1160/TH04-09-0637", "volume": "93", "author": "C Festuccia", "year": "2005", "unstructured": "158. Festuccia C, Angelucci A, Gravina GL et al. Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination. Thromb Haemost 2005;93:964\u201375.", "journal-title": "Thromb Haemost"}, {"key": "23_CR159_23", "doi-asserted-by": "publisher", "first-page": "1009", "DOI": "10.1517/14728222.9.5.1009", "volume": "9", "author": "JG Shelton", "year": "2005", "unstructured": "159. Shelton JG, Steelman LS, Abrams SL et al. The epidermal growth factor receptor gene family as a target for therapeutic intervention in numerous cancers: what\u2019s genetics got to do with it? Expert Opin Ther Targets 2005;9:1009\u201330.", "journal-title": "Expert Opin Ther Targets"}, {"key": "23_CR160_23", "doi-asserted-by": "publisher", "first-page": "7391", "DOI": "10.1128/MCB.23.20.7391-7402.2003", "volume": "23", "author": "S Miravet", "year": "2003", "unstructured": "160. Miravet S, Piedra J, Castano J et al. Tyrosine phosphorylation of plakoglobin causes contrary effects on its association with desmosomes and adherens junction components and modulates beta-catenin-mediated transcription. Mol Cell Biol 2003;23:7391\u2013402.", "journal-title": "Mol Cell Biol"}, {"key": "23_CR161_23", "doi-asserted-by": "publisher", "first-page": "C1532", "DOI": "10.1152/ajpcell.00478.2005", "volume": "290", "author": "N Ahmed", "year": "2006", "unstructured": "161. Ahmed N, Maines-Bandiera S, Quinn MA, Unger WG, Dedhar S, Auersperg N. Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epithelium. Am J Physiol Cell Physiol 2006;290:C1532\u201342.", "journal-title": "Am J Physiol Cell Physiol"}, {"key": "23_CR162_23", "doi-asserted-by": "publisher", "first-page": "1412", "DOI": "10.1054/bjoc.2001.2105", "volume": "85", "author": "N Cattan", "year": "2001", "unstructured": "162. Cattan N, Rochet N, Mazeau C et al. Establishment of two new human bladder carcinoma cell lines, CAL 29 and CAL 185. Comparative study of cell scattering and epithelial to mesenchyme transition induced by growth factors. Br J Cancer 2001;85:1412\u20137.", "journal-title": "Br J Cancer"}, {"key": "23_CR163_23", "doi-asserted-by": "publisher", "first-page": "499", "DOI": "10.1016/S1535-6108(03)00304-0", "volume": "4", "author": "Z Lu", "year": "2003", "unstructured": "163. Lu Z, Ghosh S, Wang Z, Hunter T. Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. Cancer Cell 2003;4:499\u2013515.", "journal-title": "Cancer Cell"}, {"key": "23_CR164_23", "doi-asserted-by": "publisher", "first-page": "5367", "DOI": "10.1158/1078-0432.CCR-04-0220", "volume": "10", "author": "TO Nielsen", "year": "2004", "unstructured": "164. Nielsen TO, Hsu FD, Jensen K et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 2004;10:5367\u201374.", "journal-title": "Clin Cancer Res"}, {"key": "23_CR165_23", "first-page": "249", "volume": "25", "author": "D Birnbaum", "year": "2004", "unstructured": "165. Birnbaum D, Bertucci F, Ginestier C, Tagett R, Jacquemier J, Charafe-Jauffret E. Basal and luminal breast cancers: basic or luminous? (review). Int J Oncol 2004;25:249\u201358.", "journal-title": "Int J Oncol"}, {"key": "23_CR166_23", "doi-asserted-by": "publisher", "first-page": "264", "DOI": "10.1038/modpathol.3800528", "volume": "19", "author": "CA Livasy", "year": "2006", "unstructured": "166. Livasy CA, Karaca G, Nanda R et al. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod Pathol 2006;19:264\u201371.", "journal-title": "Mod Pathol"}, {"key": "23_CR167_23", "doi-asserted-by": "publisher", "first-page": "2492", "DOI": "10.1001/jama.295.21.2492", "volume": "295", "author": "LA Carey", "year": "2006", "unstructured": "167. Carey LA, Perou CM, Livasy CA et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 2006;295:2492\u2013502.", "journal-title": "JAMA"}, {"key": "23_CR168_23", "doi-asserted-by": "publisher", "first-page": "R16", "DOI": "10.1186/bcr1649", "volume": "9", "author": "M Jumppanen", "year": "2007", "unstructured": "168. Jumppanen M, Gruvberger-Saal S, Kauraniemi P et al. Basal-like phenotype is not associated with patient survival in estrogen receptor negative breast cancers. Breast Cancer Res 2007;9:R16.", "journal-title": "Breast Cancer Res"}, {"key": "23_CR169_23", "doi-asserted-by": "publisher", "first-page": "1033", "DOI": "10.1677/ERC-06-0001", "volume": "13", "author": "M Lacroix", "year": "2006", "unstructured": "169. Lacroix M. Significance, detection and markers of disseminated breast cancer cells. Endocr Relat Cancer 2006;13:1033\u2013067.", "journal-title": "Endocr Relat Cancer"}, {"key": "23_CR170_23", "doi-asserted-by": "publisher", "first-page": "R34", "DOI": "10.1186/bcr1517", "volume": "8", "author": "S Calza", "year": "2006", "unstructured": "170. Calza S, Hall P, Auer G et al. Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients. Breast Cancer Res 2006;8:R34.", "journal-title": "Breast Cancer Res"}, {"key": "23_CR171_23", "doi-asserted-by": "publisher", "first-page": "478", "DOI": "10.1159/000090986", "volume": "69", "author": "P Potemski", "year": "2005", "unstructured": "171. Potemski P, Kusinska R, Watala C, Pluciennik E, Bednarek AK, Kordek R. Prognostic relevance of basal cytokeratin expression in operable breast cancer. Oncology 2005;69:478\u201385.", "journal-title": "Oncology"}, {"key": "23_CR172_23", "doi-asserted-by": "publisher", "first-page": "25", "DOI": "10.1002/cncr.22381", "volume": "109", "author": "EA Rakha", "year": "2007", "unstructured": "172. Rakha EA, El-Sayed ME, Green AR, Lee AH, Robertson JF, Ellis IO. Prognostic markers in triple-negative breast cancer. Cancer 2007;109:25\u201332.", "journal-title": "Cancer"}, {"key": "23_CR173_23", "doi-asserted-by": "publisher", "first-page": "207", "DOI": "10.1016/S0092-8674(03)00234-4", "volume": "113", "author": "N Fujita", "year": "2003", "unstructured": "173. Fujita N, Jaye DL, Kajita M, Geigerman C, Moreno CS, Wade PA. MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell 2003;113:207\u201319.", "journal-title": "Cell"}, {"key": "23_CR174_23", "doi-asserted-by": "publisher", "first-page": "470", "DOI": "10.1038/ncb1559", "volume": "9", "author": "X Wang", "year": "2007", "unstructured": "174. Wang X, Belguise K, Kersual N et al. Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2. Nat Cell Biol 2007;9:470\u20138.", "journal-title": "Nat Cell Biol"}, {"key": "23_CR175_23", "doi-asserted-by": "publisher", "first-page": "1743", "DOI": "10.1038/nprot.2006.269", "volume": "1", "author": "M Hu", "year": "2006", "unstructured": "175. Hu M, Polyak K. Serial analysis of gene expression. Nat Protoc 2006;1:1743\u201360.", "journal-title": "Nat Protoc"}, {"key": "23_CR176_23", "doi-asserted-by": "publisher", "first-page": "110", "DOI": "10.1016/S1359-6446(05)03694-9", "volume": "11", "author": "D Porter", "year": "2006", "unstructured": "176. Porter D, Yao J, Polyak K. SAGE and related approaches for cancer target identification. Drug Discov Today 2006;11:110\u20138.", "journal-title": "Drug Discov Today"}, {"key": "23_CR177_23", "doi-asserted-by": "publisher", "first-page": "341", "DOI": "10.1038/nrg2101", "volume": "8", "author": "DX Nguyen", "year": "2007", "unstructured": "177. Nguyen DX, Massague J. Genetic determinants of cancer metastasis. Nat Rev Genet 2007;8:341\u201352.", "journal-title": "Nat Rev Genet"}, {"key": "23_CR178_23", "unstructured": "178. Price ND, Foltz G, Madan A, Hood L, Tian Q. Systems Biology and Cancer Stem Cells. J Cell Mol Med 2007."}, {"key": "23_CR179_23", "doi-asserted-by": "publisher", "first-page": "919", "DOI": "10.1002/hep.22082", "volume": "47", "author": "ZF Yang", "year": "2008", "unstructured": "179. Yang ZF, Ngai P, Ho DW et al. Identification of local and circulating cancer stem cells in human liver cancer. Hepatology 2008;47:919\u201328.", "journal-title": "Hepatology"}, {"key": "23_CR180_23", "doi-asserted-by": "publisher", "first-page": "1238", "DOI": "10.1038/sj.cdd.4401872", "volume": "13", "author": "A Eramo", "year": "2006", "unstructured": "180. Eramo A, Ricci-Vitiani L, Zeuner A et al. Chemotherapy resistance of glioblastoma stem cells. Cell Death Differ 2006;13:1238\u201341.", "journal-title": "Cell Death Differ"}, {"key": "23_CR181_23", "doi-asserted-by": "publisher", "first-page": "850", "DOI": "10.1002/glia.20414", "volume": "54", "author": "A Salmaggi", "year": "2006", "unstructured": "181. Salmaggi A, Boiardi A, Gelati M et al. Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype. Glia 2006;54:850\u201360.", "journal-title": "Glia"}, {"key": "23_CR182_23", "doi-asserted-by": "publisher", "first-page": "4320", "DOI": "10.1158/0008-5472.CAN-04-3327", "volume": "65", "author": "NY Frank", "year": "2005", "unstructured": "182. Frank NY, Margaryan A, Huang Y et al. ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res 2005;65:4320\u201333.", "journal-title": "Cancer Res"}, {"key": "23_CR183_23", "doi-asserted-by": "publisher", "first-page": "217", "DOI": "10.1056/NEJMoa063994", "volume": "356", "author": "R Liu", "year": "2007", "unstructured": "183. Liu R, Wang X, Chen GY et al. The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med 2007;356:217\u201326.", "journal-title": "N Engl J Med"}, {"key": "23_CR184_23", "doi-asserted-by": "publisher", "first-page": "259", "DOI": "10.1016/j.ccr.2007.01.013", "volume": "11", "author": "M Shipitsin", "year": "2007", "unstructured": "184. Shipitsin M, Campbell LL, Argani P et al. Molecular definition of breast tumor heterogeneity. Cancer Cell 2007;11:259\u201373.", "journal-title": "Cancer Cell"}, {"key": "23_CR185_23", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1080/10428190500407996", "volume": "47", "author": "J Goldman", "year": "2006", "unstructured": "185. Goldman J, Gordon M. Why do chronic myelogenous leukemia stem cells survive allogeneic stem cell transplantation or imatinib: does it really matter? Leuk Lymphoma 2006;47:1\u20137.", "journal-title": "Leuk Lymphoma"}, {"key": "23_CR186_23", "doi-asserted-by": "publisher", "first-page": "349", "DOI": "10.1080/10245330500234195", "volume": "10", "author": "M Copland", "year": "2005", "unstructured": "186. Copland M, Jorgensen HG, Holyoake TL. Evolving molecular therapy for chronic myeloid leukaemia\u2013are we on target? Hematology 2005;10:349\u201359.", "journal-title": "Hematology"}, {"key": "23_CR187_23", "doi-asserted-by": "publisher", "first-page": "4532", "DOI": "10.1182/blood-2005-07-2947", "volume": "107", "author": "M Copland", "year": "2006", "unstructured": "187. Copland M, Hamilton A, Elrick LJ et al. Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction. Blood 2006;107:4532\u20139.", "journal-title": "Blood"}, {"key": "23_CR188_23", "unstructured": "188. Mauro MJ. Defining and managing imatinib resistance. Hematology Am Soc Hematol Educ Program 2006;219\u201325.", "DOI": "10.1182/asheducation-2006.1.219", "doi-asserted-by": "crossref"}, {"key": "23_CR189_23", "doi-asserted-by": "publisher", "first-page": "43", "DOI": "10.3322/canjclin.57.1.43", "volume": "57", "author": "A Jemal", "year": "2007", "unstructured": "189. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43\u201366.", "journal-title": "CA Cancer J Clin"}, {"key": "23_CR190_23", "doi-asserted-by": "publisher", "first-page": "111", "DOI": "10.1111/j.1582-4934.2007.00153.x", "volume": "12", "author": "P Knizetova", "year": "2008", "unstructured": "190. Knizetova P, Darling JL, Bartek J. Vascular endothelial growth factor in astroglioma stem cell biology and response to therapy. J Cell Mol Med 2008;12:111\u201325.", "journal-title": "J Cell Mol Med"}, {"key": "23_CR191_23", "doi-asserted-by": "publisher", "first-page": "837", "DOI": "10.1089/scd.2007.0006", "volume": "16", "author": "MK Kang", "year": "2007", "unstructured": "191. Kang MK, Kang SK. Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma. Stem Cells Dev 2007;16:837\u201347.", "journal-title": "Stem Cells Dev"}, {"key": "23_CR192_23", "doi-asserted-by": "publisher", "first-page": "468", "DOI": "10.1242/jcs.03348", "volume": "120", "author": "MS Chen", "year": "2007", "unstructured": "192. Chen MS, Woodward WA, Behbod F et al. Wnt/beta-catenin mediates radiation resistance of Sca1+ progenitors in an immortalized mammary gland cell line. J Cell Sci 2007;120:468\u201377.", "journal-title": "J Cell Sci"}, {"key": "23_CR193_23", "doi-asserted-by": "publisher", "first-page": "1182", "DOI": "10.1016/j.mehy.2004.09.026", "volume": "64", "author": "S Kurbel", "year": "2005", "unstructured": "193. Kurbel S. Selective reduction of estrogen receptor (ER) positive breast cancer occurrence by estrogen receptor modulators supports etiological distinction between ER positive and ER negative breast cancers. Med Hypotheses 2005;64:1182\u20137.", "journal-title": "Med Hypotheses"}, {"key": "23_CR194_23", "doi-asserted-by": "publisher", "first-page": "7445", "DOI": "10.1158/0008-5472.CAN-06-0858", "volume": "66", "author": "X Fan", "year": "2006", "unstructured": "194. Fan X, Matsui W, Khaki L et al. Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. Cancer Res 2006;66:7445\u201352.", "journal-title": "Cancer Res"}, {"key": "23_CR195_23", "doi-asserted-by": "publisher", "first-page": "707", "DOI": "10.1038/nature02962", "volume": "431", "author": "SS Karhadkar", "year": "2004", "unstructured": "195. Karhadkar SS, Bova GS, Abdallah N et al. Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 2004;431:707\u201312.", "journal-title": "Nature"}, {"key": "23_CR196_23", "doi-asserted-by": "publisher", "first-page": "851", "DOI": "10.1038/nature05661", "volume": "445", "author": "V Gray-Schopfer", "year": "2007", "unstructured": "196. Gray-Schopfer V, Wellbrock C, Marais R. Melanoma biology and new targeted therapy. Nature 2007;445:851\u20137.", "journal-title": "Nature"}, {"key": "23_CR197_23", "doi-asserted-by": "publisher", "first-page": "1613", "DOI": "10.1016/S0002-9440(10)63007-6", "volume": "159", "author": "A Jung", "year": "2001", "unstructured": "197. Jung A, Schrauder M, Oswald U et al. The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear beta-catenin, cyclin D1, and p16INK4A and is a region of low proliferation. Am J Pathol 2001;159:1613\u20137.", "journal-title": "Am J Pathol"}, {"key": "23_CR198_23", "doi-asserted-by": "publisher", "first-page": "417", "DOI": "10.1042/CS20010216", "volume": "102", "author": "RC Rintoul", "year": "2002", "unstructured": "198. Rintoul RC, Sethi T. Extracellular matrix regulation of drug resistance in small-cell lung cancer. Clin Sci (Lond) 2002;102:417\u201324.", "journal-title": "Clin Sci (Lond)"}, {"key": "23_CR199_23", "first-page": "527", "volume": "3", "author": "GS Warshamana-Greene", "year": "2004", "unstructured": "199. Warshamana-Greene GS, Litz J, Buchdunger E, Hofmann F, Garcia-Echeverria C, Krystal GW. The insulin-like growth factor-I (IGF-I) receptor kinase inhibitor NVP-ADW742, in combination with STI571, delineates a spectrum of dependence of small cell lung cancer on IGF-I and stem cell factor signaling. Mol Cancer Ther 2004;3:527\u201335.", "journal-title": "Mol Cancer Ther"}, {"key": "23_CR200_23", "doi-asserted-by": "publisher", "first-page": "879", "DOI": "10.1634/stemcells.2004-0342", "volume": "23", "author": "M Kucia", "year": "2005", "unstructured": "200. Kucia M, Reca R, Miekus K et al. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 2005;23:879\u201394.", "journal-title": "Stem Cells"}, {"key": "23_CR201_23", "doi-asserted-by": "publisher", "first-page": "1563", "DOI": "10.1158/1078-0432.CCR-04-1544", "volume": "11", "author": "GS Warshamana-Greene", "year": "2005", "unstructured": "201. Warshamana-Greene GS, Litz J, Buchdunger E, Garcia-Echeverria C, Hofmann F, Krystal GW. The insulin-like growth factor-I receptor kinase inhibitor, NVP-ADW742, sensitizes small cell lung cancer cell lines to the effects of chemotherapy. Clin Cancer Res 2005;11:1563\u201371.", "journal-title": "Clin Cancer Res"}, {"key": "23_CR202_23", "doi-asserted-by": "publisher", "first-page": "2187", "DOI": "10.1158/0008-5472.CAN-06-3281", "volume": "67", "author": "G Feldmann", "year": "2007", "unstructured": "202. Feldmann G, Dhara S, Fendrich V et al. Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. Cancer Res 2007;67:2187\u201396.", "journal-title": "Cancer Res"}, {"key": "23_CR203_23", "doi-asserted-by": "publisher", "first-page": "4142", "DOI": "10.1158/1078-0432.CCR-06-0952", "volume": "12", "author": "S Biswas", "year": "2006", "unstructured": "203. Biswas S, Criswell TL, Wang SE, Arteaga CL. Inhibition of transforming growth factor-beta signaling in human cancer: targeting a tumor suppressor network as a therapeutic strategy. Clin Cancer Res 2006;12:4142\u20136.", "journal-title": "Clin Cancer Res"}, {"key": "23_CR204_23", "doi-asserted-by": "publisher", "first-page": "506", "DOI": "10.1038/nrc1926", "volume": "6", "author": "B Bierie", "year": "2006", "unstructured": "204. Bierie B, Moses HL. Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer 2006;6:506\u201320.", "journal-title": "Nat Rev Cancer"}, {"key": "23_CR205_23", "doi-asserted-by": "publisher", "first-page": "1526", "DOI": "10.1158/0008-5472.CAN-05-3071", "volume": "66", "author": "CC Park", "year": "2006", "unstructured": "205. Park CC, Zhang H, Pallavicini M et al. Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo. Cancer Res 2006;66:1526\u201335.", "journal-title": "Cancer Res"}, {"key": "23_CR206_23", "doi-asserted-by": "publisher", "first-page": "967", "DOI": "10.1158/1535-7163.MCT-06-0648", "volume": "6", "author": "M Mimeault", "year": "2007", "unstructured": "206. Mimeault M, Johansson SL, Venkatraman G et al. Combined targeting of epidermal growth factor receptor and hedgehog signaling by gefitinib and cyclopamine cooperatively improves the cytotoxic effects of docetaxel on metastatic prostate cancer cells. Mol Cancer Ther 2007;6:967\u201378.", "journal-title": "Mol Cancer Ther"}, {"issue": "1", "key": "23_CR207_23", "doi-asserted-by": "publisher", "first-page": "160", "DOI": "10.1002/ijc.22268", "volume": "120", "author": "M Mimeault", "year": "2007", "unstructured": "207. Mimeault M, Venkatraman G, Johansson SL et al. Novel combination therapy against metastatic and androgen-independent prostate cancer by using gefitinib, tamoxifen and etoposide. Int etoposide. Int etoposide. Int J Cancer 2007;120(1):160\u2013169.", "journal-title": "Int etoposide. Int J Cancer"}, {"key": "23_CR208_23", "doi-asserted-by": "publisher", "first-page": "400", "DOI": "10.1080/08977190801930935", "volume": "25", "author": "M Mimeault", "year": "2007", "unstructured": "208. Mimeault M, Mehta PP, Hauke R et al. Improvement of cytotoxic effects of mitoxantrone on hormone-refractory metastatic prostate cancer cells by co-targeting epidermal growth factor receptor and hedgehog signaling cascades. Growth Factors 2007;25:400\u201316.", "journal-title": "Growth Factors"}, {"key": "23_CR209_23", "doi-asserted-by": "publisher", "first-page": "401", "DOI": "10.1097/01.mlg.0000195075.14093.fb", "volume": "116", "author": "JS Chen", "year": "2006", "unstructured": "209. Chen JS, Pardo FS, Wang-Rodriguez J et al. EGFR regulates the side population in head and neck squamous cell carcinoma. Laryngoscope 2006;116:401\u20136.", "journal-title": "Laryngoscope"}, {"key": "23_CR210_23", "doi-asserted-by": "publisher", "first-page": "4048", "DOI": "10.1073/pnas.0611682104", "volume": "104", "author": "CD Peacock", "year": "2007", "unstructured": "210. Peacock CD, Wang Q, Gesell GS et al. Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma. Proc Natl Acad Sci USA 2007;104:4048\u201353.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "23_CR211_23", "doi-asserted-by": "publisher", "first-page": "5674", "DOI": "10.1038/sj.onc.1210356", "volume": "26", "author": "J Sims-Mourtada", "year": "2007", "unstructured": "211. Sims-Mourtada J, Izzo JG, Ajani J, Chao KS. Sonic Hedgehog promotes multiple drug resistance by regulation of drug transport. Oncogene 2007;26:5674\u20139.", "journal-title": "Oncogene"}, {"key": "23_CR212_23", "doi-asserted-by": "publisher", "first-page": "165", "DOI": "10.1016/j.cub.2006.11.033", "volume": "17", "author": "V Clement", "year": "2007", "unstructured": "212. Clement V, Sanchez P, de Tribolet N, Radovanovic I, Altaba A. HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol 2007;17:165\u201372.", "journal-title": "Curr Biol"}, {"key": "23_CR213_23", "doi-asserted-by": "publisher", "first-page": "603", "DOI": "10.2174/092986706776055661", "volume": "13", "author": "E Galmozzi", "year": "2006", "unstructured": "213. Galmozzi E, Facchetti F, La Porta CA. Cancer stem cells and therapeutic perspectives. Curr Med Chem 2006;13:603\u20137.", "journal-title": "Curr Med Chem"}, {"key": "23_CR214_23", "doi-asserted-by": "publisher", "first-page": "3716", "DOI": "10.1158/0008-5472.CAN-06-4343", "volume": "67", "author": "J Wang", "year": "2007", "unstructured": "214. Wang J, Guo LP, Chen LZ, Zeng YX, Lu SH. Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line. Cancer Res 2007;67:3716\u201324.", "journal-title": "Cancer Res"}, {"key": "23_CR215_23", "doi-asserted-by": "publisher", "first-page": "360", "DOI": "10.1016/j.breast.2004.12.007", "volume": "14", "author": "H Kang", "year": "2005", "unstructured": "215. Kang H, Watkins G, Douglas-Jones A, Mansel RE, Jiang WG. The elevated level of CXCR4 is correlated with nodal metastasis of human breast cancer. Breast 2005;14:360\u20137.", "journal-title": "Breast"}, {"key": "23_CR216_23", "doi-asserted-by": "publisher", "first-page": "13513", "DOI": "10.1073/pnas.2235846100", "volume": "100", "author": "JB Rubin", "year": "2003", "unstructured": "216. Rubin JB, Kung AL, Klein RS et al. A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc Natl Acad Sci USA 2003;100:13513\u20138.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "23_CR217_23", "doi-asserted-by": "publisher", "first-page": "4302", "DOI": "10.1158/0008-5472.CAN-03-3958", "volume": "64", "author": "Z Liang", "year": "2004", "unstructured": "217. Liang Z, Wu T, Lou H et al. Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res 2004;64:4302\u20138.", "journal-title": "Cancer Res"}, {"key": "23_CR218_23", "doi-asserted-by": "publisher", "first-page": "489", "DOI": "10.1387/ijdb.041814hk", "volume": "48", "author": "H Kulbe", "year": "2004", "unstructured": "218. Kulbe H, Levinson NR, Balkwill F, Wilson JL. The chemokine network in cancer\u2013much more than directing cell movement. Int J Dev Biol 2004;48:489\u201396.", "journal-title": "Int J Dev Biol"}, {"key": "23_CR219_23", "doi-asserted-by": "publisher", "first-page": "540", "DOI": "10.1038/nrc1388", "volume": "4", "author": "F Balkwill", "year": "2004", "unstructured": "219. Balkwill F. Cancer and the chemokine network. Nat Rev Cancer 2004;4:540\u201350.", "journal-title": "Nat Rev Cancer"}, {"key": "23_CR220_23", "doi-asserted-by": "crossref", "first-page": "503", "DOI": "10.1038/sj.bjc.6602325", "volume": "92", "author": "CA Hart", "year": "2005", "unstructured": "220. Hart CA, Brown M, Bagley S, Sharrard M, Clarke NW. Invasive characteristics of human prostatic epithelial cells: understanding the metastatic process. Br J Cancer 2005;92:503\u201312.", "journal-title": "Br J Cancer"}, {"key": "23_CR221_23", "doi-asserted-by": "publisher", "first-page": "290", "DOI": "10.1593/neo.05694", "volume": "8", "author": "T Engl", "year": "2006", "unstructured": "221. Engl T, Relja B, Marian D et al. CXCR4 chemokine receptor mediates prostate tumor cell adhesion through alpha5 and beta3 integrins. Neoplasia 2006;8:290\u2013301.", "journal-title": "Neoplasia"}, {"key": "23_CR222_23", "doi-asserted-by": "publisher", "first-page": "5731", "DOI": "10.1038/sj.onc.1208918", "volume": "24", "author": "L Strizzi", "year": "2005", "unstructured": "222. Strizzi L, Bianco C, Normanno N, Salomon D. Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis. Oncogene 2005;24:5731\u201341.", "journal-title": "Oncogene"}, {"key": "23_CR223_23", "doi-asserted-by": "publisher", "first-page": "383", "DOI": "10.1517/14728222.9.2.383", "volume": "9", "author": "XF Hu", "year": "2005", "unstructured": "223. Hu XF, Xing PX. Cripto as a target for cancer immunotherapy. Expert Opin Ther Targets 2005;9:383\u201394.", "journal-title": "Expert Opin Ther Targets"}, {"key": "23_CR224_23", "doi-asserted-by": "publisher", "first-page": "389", "DOI": "10.1016/j.stem.2007.08.001", "volume": "1", "author": "M Todaro", "year": "2007", "unstructured": "224. Todaro M, Mileidys Perez Alea MP, Di Stefano AB et al. Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cells 2007;1:389\u2013402.", "journal-title": "Cell Stem Cells"}, {"key": "23_CR225_23", "doi-asserted-by": "publisher", "first-page": "197", "DOI": "10.1207/s15327914nc5102_10", "volume": "51", "author": "T Sano", "year": "2005", "unstructured": "225. Sano T, Kagawa M, Okuno M et al. Prevention of rat hepatocarcinogenesis by acyclic retinoid is accompanied by reduction in emergence of both TGF-alpha-expressing oval-like cells and activated hepatic stellate cells. Nutr Cancer 2005;51:197\u2013206.", "journal-title": "Nutr Cancer"}, {"key": "23_CR226_23", "doi-asserted-by": "publisher", "first-page": "1118", "DOI": "10.1093/annonc/mdl331", "volume": "18", "author": "FG Perabo", "year": "2007", "unstructured": "226. Perabo FG, Muller SC. New agents for treatment of advanced transitional cell carcinoma. Ann Oncol 2007;18:1118.", "journal-title": "Ann Oncol"}, {"key": "23_CR227_23", "first-page": "2870", "volume": "7", "author": "AM Davidoff", "year": "2001", "unstructured": "227. Davidoff AM, Ng CY, Brown P et al. Bone marrow-derived cells contribute to tumor neovasculature and, when modified to express an angiogenesis inhibitor, can restrict tumor growth in mice. Clin Cancer Res 2001;7:2870\u20139.", "journal-title": "Clin Cancer Res"}, {"key": "23_CR228_23", "unstructured": "228.Rafii S, Lyden D. Contribution of hematopoietic and vascular progenitor cells to the neoangiogenic niche. Am Assoc Res Edu Book 2006;181\u20135."}, {"key": "23_CR229_23", "doi-asserted-by": "publisher", "first-page": "777", "DOI": "10.1111/j.1582-4934.2005.tb00379.x", "volume": "9", "author": "AM Byrne", "year": "2005", "unstructured": "229. Byrne AM, Bouchier-Hayes DJ, Harmey JH. Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). J Cell Mol Med 2005;9:777\u201394.", "journal-title": "J Cell Mol Med"}, {"key": "23_CR230_23", "doi-asserted-by": "publisher", "first-page": "223", "DOI": "10.2174/187152007780058687", "volume": "7", "author": "IS Moreira", "year": "2007", "unstructured": "230. Moreira IS, Fernandes PA, Ramos MJ. Vascular endothelial growth factor (VEGF) inhibition\u2013a critical review. Anticancer Agents Med Chem 2007;7:223\u201345.", "journal-title": "Anticancer Agents Med Chem"}, {"key": "23_CR231_23", "doi-asserted-by": "publisher", "first-page": "S45", "DOI": "10.1053/j.seminoncol.2005.12.002", "volume": "33", "author": "R Rosell", "year": "2006", "unstructured": "231. Rosell R, Cecere F, Cognetti F et al. Future directions in the second-line treatment of non-small cell lung cancer. Semin Oncol 2006;33:S45\u201351.", "journal-title": "Semin Oncol"}, {"key": "23_CR232_23", "doi-asserted-by": "publisher", "first-page": "69", "DOI": "10.1016/j.ccr.2006.11.020", "volume": "11", "author": "C Calabrese", "year": "2007", "unstructured": "232. Calabrese C, Poppleton H, Kocak M et al. A perivascular niche for brain tumor stem cells. Cancer Cell 2007;11:69\u201382.", "journal-title": "Cancer Cell"}, {"key": "23_CR233_23", "doi-asserted-by": "publisher", "first-page": "3560", "DOI": "10.1158/0008-5472.CAN-06-4238", "volume": "67", "author": "C Folkins", "year": "2007", "unstructured": "233. Folkins C, Man S, Xu P, Shaked Y, Hicklin DJ, Kerbel RS. Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors. Cancer Res 2007;67:3560\u20134.", "journal-title": "Cancer Res"}, {"key": "23_CR234_23", "doi-asserted-by": "publisher", "first-page": "3", "DOI": "10.1016/j.ccr.2006.12.007", "volume": "11", "author": "ZJ Yang", "year": "2007", "unstructured": "234. Yang ZJ, Wechsler-Reya RJ. Hit \u2019em where they live: targeting the cancer stem cell niche. Cancer Cell 2007;11:3\u20135.", "journal-title": "Cancer Cell"}, {"key": "23_CR235_23", "doi-asserted-by": "publisher", "first-page": "662", "DOI": "10.1093/jnci/djh123", "volume": "96", "author": "SY Sun", "year": "2004", "unstructured": "235. Sun SY, Hail N, Jr., Lotan R. Apoptosis as a novel target for cancer chemoprevention. J Natl Cancer Inst 2004;96:662\u201372.", "journal-title": "J Natl Cancer Inst"}, {"key": "23_CR236_23", "doi-asserted-by": "publisher", "first-page": "319", "DOI": "10.1007/3-7643-7426-8_9", "volume": "62", "author": "JC Miller", "year": "2005", "unstructured": "236. Miller JC, Sorensen AG. Imaging biomarkers predictive of disease/therapy outcome: ischemic stroke and drug development. Prog Drug Res 2005;62:319\u201356.", "journal-title": "Prog Drug Res"}, {"key": "23_CR237_23", "doi-asserted-by": "publisher", "first-page": "971", "DOI": "10.1124/jpet.105.084145", "volume": "315", "author": "A Arora", "year": "2005", "unstructured": "237. Arora A, Scholar EM. Role of tyrosine kinase inhibitors in cancer therapy. J Pharmacol Exp Ther 2005;315:971\u20139.", "journal-title": "J Pharmacol Exp Ther"}, {"key": "23_CR238_23", "doi-asserted-by": "publisher", "first-page": "849", "DOI": "10.2174/092986706776361085", "volume": "13", "author": "H Zhong", "year": "2006", "unstructured": "238. Zhong H, Bowen JP. Antiangiogenesis drug design: multiple pathways targeting tumor vasculature. Curr Med Chem 2006;13:849\u201362.", "journal-title": "Curr Med Chem"}, {"key": "23_CR239_23", "doi-asserted-by": "publisher", "first-page": "51", "DOI": "10.1016/j.critrevonc.2006.01.003", "volume": "59", "author": "JB Meric", "year": "2006", "unstructured": "239. Meric JB, Rottey S, Olaussen K et al. Cyclooxygenase-2 as a target for anticancer drug development. Crit Rev Oncol Hematol 2006;59:51\u201364.", "journal-title": "Crit Rev Oncol Hematol"}, {"key": "23_CR240_23", "doi-asserted-by": "publisher", "first-page": "1605", "DOI": "10.1016/j.bcp.2006.06.029", "volume": "72", "author": "BB Aggarwal", "year": "2006", "unstructured": "240. Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G. Inflammation and cancer: How hot is the link? Biochem Pharmacol 2006;72:1605\u201321.", "journal-title": "Biochem Pharmacol"}, {"key": "23_CR241_23", "first-page": "1125", "volume": "21", "author": "H Kobayashi", "year": "2006", "unstructured": "241. Kobayashi H, Lin PC. Antiangiogenic and radiotherapy for cancer treatment. Histol Histopathol 2006;21:1125\u201334.", "journal-title": "Histol Histopathol"}, {"key": "23_CR242_23", "doi-asserted-by": "publisher", "first-page": "736", "DOI": "10.1093/jnci/djj206", "volume": "98", "author": "S Grosch", "year": "2006", "unstructured": "242. Grosch S, Maier TJ, Schiffmann S, Geisslinger G. Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors. J Natl Cancer Inst 2006;98:736\u201347.", "journal-title": "J Natl Cancer Inst"}, {"key": "23_CR243_23", "doi-asserted-by": "publisher", "first-page": "61", "DOI": "10.1158/1541-7786.MCR-06-0002", "volume": "4", "author": "R Cairns", "year": "2006", "unstructured": "243. Cairns R, Papandreou I, Denko N. Overcoming physiologic barriers to cancer treatment by molecularly targeting the tumor microenvironment. Mol Cancer Res 2006;4:61\u201370.", "journal-title": "Mol Cancer Res"}, {"key": "23_CR244_23", "doi-asserted-by": "publisher", "first-page": "221", "DOI": "10.1158/1541-7786.MCR-05-0261", "volume": "4", "author": "H Lu", "year": "2006", "unstructured": "244. Lu H, Ouyang W, Huang C. Inflammation, a Key Event in Cancer Development. Mol Cancer Res 2006;4:221\u201333.", "journal-title": "Mol Cancer Res"}, {"key": "23_CR245_23", "doi-asserted-by": "publisher", "first-page": "1194", "DOI": "10.1038/nm1101-1194", "volume": "7", "author": "D Lyden", "year": "2001", "unstructured": "245. Lyden D, Hattori K, Dias S et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001;7:1194\u2013201.", "journal-title": "Nat Med"}, {"key": "23_CR246_23", "doi-asserted-by": "publisher", "first-page": "1294", "DOI": "10.1158/0008-5472.CAN-03-3986", "volume": "65", "author": "S Vosseler", "year": "2005", "unstructured": "246. Vosseler S, Mirancea N, Bohlen P, Mueller MM, Fusenig NE. Angiogenesis inhibition by vascular endothelial growth factor receptor-2 blockade reduces stromal matrix metalloproteinase expression, normalizes stromal tissue, and reverts epithelial tumor phenotype in surface heterotransplants. Cancer Res 2005;65:1294\u2013305.", "journal-title": "Cancer Res"}, {"key": "23_CR247_23", "doi-asserted-by": "publisher", "first-page": "2339", "DOI": "10.1182/blood-2006-02-004291", "volume": "108", "author": "J van Beijnum", "year": "2006", "unstructured": "247. van Beijnum J, Dings RP, van der LE et al. Gene expression of tumor angiogenesis dissected; specific targeting of colon cancer angiogenic vasculature. Blood 2006;108:2339\u201348.", "journal-title": "Blood"}], "container-title": ["Stem Cells and Cancer"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-1-60327-933-8_23", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 27]], "date-time": "2019-04-27T13:02:40Z", "timestamp": 1556370160000}, "score": 21.723186, "issued": {"date-parts": [[2009]]}, "ISBN": ["9781603279321", "9781603279338"], "references-count": 247, "URL": "http://dx.doi.org/10.1007/978-1-60327-933-8_23", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T07:21:45Z", "timestamp": 1575444105833}, "reference-count": 0, "publisher": "Open Access Publishing London", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["OA Emergency Medicine"], "DOI": "10.13172/2054-1902-1-1-648", "type": "journal-article", "created": {"date-parts": [[2014, 3, 2]], "date-time": "2014-03-02T15:59:02Z", "timestamp": 1393775942000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["The role of Kupffer cells in the progression of acute pancreatitis"], "prefix": "10.13172", "volume": "1", "author": [{"given": "K", "family": "Wu", "sequence": "first", "affiliation": []}, {"given": "JP", "family": "Gong", "sequence": "first", "affiliation": []}], "member": "5278", "published-online": {"date-parts": [[2013, 8]]}, "container-title": ["OA Emergency Medicine"], "original-title": ["English"], "deposited": {"date-parts": [[2014, 3, 2]], "date-time": "2014-03-02T15:59:04Z", "timestamp": 1393775944000}, "score": 20.863163, "issued": {"date-parts": [[2013, 8]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2013]]}, "issue": "1"}, "URL": "http://dx.doi.org/10.13172/2054-1902-1-1-648", "ISSN": ["2054-1902"], "issn-type": [{"value": "2054-1902", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T05:08:09Z", "timestamp": 1575176889589}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "7", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Research"], "published-print": {"date-parts": [[2013, 4, 1]]}, "DOI": "10.1158/0008-5472.can-12-4184", "type": "journal-article", "created": {"date-parts": [[2013, 1, 31]], "date-time": "2013-01-31T02:06:30Z", "timestamp": 1359597990000}, "page": "2127-2138", "source": "Crossref", "is-referenced-by-count": 40, "title": ["Anti-CD20 Antibody Promotes Cancer Escape via Enrichment of Tumor-Evoked Regulatory B Cells Expressing Low Levels of CD20 and CD137L"], "prefix": "10.1158", "volume": "73", "author": [{"given": "M.", "family": "Bodogai", "sequence": "first", "affiliation": []}, {"given": "C.", "family": "Lee Chang", "sequence": "additional", "affiliation": []}, {"given": "K.", "family": "Wejksza", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Lai", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Merino", "sequence": "additional", "affiliation": []}, {"given": "R. P.", "family": "Wersto", "sequence": "additional", "affiliation": []}, {"given": "R. E.", "family": "Gress", "sequence": "additional", "affiliation": []}, {"given": "A. C.", "family": "Chan", "sequence": "additional", "affiliation": []}, {"given": "C.", "family": "Hesdorffer", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Biragyn", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2013, 1, 30]]}, "container-title": ["Cancer Research"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/0008-5472.CAN-12-4184", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T12:25:13Z", "timestamp": 1482495913000}, "score": 20.861307, "issued": {"date-parts": [[2013, 1, 30]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2013, 4, 2]]}, "published-print": {"date-parts": [[2013, 4, 1]]}, "issue": "7"}, "URL": "http://dx.doi.org/10.1158/0008-5472.can-12-4184", "ISSN": ["0008-5472", "1538-7445"], "issn-type": [{"value": "0008-5472", "type": "print"}, {"value": "1538-7445", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T00:35:08Z", "timestamp": 1574296508826}, "publisher-location": "New York, NY", "reference-count": 72, "publisher": "Springer US", "isbn-type": [{"value": "9780387886107", "type": "print"}, {"value": "9780387886114", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2009]]}, "DOI": "10.1007/978-0-387-88611-4_18", "type": "book-chapter", "created": {"date-parts": [[2009, 4, 18]], "date-time": "2009-04-18T21:14:16Z", "timestamp": 1240089256000}, "page": "257-268", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Dendritic Cell Maturation Versus Polarization in Tumor Escape"], "prefix": "10.1007", "author": [{"given": "Michael W.", "family": "Lipscomb", "sequence": "first", "affiliation": []}, {"given": "Walter J.", "family": "Storkus", "sequence": "additional", "affiliation": []}, {"given": "Amy K.", "family": "Wesa", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2009, 2, 26]]}, "reference": [{"key": "18_CR1", "doi-asserted-by": "publisher", "first-page": "1417", "DOI": "10.1084/jem.190.10.1417", "volume": "190", "author": "D. Bell", "year": "1999", "unstructured": "Bell, D., Chomarat, P., Broyles, D., Netto, G., Harb, G. M., Lebecque, S., Valladeau, J., Davoust, J., Palucka, K. A. and Banchereau, J. 1999. In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J Exp Med 190:1417\u20131426.", "journal-title": "J Exp Med"}, {"key": "18_CR2", "doi-asserted-by": "publisher", "first-page": "1170", "DOI": "10.1183/09031936.06.00114205", "volume": "28", "author": "A. Bergeron", "year": "2006", "unstructured": "Bergeron, A., El-Hage, F., Kambouchner, M., Lecossier, D. and Tazi, A. 2006. Characterisation of dendritic cell subsets in lung cancer micro-environments. Eur Respir J 28:1170\u20131177.", "journal-title": "Eur Respir J"}, {"key": "18_CR3", "doi-asserted-by": "crossref", "first-page": "1628", "DOI": "10.4049/jimmunol.175.3.1628", "volume": "175", "author": "C. A. Carlos", "year": "2005", "unstructured": "Carlos, C. A., Dong, H. F., Howard, O. M., Oppenheim, J. J., Hanisch, F. G. and Finn, O. J. 2005. Human tumor antigen MUC1 is chemotactic for immature dendritic cells and elicits maturation but does not promote Th1 type immunity. J Immunol 175:1628\u20131635.", "journal-title": "J Immunol"}, {"key": "18_CR4", "doi-asserted-by": "publisher", "first-page": "345", "DOI": "10.1007/s002810000053", "volume": "22", "author": "C. Caux", "year": "2000", "unstructured": "Caux, C., Ait-Yahia, S., Chemin, K., de Bouteiller, O., Dieu-Nosjean, M. C., Homey, B., Massacrier, C., Vanbervliet, B., Zlotnik, A. and Vicari, A. 2000. Dendritic cell biology and regulation of dendritic cell trafficking by chemokines. Springer Semin Immunopathol 22:345\u2013369.", "journal-title": "Springer Semin Immunopathol"}, {"key": "18_CR5", "doi-asserted-by": "publisher", "first-page": "619", "DOI": "10.1002/(SICI)1097-0215(19970807)72:4<619::AID-IJC12>3.0.CO;2-6", "volume": "72", "author": "P. Chaux", "year": "1997", "unstructured": "Chaux, P., Favre, N., Martin, M. and Martin, F. 1997. Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression in rats. Int J Cancer 72:619\u2013624.", "journal-title": "Int J Cancer"}, {"key": "18_CR6", "doi-asserted-by": "publisher", "first-page": "1219", "DOI": "10.1038/ni1141", "volume": "5", "author": "M. Colonna", "year": "2004", "unstructured": "Colonna, M., Trinchieri, G. and Liu, Y. J. 2004. Plasmacytoid dendritic cells in immunity. Nat Immunol 5:1219\u20131226.", "journal-title": "Nat Immunol"}, {"key": "18_CR7", "doi-asserted-by": "publisher", "first-page": "263", "DOI": "10.1016/j.cell.2006.01.007", "volume": "124", "author": "J. Condeelis", "year": "2006", "unstructured": "Condeelis, J. and Pollard, J. W. 2006. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124:263\u2013266.", "journal-title": "Cell"}, {"key": "18_CR8", "doi-asserted-by": "publisher", "first-page": "1167", "DOI": "10.1172/JCI31202", "volume": "117", "author": "T. J. Curiel", "year": "2007", "unstructured": "Curiel, T. J. 2007. Tregs and rethinking cancer immunotherapy. J Clin Invest 117:1167\u20131174.", "journal-title": "J Clin Invest"}, {"key": "18_CR9", "doi-asserted-by": "publisher", "first-page": "2205", "DOI": "10.1158/0008-5472.CAN-03-2646", "volume": "64", "author": "E. A. Danna", "year": "2004", "unstructured": "Danna, E. A., Sinha, P., Gilbert, M., Clements, V. K., Pulaski, B. A. and Ostrand-Rosenberg, S. 2004. Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease. Cancer Res 64:2205\u20132211.", "journal-title": "Cancer Res"}, {"key": "18_CR10", "doi-asserted-by": "publisher", "first-page": "289", "DOI": "10.1007/s00281-004-0167-1", "volume": "26", "author": "E. C. Jong de", "year": "2005", "unstructured": "de Jong, E. C., Smits, H. H. and Kapsenberg, M. L. 2005. Dendritic cell-mediated T cell polarization. Springer Semin Immunopathol 26:289\u2013307.", "journal-title": "Springer Semin Immunopathol"}, {"key": "18_CR11", "doi-asserted-by": "crossref", "first-page": "215", "DOI": "10.4049/jimmunol.174.1.215", "volume": "174", "author": "M. M. Dikov", "year": "2005", "unstructured": "Dikov, M. M., Ohm, J. E., Ray, N., Tchekneva, E. E., Burlison, J., Moghanaki, D., Nadaf, S. and Carbone, D. P. 2005. Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation. J Immunol 174:215\u2013222.", "journal-title": "J Immunol"}, {"key": "18_CR12", "doi-asserted-by": "publisher", "first-page": "1277", "DOI": "10.1084/jem.20030705", "volume": "198", "author": "V. Doyen", "year": "2003", "unstructured": "Doyen, V., Rubio, M., Braun, D., Nakajima, T., Abe, J., Saito, H., Delespesse, G. and Sarfati, M. 2003. Thrombospondin 1 is an autocrine negative regulator of human dendritic cell activation. J Exp Med 198:1277\u20131283.", "journal-title": "J Exp Med"}, {"key": "18_CR13", "doi-asserted-by": "crossref", "first-page": "336", "DOI": "10.1002/jlb.66.2.336", "volume": "66", "author": "C. Esche", "year": "1999", "unstructured": "Esche, C., Lokshin, A., Shurin, G. V., Gastman, B. R., Rabinowich, H., Watkins, S. C., Lotze, M. T. and Shurin, M. R. 1999. Tumor's other immune targets: dendritic cells. J Leukoc Biol 66:336\u2013344.", "journal-title": "J Leukoc Biol"}, {"key": "18_CR14", "doi-asserted-by": "publisher", "first-page": "90", "DOI": "10.1172/JCI26169", "volume": "116", "author": "K. Evel-Kabler", "year": "2006", "unstructured": "Evel-Kabler, K., Song, X. T., Aldrich, M., Huang, X. F. and Chen, S. Y. 2006. SOCS1 restricts dendritic cells' ability to break self tolerance and induce antitumor immunity by regulating IL-12 production and signaling. J Clin Invest 116:90\u2013100.", "journal-title": "J Clin Invest"}, {"key": "18_CR15", "doi-asserted-by": "publisher", "first-page": "522", "DOI": "10.1096/fj.07-9034com", "volume": "22", "author": "O. Fainaru", "year": "2008", "unstructured": "Fainaru, O., Adini, A., Benny, O., Adini, I., Short, S., Bazinet, L., Nakai, K., Pravda, E., Hornstein, M. D., D'Amato, R. J. and Folkman, J. 2008. Dendritic cells support angiogenesis and promote lesion growth in a murine model of endometriosis. Faseb J 22:522\u2013529.", "journal-title": "Faseb J"}, {"key": "18_CR16", "doi-asserted-by": "publisher", "first-page": "275", "DOI": "10.1002/ijc.21046", "volume": "116", "author": "E. Feijoo", "year": "2005", "unstructured": "Feijoo, E., Alfaro, C., Mazzolini, G., Serra, P., Penuelas, I., Arina, A., Huarte, E., Tirapu, I., Palencia, B., Murillo, O., Ruiz, J., Sangro, B., Richter, J. A., Prieto, J. and Melero, I. 2005. Dendritic cells delivered inside human carcinomas are sequestered by interleukin-8. Int J Cancer 116:275\u2013281.", "journal-title": "Int J Cancer"}, {"key": "18_CR17", "doi-asserted-by": "publisher", "first-page": "459", "DOI": "10.1080/08820130600803429", "volume": "35", "author": "I. Fricke", "year": "2006", "unstructured": "Fricke, I. and Gabrilovich, D. I. 2006. Dendritic cells and tumor microenvironment: a dangerous liaison. Immunol Invest 35:459\u2013483.", "journal-title": "Immunol Invest"}, {"key": "18_CR18", "doi-asserted-by": "publisher", "first-page": "941", "DOI": "10.1038/nri1498", "volume": "4", "author": "D. Gabrilovich", "year": "2004", "unstructured": "Gabrilovich, D. 2004. Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat Rev Immunol 4:941\u2013952.", "journal-title": "Nat Rev Immunol"}, {"key": "18_CR19", "doi-asserted-by": "publisher", "first-page": "777", "DOI": "10.1007/s10585-008-9191-1", "volume": "25", "author": "M. Gulubova", "year": "2008", "unstructured": "Gulubova, M., Manolova, I., Cirowski, G., et al. 2008. Recruitment of dendritic cells in human liver with metastases. Clin Exp Metastasis 25:777\u2013785, [Epub ahead of print].", "journal-title": "Clin Exp Metastasis"}, {"key": "18_CR20", "doi-asserted-by": "crossref", "first-page": "4325", "DOI": "10.4049/jimmunol.174.7.4325", "volume": "174", "author": "T. Hanada", "year": "2005", "unstructured": "Hanada, T., Tanaka, K., Matsumura, Y., Yamauchi, M., Nishinakamura, H., Aburatani, H., Mashima, R., Kubo, M., Kobayashi, T. and Yoshimura, A. 2005. Induction of hyper Th1 cell-type immune responses by dendritic cells lacking the suppressor of cytokine signaling-1 gene. J Immunol 174:4325\u20134332.", "journal-title": "J Immunol"}, {"key": "18_CR21", "doi-asserted-by": "crossref", "first-page": "1439", "DOI": "10.1096/fj.03-0969fje", "volume": "18", "author": "S. Hegde", "year": "2004", "unstructured": "Hegde, S., Pahne, J. and Smola-Hess, S. 2004. Novel immunosuppressive properties of interleukin-6 in dendritic cells: inhibition of NF-kappaB binding activity and CCR7 expression. Faseb J 18:1439\u20131441.", "journal-title": "Faseb J"}, {"key": "18_CR22", "doi-asserted-by": "publisher", "first-page": "86", "DOI": "10.1016/j.canlet.2006.12.012", "volume": "252", "author": "B. Huang", "year": "2007", "unstructured": "Huang, B., Lei, Z., Zhao, J., Gong, W., Liu, J., Chen, Z., Liu, Y., Li, D., Yuan, Y., Zhang, G. M. and Feng, Z. H. 2007. CCL2/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancers. Cancer Lett 252:86\u201392.", "journal-title": "Cancer Lett"}, {"key": "18_CR23", "doi-asserted-by": "publisher", "first-page": "80", "DOI": "10.1038/sj.cdd.4402237", "volume": "15", "author": "M. Iero", "year": "2008", "unstructured": "Iero, M., Valenti, R., Huber, V., Filipazzi, P., Parmiani, G., Fais, S. and Rivoltini, L. 2008. Tumour-released exosomes and their implications in cancer immunity. Cell Death Differ 15:80\u201388.", "journal-title": "Cell Death Differ"}, {"key": "18_CR24", "doi-asserted-by": "crossref", "first-page": "2627", "DOI": "10.4049/jimmunol.179.4.2627", "volume": "179", "author": "M. Inokuma", "year": "2007", "unstructured": "Inokuma, M., dela Rosa, C., Schmitt, C., Haaland, P., Siebert, J., Petry, D., Tang, M., Suni, M. A., Ghanekar, S. A., Gladding, D., Dunne, J. F., Maino, V. C., Disis, M. L. and Maecker, H. T. 2007. Functional T cell responses to tumor antigens in breast cancer patients have a distinct phenotype and cytokine signature. J Immunol 179:2627\u20132633.", "journal-title": "J Immunol"}, {"key": "18_CR25", "doi-asserted-by": "publisher", "first-page": "92", "DOI": "10.1002/ijc.10915", "volume": "104", "author": "M. Iwamoto", "year": "2003", "unstructured": "Iwamoto, M., Shinohara, H., Miyamoto, A., Okuzawa, M., Mabuchi, H., Nohara, T., Gon, G., Toyoda, M. and Tanigawa, N. 2003. Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas. Int J Cancer 104:92\u201397.", "journal-title": "Int J Cancer"}, {"key": "18_CR26", "doi-asserted-by": "crossref", "first-page": "2307", "DOI": "10.4049/jimmunol.172.4.2307", "volume": "172", "author": "S. H. Jackson", "year": "2004", "unstructured": "Jackson, S. H., Yu, C. R., Mahdi, R. M., Ebong, S. and Egwuagu, C. E. 2004. Dendritic cell maturation requires STAT1 and is under feedback regulation by suppressors of cytokine signaling. J Immunol 172:2307\u20132315.", "journal-title": "J Immunol"}, {"key": "18_CR27", "doi-asserted-by": "publisher", "first-page": "852", "DOI": "10.1038/nature01441", "volume": "421", "author": "E. M. Janssen", "year": "2003", "unstructured": "Janssen, E. M., Lemmens, E. E., Wolfe, T., Christen, U., von Herrath, M. G. and Schoenberger, S. P. 2003. CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature 421:852\u2013856.", "journal-title": "Nature"}, {"key": "18_CR28", "doi-asserted-by": "publisher", "first-page": "984", "DOI": "10.1038/nri1246", "volume": "3", "author": "M. L. Kapsenberg", "year": "2003", "unstructured": "Kapsenberg, M. L. 2003. Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 3:984\u2013993.", "journal-title": "Nat Rev Immunol"}, {"key": "18_CR29", "doi-asserted-by": "publisher", "first-page": "189", "DOI": "10.1111/j.1365-2249.2006.03215.x", "volume": "146", "author": "R. Kim", "year": "2006", "unstructured": "Kim, R., Emi, M. and Tanabe, K. 2006a. Functional roles of immature dendritic cells in impaired immunity of solid tumour and their targeted strategies for provoking tumour immunity. Clin Exp Immunol 146:189\u2013196.", "journal-title": "Clin Exp Immunol"}, {"key": "18_CR30", "doi-asserted-by": "publisher", "first-page": "5527", "DOI": "10.1158/0008-5472.CAN-05-4128", "volume": "66", "author": "R. Kim", "year": "2006", "unstructured": "Kim, R., Emi, M., Tanabe, K. and Arihiro, K. 2006b. Tumor-driven evolution of immunosuppressive networks during malignant progression. Cancer Res 66:5527\u20135536.", "journal-title": "Cancer Res"}, {"key": "18_CR31", "doi-asserted-by": "publisher", "first-page": "315", "DOI": "10.1007/s10555-005-1580-1", "volume": "24", "author": "M. Kortylewski", "year": "2005", "unstructured": "Kortylewski, M., Jove, R. and Yu, H. 2005. Targeting STAT3 affects melanoma on multiple fronts. Cancer Metastasis Rev 24:315\u2013327.", "journal-title": "Cancer Metastasis Rev"}, {"key": "18_CR32", "doi-asserted-by": "publisher", "first-page": "48", "DOI": "10.1007/s00262-006-0160-8", "volume": "56", "author": "N. Larmonier", "year": "2007", "unstructured": "Larmonier, N., Marron, M., Zeng, Y., Cantrell, J., Romanoski, A., Sepassi, M., Thompson, S., Chen, X., Andreansky, S. and Katsanis, E. 2007. Tumor-derived CD4(+)CD25(+) regulatory T cell suppression of dendritic cell function involves TGF-beta and IL-10. Cancer Immunol Immunother 56:48\u201359.", "journal-title": "Cancer Immunol Immunother"}, {"key": "18_CR33", "doi-asserted-by": "publisher", "first-page": "38", "DOI": "10.1016/j.imlet.2007.09.003", "volume": "114", "author": "L. Li", "year": "2007", "unstructured": "Li, L., Li, S. P., Min, J. and Zheng, L. 2007. Hepatoma cells inhibit the differentiation and maturation of dendritic cells and increase the production of regulatory T cells. Immunol Lett 114:38\u201345.", "journal-title": "Immunol Lett"}, {"key": "18_CR34", "doi-asserted-by": "crossref", "first-page": "1679", "DOI": "10.4049/jimmunol.177.3.1679", "volume": "177", "author": "Y. Li", "year": "2006", "unstructured": "Li, Y., Chu, N., Rostami, A. and Zhang, G. X. 2006. Dendritic cells transduced with SOCS-3 exhibit a tolerogenic/DC2 phenotype that directs type 2 Th cell differentiation in vitro and in vivo. J Immunol 177:1679\u20131688.", "journal-title": "J Immunol"}, {"key": "18_CR35", "doi-asserted-by": "publisher", "first-page": "315", "DOI": "10.1007/s10555-006-9001-7", "volume": "25", "author": "A. Mantovani", "year": "2006", "unstructured": "Mantovani, A., Schioppa, T., Porta, C., Allavena, P. and Sica, A. 2006. Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev 25:315\u2013322.", "journal-title": "Cancer Metastasis Rev"}, {"key": "18_CR36", "doi-asserted-by": "publisher", "first-page": "162", "DOI": "10.1111/j.1600-065X.2008.00602.x", "volume": "222", "author": "I. Marigo", "year": "2008", "unstructured": "Marigo, I., Dolcetti, L., Serafini, P., Zanovello, P. and Bronte, V. 2008. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. Immunol Rev 222:162\u2013179.", "journal-title": "Immunol Rev"}, {"key": "18_CR37", "doi-asserted-by": "publisher", "first-page": "3860", "DOI": "10.1182/blood-2005-05-1843", "volume": "106", "author": "F. Marteau", "year": "2005", "unstructured": "Marteau, F., Gonzalez, N. S., Communi, D., Goldman, M., Boeynaems, J. M. and Communi, D. 2005. Thrombospondin-1 and indoleamine 2,3-dioxygenase are major targets of extracellular ATP in human dendritic cells. Blood 106:3860\u20133866.", "journal-title": "Blood"}, {"key": "18_CR38", "doi-asserted-by": "crossref", "first-page": "1652", "DOI": "10.4049/jimmunol.171.4.1652", "volume": "171", "author": "A. L. Mellor", "year": "2003", "unstructured": "Mellor, A. L., Baban, B., Chandler, P., Marshall, B., Jhaver, K., Hansen, A., Koni, P. A., Iwashima, M. and Munn, D. H. 2003. Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion. J Immunol 171:1652\u20131655.", "journal-title": "J Immunol"}, {"key": "18_CR39", "doi-asserted-by": "publisher", "first-page": "2192", "DOI": "10.1158/0008-5472.CAN-03-2969", "volume": "64", "author": "M. Movassagh", "year": "2004", "unstructured": "Movassagh, M., Spatz, A., Davoust, J., Lebecque, S., Romero, P., Pittet, M., Rimoldi, D., Lienard, D., Gugerli, O., Ferradini, L., Robert, C., Avril, M. F., Zitvogel, L. and Angevin, E. 2004. Selective accumulation of mature DC-Lamp+ dendritic cells in tumor sites is associated with efficient T-cell-mediated antitumor response and control of metastatic dissemination in melanoma. Cancer Res 64:2192\u20132198.", "journal-title": "Cancer Res"}, {"key": "18_CR40", "doi-asserted-by": "crossref", "first-page": "280", "DOI": "10.1172/JCI21583", "volume": "114", "author": "D. H. Munn", "year": "2004", "unstructured": "Munn, D. H., Sharma, M. D., Hou, D., Baban, B., Lee, J. R., Antonia, S. J., Messina, J. L., Chandler, P., Koni, P. A. and Mellor, A. L. 2004. Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J Clin Invest 114:280\u2013290.", "journal-title": "J Clin Invest"}, {"key": "18_CR41", "doi-asserted-by": "publisher", "first-page": "618", "DOI": "10.1038/nrc2444", "volume": "8", "author": "C. Murdoch", "year": "2008", "unstructured": "Murdoch, C., Muthana, M., Coffelt, S. B. and Lewis, C. E. 2008. The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer 8:618\u2013631.", "journal-title": "Nat Rev Cancer"}, {"key": "18_CR42", "doi-asserted-by": "publisher", "first-page": "62", "DOI": "10.1186/1479-5876-5-62", "volume": "5", "author": "D. Nagorsen", "year": "2007", "unstructured": "Nagorsen, D., Voigt, S., Berg, E., Stein, H., Thiel, E. and Loddenkemper, C. 2007. Tumor-infiltrating macrophages and dendritic cells in human colorectal cancer: relation to local regulatory T cells, systemic T-cell response against tumor-associated antigens and survival. J Transl Med 5:62.", "journal-title": "J Transl Med"}, {"key": "18_CR43", "doi-asserted-by": "crossref", "first-page": "464", "DOI": "10.4049/jimmunol.172.1.464", "volume": "172", "author": "Y. Nefedova", "year": "2004", "unstructured": "Nefedova, Y., Huang, M., Kusmartsev, S., Bhattacharya, R., Cheng, P., Salup, R., Jove, R. and Gabrilovich, D. 2004. Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer. J Immunol 172:464\u2013474.", "journal-title": "J Immunol"}, {"key": "18_CR44", "doi-asserted-by": "crossref", "first-page": "2763", "DOI": "10.4049/jimmunol.178.5.2763", "volume": "178", "author": "I. Perrot", "year": "2007", "unstructured": "Perrot, I., Blanchard, D., Freymond, N., Isaac, S., Guibert, B., Pacheco, Y. and Lebecque, S. 2007. Dendritic cells infiltrating human non-small cell lung cancer are blocked at immature stage. J Immunol 178:2763\u20132769.", "journal-title": "J Immunol"}, {"key": "18_CR45", "doi-asserted-by": "publisher", "first-page": "825", "DOI": "10.1084/jem.20071341", "volume": "205", "author": "S. Piconese", "year": "2008", "unstructured": "Piconese, S., Valzasina, B. and Colombo, M. P. 2008. OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection. J Exp Med 205:825\u2013839.", "journal-title": "J Exp Med"}, {"key": "18_CR46", "doi-asserted-by": "publisher", "first-page": "451", "DOI": "10.1111/j.1440-1711.2005.01371.x", "volume": "83", "author": "A. Pinzon-Charry", "year": "2005", "unstructured": "Pinzon-Charry, A., Maxwell, T. and Lopez, J. A. 2005. Dendritic cell dysfunction in cancer: a mechanism for immunosuppression. Immunol Cell Biol 83:451\u2013461.", "journal-title": "Immunol Cell Biol"}, {"key": "18_CR47", "doi-asserted-by": "publisher", "first-page": "506", "DOI": "10.1054/bjoc.2000.1289", "volume": "83", "author": "G. Pirtskhalaishvili", "year": "2000", "unstructured": "Pirtskhalaishvili, G., Shurin, G. V., Esche, C., Cai, Q., Salup, R. R., Bykovskaia, S. N., Lotze, M. T. and Shurin, M. R. 2000. Cytokine-mediated protection of human dendritic cells from prostate cancer-induced apoptosis is regulated by the Bcl-2 family of proteins. Br J Cancer 83:506\u2013513.", "journal-title": "Br J Cancer"}, {"key": "18_CR48", "doi-asserted-by": "publisher", "first-page": "145", "DOI": "10.1007/s00109-007-0262-6", "volume": "86", "author": "A. Popov", "year": "2008", "unstructured": "Popov, A. and Schultze, J. L. 2008. IDO-expressing regulatory dendritic cells in cancer and chronic infection. J Mol Med 86:145\u2013160.", "journal-title": "J Mol Med"}, {"key": "18_CR49", "doi-asserted-by": "publisher", "first-page": "267", "DOI": "10.1146/annurev.immunol.25.022106.141609", "volume": "25", "author": "G. A. Rabinovich", "year": "2007", "unstructured": "Rabinovich, G. A., Gabrilovich, D. and Sotomayor, E. M. 2007. Immunosuppressive strategies that are mediated by tumor cells. Annu Rev Immunol 25:267\u2013296.", "journal-title": "Annu Rev Immunol"}, {"key": "18_CR50", "doi-asserted-by": "publisher", "first-page": "1435", "DOI": "10.1182/blood-2006-03-006403", "volume": "108", "author": "S. Rutella", "year": "2006", "unstructured": "Rutella, S., Danese, S. and Leone, G. 2006. Tolerogenic dendritic cells: cytokine modulation comes of age. Blood 108:1435\u20131440.", "journal-title": "Blood"}, {"key": "18_CR51", "doi-asserted-by": "publisher", "first-page": "2570", "DOI": "10.1172/JCI31911", "volume": "117", "author": "M. D. Sharma", "year": "2007", "unstructured": "Sharma, M. D., Baban, B., Chandler, P., Hou, D. Y., Singh, N., Yagita, H., Azuma, M., Blazar, B. R., Mellor, A. L. and Munn, D. H. 2007. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J Clin Invest 117:2570\u20132582.", "journal-title": "J Clin Invest"}, {"key": "18_CR52", "doi-asserted-by": "publisher", "first-page": "19", "DOI": "10.1038/nri1996", "volume": "7", "author": "K. Shortman", "year": "2007", "unstructured": "Shortman, K. and Naik, S. H. 2007. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 7:19\u201330.", "journal-title": "Nat Rev Immunol"}, {"key": "18_CR53", "first-page": "65", "volume": "11", "author": "M. R. Shurin", "year": "2001", "unstructured": "Shurin, M. R. and Gabrilovich, D. I. 2001. Regulation of dendritic cell system by tumor. Cancer Res Ther Control 11:65\u201378.", "journal-title": "Cancer Res Ther Control"}, {"key": "18_CR54", "first-page": "363", "volume": "61", "author": "G. V. Shurin", "year": "2001", "unstructured": "Shurin, G. V., Shurin, M. R., Bykovskaia, S., Shogan, J., Lotze, M. T. and Barksdale, E. M., Jr. 2001. Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function. Cancer Res 61:363\u2013369.", "journal-title": "Cancer Res"}, {"key": "18_CR55", "doi-asserted-by": "publisher", "first-page": "333", "DOI": "10.1007/s10555-006-9010-6", "volume": "25", "author": "M. R. Shurin", "year": "2006", "unstructured": "Shurin, M. R., Shurin, G. V., Lokshin, A., Yurkovetsky, Z. R., Gutkin, D. W., Chatta, G., Zhong, H., Han, B. and Ferris, R. L. 2006. Intratumoral cytokines/chemokines/growth factors and tumor infiltrating dendritic cells: friends or enemies? Cancer Metastasis Rev 25:333\u2013356.", "journal-title": "Cancer Metastasis Rev"}, {"key": "18_CR56", "first-page": "1634", "volume": "93", "author": "K. Steinbrink", "year": "1999", "unstructured": "Steinbrink, K., Jonuleit, H., Muller, G., Schuler, G., Knop, J. and Enk, A. H. 1999. Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. Blood 93:1634\u20131642.", "journal-title": "Blood"}, {"key": "18_CR57", "doi-asserted-by": "publisher", "first-page": "1665", "DOI": "10.1007/s00262-008-0487-4", "volume": "57", "author": "P. Stoitzner", "year": "2008", "unstructured": "Stoitzner, P., Green, L. K., Jung, J. Y., Price, K. M., Atarea, H., Kivell, B. and Ronchese, F. 2008. Inefficient presentation of tumor-derived antigen by tumor-infiltrating dendritic cells. Cancer Immunol Immunother 57:1665\u20131673.", "journal-title": "Cancer Immunol Immunother"}, {"key": "18_CR58", "doi-asserted-by": "publisher", "first-page": "37", "DOI": "10.1002/path.1018", "volume": "196", "author": "A. Suzuki", "year": "2002", "unstructured": "Suzuki, A., Masuda, A., Nagata, H., Kameoka, S., Kikawada, Y., Yamakawa, M. and Kasajima, T. 2002. Mature dendritic cells make clusters with T cells in the invasive margin of colorectal carcinoma. J Pathol 196:37\u201343.", "journal-title": "J Pathol"}, {"key": "18_CR59", "doi-asserted-by": "publisher", "first-page": "121", "DOI": "10.1159/000048257", "volume": "62", "author": "A. Takahashi", "year": "2002", "unstructured": "Takahashi, A., Kono, K., Itakura, J., Amemiya, H., Feng Tang, R., Iizuka, H., Fujii, H. and Matsumoto, Y. 2002. Correlation of vascular endothelial growth factor-C expression with tumor-infiltrating dendritic cells in gastric cancer. Oncology 62:121\u2013127.", "journal-title": "Oncology"}, {"key": "18_CR60", "first-page": "4481", "volume": "63", "author": "T. Tatsumi", "year": "2003", "unstructured": "Tatsumi, T., Herrem, C. J., Olson, W. C., Finke, J. H., Bukowski, R. M., Kinch, M. S., Ranieri, E. and Storkus, W. J. 2003. Disease stage variation in CD4+ and CD8+ T-cell reactivity to the receptor tyrosine kinase EphA2 in patients with renal cell carcinoma. Cancer Res 63:4481\u20134489.", "journal-title": "Cancer Res"}, {"key": "18_CR61", "doi-asserted-by": "publisher", "first-page": "619", "DOI": "10.1084/jem.20012142", "volume": "196", "author": "T. Tatsumi", "year": "2002", "unstructured": "Tatsumi, T., Kierstead, L. S., Ranieri, E., Gesualdo, L., Schena, F. P., Finke, J. H., Bukowski, R. M., Mueller-Berghaus, J., Kirkwood, J. M., Kwok, W. W. and Storkus, W. J. 2002. Disease-associated bias in T helper type 1 (Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma. J Exp Med 196:619\u2013628.", "journal-title": "J Exp Med"}, {"key": "18_CR62", "doi-asserted-by": "crossref", "first-page": "4679", "DOI": "10.4049/jimmunol.180.7.4679", "volume": "180", "author": "M. Terme", "year": "2008", "unstructured": "Terme, M., Chaput, N., Combadiere, B., Ma, A., Ohteki, T. and Zitvogel, L. 2008. Regulatory T cells control dendritic cell/NK cell cross-talk in lymph nodes at the steady state by inhibiting CD4+ self-reactive T cells. J Immunol 180:4679\u20134686.", "journal-title": "J Immunol"}, {"key": "18_CR63", "doi-asserted-by": "publisher", "first-page": "2442", "DOI": "10.1158/0008-5472.CAN-05-1681", "volume": "66", "author": "I. Tirapu", "year": "2006", "unstructured": "Tirapu, I., Huarte, E., Guiducci, C., Arina, A., Zaratiegui, M., Murillo, O., Gonzalez, A., Berasain, C., Berraondo, P., Fortes, P., Prieto, J., Colombo, M. P., Chen, L. and Melero, I. 2006. Low surface expression of B7-1 (CD80) is an immunoescape mechanism of colon carcinoma. Cancer Res 66:2442\u20132450.", "journal-title": "Cancer Res"}, {"key": "18_CR64", "first-page": "585", "volume": "4", "author": "A. J. Troy", "year": "1998", "unstructured": "Troy, A. J., Summers, K. L., Davidson, P. J., Atkinson, C. H. and Hart, D. N. 1998. Minimal recruitment and activation of dendritic cells within renal cell carcinoma. Clin Cancer Res 4:585\u2013593.", "journal-title": "Clin Cancer Res"}, {"key": "18_CR65", "doi-asserted-by": "publisher", "first-page": "2912", "DOI": "10.1158/0008-5472.CAN-07-0520", "volume": "67", "author": "R. Valenti", "year": "2007", "unstructured": "Valenti, R., Huber, V., Iero, M., Filipazzi, P., Parmiani, G. and Rivoltini, L. 2007. Tumor-released microvesicles as vehicles of immunosuppression. Cancer Res 67:2912\u20132915.", "journal-title": "Cancer Res"}, {"key": "18_CR66", "doi-asserted-by": "publisher", "first-page": "255", "DOI": "10.1002/path.1344", "volume": "200", "author": "W. Vermi", "year": "2003", "unstructured": "Vermi, W., Bonecchi, R., Facchetti, F., Bianchi, D., Sozzani, S., Festa, S., Berenzi, A., Cella, M. and Colonna, M. 2003. Recruitment of immature plasmacytoid dendritic cells (plasmacytoid monocytes) and myeloid dendritic cells in primary cutaneous melanomas. J Pathol 200:255\u2013268.", "journal-title": "J Pathol"}, {"key": "18_CR67", "doi-asserted-by": "publisher", "first-page": "541", "DOI": "10.1084/jem.20020732", "volume": "196", "author": "A. P. Vicari", "year": "2002", "unstructured": "Vicari, A. P., Chiodoni, C., Vaure, C., Ait-Yahia, S., Dercamp, C., Matsos, F., Reynard, O., Taverne, C., Merle, P., Colombo, M. P., O'Garra, A., Trinchieri, G. and Caux, C. 2002. Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody. J Exp Med 196:541\u2013549.", "journal-title": "J Exp Med"}, {"key": "18_CR68", "doi-asserted-by": "publisher", "first-page": "2409", "DOI": "10.1002/1521-4141(200209)32:9<2409::AID-IMMU2409>3.0.CO;2-H", "volume": "32", "author": "F. Wilkin", "year": "2002", "unstructured": "Wilkin, F., Stordeur, P., Goldman, M., Boeynaems, J. M. and Robaye, B. 2002. Extracellular adenine nucleotides modulate cytokine production by human monocyte-derived dendritic cells: dual effect on IL-12 and stimulation of IL-10. Eur J Immunol 32:2409\u20132417.", "journal-title": "Eur J Immunol"}, {"key": "18_CR69", "first-page": "45", "volume": "42", "author": "K. Wojas", "year": "2004", "unstructured": "Wojas, K., Tabarkiewicz, J., Jankiewicz, M. and Rolinski, J. 2004. Dendritic cells in peripheral blood of patients with breast and lung cancer \u2013 a pilot study. Folia Histochem Cytobiol 42:45\u201348.", "journal-title": "Folia Histochem Cytobiol"}, {"key": "18_CR70", "doi-asserted-by": "publisher", "first-page": "13", "DOI": "10.1016/S0065-230X(04)92002-7", "volume": "92", "author": "L. Yang", "year": "2004", "unstructured": "Yang, L. and Carbone, D. P. 2004. Tumor-host immune interactions and dendritic cell dysfunction. Adv Cancer Res 92:13\u201327.", "journal-title": "Adv Cancer Res"}, {"key": "18_CR71", "doi-asserted-by": "publisher", "first-page": "41", "DOI": "10.1038/nri1995", "volume": "7", "author": "H. Yu", "year": "2007", "unstructured": "Yu, H., Kortylewski, M. and Pardoll, D. 2007. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat Rev Immunol 7:41\u201351.", "journal-title": "Nat Rev Immunol"}, {"key": "18_CR72", "doi-asserted-by": "publisher", "first-page": "1339", "DOI": "10.1038/nm1201-1339", "volume": "7", "author": "W. Zou", "year": "2001", "unstructured": "Zou, W., Machelon, V., Coulomb-L'Hermin, A., Borvak, J., Nome, F., Isaeva, T., Wei, S., Krzysiek, R., Durand-Gasselin, I., Gordon, A., Pustilnik, T., Curiel, D. T., Galanaud, P., Capron, F., Emilie, D. and Curiel, T. J. 2001. Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat Med 7:1339\u20131346.", "journal-title": "Nat Med"}], "container-title": ["Dendritic Cells in Cancer"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-0-387-88611-4_18", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 1, 20]], "date-time": "2019-01-20T02:31:34Z", "timestamp": 1547951494000}, "score": 20.846949, "issued": {"date-parts": [[2009]]}, "ISBN": ["9780387886107", "9780387886114"], "references-count": 72, "URL": "http://dx.doi.org/10.1007/978-0-387-88611-4_18", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T04:49:47Z", "timestamp": 1574484587667}, "reference-count": 40, "publisher": "Springer Science and Business Media LLC", "issue": "3", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2010, 12, 14]], "date-time": "2010-12-14T00:00:00Z", "timestamp": 1292284800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Immunol Immunother"], "published-print": {"date-parts": [[2011, 3]]}, "DOI": "10.1007/s00262-010-0948-4", "type": "journal-article", "created": {"date-parts": [[2010, 12, 15]], "date-time": "2010-12-15T18:57:52Z", "timestamp": 1292439472000}, "page": "381-388", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Adenoviral-transduced dendritic cells are susceptible to suppression by T regulatory cells and promote interleukin 17 production"], "prefix": "10.1007", "volume": "60", "author": [{"given": "Adele Y.", "family": "Wang", "sequence": "first", "affiliation": []}, {"given": "Sarah Q.", "family": "Crome", "sequence": "additional", "affiliation": []}, {"given": "Kristina M.", "family": "Jenkins", "sequence": "additional", "affiliation": []}, {"given": "Jeffrey A.", "family": "Medin", "sequence": "additional", "affiliation": []}, {"given": "Jonathan L.", "family": "Bramson", "sequence": "additional", "affiliation": []}, {"given": "Megan K.", "family": "Levings", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2010, 12, 14]]}, "reference": [{"key": "948_CR1", "unstructured": "Scheid E, Ricci M, Foley M (2010) Dendritic cell based cancer vaccines: practical considerations. In: Medin J, Fowler D (eds) Experimental and applied immunotherapy, Humana Press, pp 107\u2013126"}, {"key": "948_CR2", "first-page": "203", "volume": "20", "author": "S Nayak", "year": "2009", "unstructured": "Nayak S, Herzog RW (2009) Progress and prospects: immune responses to viral vectors. Gene Ther 20:203\u2013301", "journal-title": "Gene Ther"}, {"key": "948_CR3", "doi-asserted-by": "crossref", "first-page": "1651", "DOI": "10.1182/blood-2008-07-168666", "volume": "113", "author": "R Fontana", "year": "2009", "unstructured": "Fontana R et al (2009) Peripheral blood lymphocytes genetically modified to express the self/tumor antigen MAGE-A3 induce antitumor immune responses in cancer patients. Blood 113:1651\u20131660", "journal-title": "Blood"}, {"key": "948_CR4", "doi-asserted-by": "crossref", "first-page": "163", "DOI": "10.1159/000086770", "volume": "68", "author": "M Nakamura", "year": "2005", "unstructured": "Nakamura M et al (2005) Dendritic cells transduced with tumor-associated antigen gene elicit potent therapeutic antitumor immunity: comparison with immunodominant peptide-pulsed DCs. Oncology 68:163\u2013170", "journal-title": "Oncology"}, {"key": "948_CR5", "doi-asserted-by": "crossref", "first-page": "294", "DOI": "10.1097/CJI.0b013e31816a8910", "volume": "31", "author": "LH Butterfield", "year": "2008", "unstructured": "Butterfield LH et al (2008) Adenovirus MART-1-engineered autologous dendritic cell vaccine for metastatic melanoma. J Immunother 31:294\u2013309", "journal-title": "J Immunother"}, {"key": "948_CR6", "doi-asserted-by": "crossref", "first-page": "799", "DOI": "10.1001/archderm.138.6.799", "volume": "138", "author": "H Tsao", "year": "2002", "unstructured": "Tsao H et al (2002) Hypopigmentation associated with an adenovirus-mediated gp100/MART-1-transduced dendritic cell vaccine for metastatic melanoma. Arch Dermatol 138:799\u2013802", "journal-title": "Arch Dermatol"}, {"issue": "7", "key": "948_CR7", "doi-asserted-by": "crossref", "first-page": "1019", "DOI": "10.1517/14712598.2010.482207", "volume": "10", "author": "TL Whiteside", "year": "2010", "unstructured": "Whiteside TL (2010) Inhibiting the inhibitors: evaluating agents targeting cancer immunosuppression. Expert Opin Biol Ther 10(7):1019\u20131035", "journal-title": "Expert Opin Biol Ther"}, {"key": "948_CR8", "doi-asserted-by": "crossref", "first-page": "295", "DOI": "10.1038/nri1806", "volume": "6", "author": "W Zou", "year": "2006", "unstructured": "Zou W (2006) Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 6:295\u2013307", "journal-title": "Nat Rev Immunol"}, {"key": "948_CR9", "doi-asserted-by": "crossref", "first-page": "137", "DOI": "10.1016/j.immuni.2004.07.017", "volume": "21", "author": "GP Dunn", "year": "2004", "unstructured": "Dunn GP, Old LJ, Schreiber RD (2004) The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21:137\u2013148", "journal-title": "Immunity"}, {"key": "948_CR10", "doi-asserted-by": "crossref", "first-page": "345", "DOI": "10.1038/ni1178", "volume": "6", "author": "S Sakaguchi", "year": "2005", "unstructured": "Sakaguchi S (2005) Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6:345\u2013352", "journal-title": "Nat Immunol"}, {"key": "948_CR11", "doi-asserted-by": "crossref", "first-page": "523", "DOI": "10.1038/nri2343", "volume": "8", "author": "DA Vignali", "year": "2008", "unstructured": "Vignali DA, Collison LW, Workman CJ (2008) How regulatory T cells work. Nat Rev Immunol 8:523\u2013532", "journal-title": "Nat Rev Immunol"}, {"key": "948_CR12", "doi-asserted-by": "crossref", "first-page": "4184", "DOI": "10.4049/jimmunol.178.7.4184", "volume": "178", "author": "J Bayry", "year": "2007", "unstructured": "Bayry J, Triebel F, Kaveri SV, Tough DF (2007) Human dendritic cells acquire a semimature phenotype and lymph node homing potential through interaction with CD4+CD25+ regulatory T cells. J Immunol 178:4184\u20134193", "journal-title": "J Immunol"}, {"key": "948_CR13", "doi-asserted-by": "crossref", "first-page": "10113", "DOI": "10.1073/pnas.0711106105", "volume": "105", "author": "Y Onishi", "year": "2008", "unstructured": "Onishi Y, Fehervari Z, Yamaguchi T, Sakaguchi S (2008) Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc Natl Acad Sci USA 105:10113\u201310118", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "948_CR14", "doi-asserted-by": "crossref", "first-page": "5916", "DOI": "10.4049/jimmunol.180.9.5916", "volume": "180", "author": "B Liang", "year": "2008", "unstructured": "Liang B et al (2008) Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II. J Immunol 180:5916\u20135926", "journal-title": "J Immunol"}, {"key": "948_CR15", "doi-asserted-by": "crossref", "first-page": "e1000302", "DOI": "10.1371/journal.pbio.1000302", "volume": "8", "author": "S Amarnath", "year": "2010", "unstructured": "Amarnath S et al (2010) Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1. PLoS Biol 8:e1000302", "journal-title": "PLoS Biol"}, {"key": "948_CR16", "doi-asserted-by": "crossref", "first-page": "2114", "DOI": "10.1182/blood.V99.6.2114", "volume": "99", "author": "F Benchetrit", "year": "2002", "unstructured": "Benchetrit F et al (2002) Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism. Blood 99:2114\u20132121", "journal-title": "Blood"}, {"key": "948_CR17", "doi-asserted-by": "crossref", "first-page": "4169", "DOI": "10.4049/jimmunol.0901017", "volume": "183", "author": "G Murugaiyan", "year": "2009", "unstructured": "Murugaiyan G, Saha B (2009) Protumor vs. antitumor functions of IL-17. J Immunol 183:4169\u20134175", "journal-title": "J Immunol"}, {"key": "948_CR18", "doi-asserted-by": "crossref", "first-page": "883", "DOI": "10.1038/nri2660", "volume": "9", "author": "CT Weaver", "year": "2009", "unstructured": "Weaver CT, Hatton RD (2009) Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective. Nat Rev Immunol 9:883\u2013889", "journal-title": "Nat Rev Immunol"}, {"key": "948_CR19", "doi-asserted-by": "crossref", "first-page": "2340", "DOI": "10.1182/blood-2008-01-133967", "volume": "112", "author": "HJ Koenen", "year": "2008", "unstructured": "Koenen HJ, Smeets RL, Vink PM, van Rijssen E, Boots AM, Joosten I (2008) Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 112:2340\u20132352", "journal-title": "Blood"}, {"key": "948_CR20", "doi-asserted-by": "crossref", "first-page": "4793", "DOI": "10.1073/pnas.0900408106", "volume": "106", "author": "KS Voo", "year": "2009", "unstructured": "Voo KS et al (2009) Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc Natl Acad Sci USA 106:4793\u20134798", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "948_CR21", "doi-asserted-by": "crossref", "first-page": "108", "DOI": "10.1016/j.molmed.2007.01.003", "volume": "13", "author": "M Miyara", "year": "2007", "unstructured": "Miyara M, Sakaguchi S (2007) Natural regulatory T cells: mechanisms of suppression. Trends Mol Med 13:108\u2013116", "journal-title": "Trends Mol Med"}, {"key": "948_CR22", "doi-asserted-by": "crossref", "first-page": "128", "DOI": "10.1016/j.imlet.2008.11.017", "volume": "122", "author": "GJ Adema", "year": "2009", "unstructured": "Adema GJ (2009) Dendritic cells from bench to bedside and back. Immunol Lett 122:128\u2013130", "journal-title": "Immunol Lett"}, {"key": "948_CR23", "doi-asserted-by": "crossref", "first-page": "102", "DOI": "10.1016/S1471-4906(00)01813-5", "volume": "22", "author": "L Jenne", "year": "2001", "unstructured": "Jenne L, Schuler G, Steinkasserer A (2001) Viral vectors for dendritic cell-based immunotherapy. Trends Immunol 22:102\u2013107", "journal-title": "Trends Immunol"}, {"key": "948_CR24", "doi-asserted-by": "crossref", "first-page": "964", "DOI": "10.1002/(SICI)1521-4141(199903)29:03<964::AID-IMMU964>3.0.CO;2-P", "volume": "29", "author": "L Zhong", "year": "1999", "unstructured": "Zhong L, Granelli-Piperno A, Choi Y, Steinman RM (1999) Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells. Eur J Immunol 29:964\u2013972", "journal-title": "Eur J Immunol"}, {"key": "948_CR25", "doi-asserted-by": "crossref", "first-page": "845", "DOI": "10.1038/sj.gt.3300899", "volume": "6", "author": "J Diao", "year": "1999", "unstructured": "Diao J, Smythe JA, Smyth C, Rowe PB, Alexander IE (1999) Human PBMC-derived dendritic cells transduced with an adenovirus vector induce cytotoxic T-lymphocyte responses against a vector-encoded antigen in vitro. Gene Ther 6:845\u2013853", "journal-title": "Gene Ther"}, {"key": "948_CR26", "doi-asserted-by": "crossref", "first-page": "1480", "DOI": "10.1002/eji.200838908", "volume": "39", "author": "SQ Crome", "year": "2009", "unstructured": "Crome SQ, Wang AY, Kang CY, Levings MK (2009) The role of retinoic acid-related orphan receptor variant 2 and IL-17 in the development and function of human CD4+ T cells. Eur J Immunol 39:1480\u20131493", "journal-title": "Eur J Immunol"}, {"key": "948_CR27", "first-page": "577", "volume": "162", "author": "MA Antonysamy", "year": "1999", "unstructured": "Antonysamy MA et al (1999) Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors. J Immunol 162:577\u2013584", "journal-title": "J Immunol"}, {"key": "948_CR28", "doi-asserted-by": "crossref", "first-page": "141", "DOI": "10.1016/j.imlet.2004.05.003", "volume": "94", "author": "J Pan", "year": "2004", "unstructured": "Pan J et al (2004) Interferon-gamma is an autocrine mediator for dendritic cell maturation. Immunol Lett 94:141\u2013151", "journal-title": "Immunol Lett"}, {"key": "948_CR29", "doi-asserted-by": "crossref", "first-page": "950", "DOI": "10.1038/ni1497", "volume": "8", "author": "NJ Wilson", "year": "2007", "unstructured": "Wilson NJ et al (2007) Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 8:950\u2013957", "journal-title": "Nat Immunol"}, {"key": "948_CR30", "doi-asserted-by": "crossref", "first-page": "1849", "DOI": "10.1084/jem.20070663", "volume": "204", "author": "F Annunziato", "year": "2007", "unstructured": "Annunziato F et al (2007) Phenotypic and functional features of human Th17 cells. J Exp Med 204:1849\u20131861", "journal-title": "J Exp Med"}, {"key": "948_CR31", "doi-asserted-by": "crossref", "first-page": "5904", "DOI": "10.4049/jimmunol.0900732", "volume": "182", "author": "A Awasthi", "year": "2009", "unstructured": "Awasthi A et al (2009) Cutting edge: IL-23 receptor gfp reporter mice reveal distinct populations of IL-17-producing cells. J Immunol 182:5904\u20135908", "journal-title": "J Immunol"}, {"key": "948_CR32", "doi-asserted-by": "crossref", "first-page": "942", "DOI": "10.1038/ni1496", "volume": "8", "author": "EV Acosta-Rodriguez", "year": "2007", "unstructured": "Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F (2007) Interleukins 1\u03b2 and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 8:942\u2013949", "journal-title": "Nat Immunol"}, {"key": "948_CR33", "doi-asserted-by": "crossref", "first-page": "749", "DOI": "10.1093/intimm/10.6.749", "volume": "10", "author": "P Kelleher", "year": "1998", "unstructured": "Kelleher P, Knight SC (1998) IL-12 increases CD80 expression and the stimulatory capacity of bone marrow-derived dendritic cells. Int Immunol 10:749\u2013755", "journal-title": "Int Immunol"}, {"key": "948_CR34", "doi-asserted-by": "crossref", "first-page": "4240", "DOI": "10.1182/blood-2008-10-183251", "volume": "113", "author": "G Beriou", "year": "2009", "unstructured": "Beriou G et al (2009) IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood 113:4240\u20134249", "journal-title": "Blood"}, {"key": "948_CR35", "doi-asserted-by": "crossref", "first-page": "600", "DOI": "10.1182/blood.V99.2.600", "volume": "99", "author": "LA Lyakh", "year": "2002", "unstructured": "Lyakh LA, Koski GK, Young HA, Spence SE, Cohen PA, Rice NR (2002) Adenovirus type 5 vectors induce dendritic cell differentiation in human CD14(+) monocytes cultured under serum-free conditions. Blood 99:600\u2013608", "journal-title": "Blood"}, {"key": "948_CR36", "doi-asserted-by": "crossref", "first-page": "9358", "DOI": "10.1074/jbc.C600321200", "volume": "282", "author": "XO Yang", "year": "2007", "unstructured": "Yang XO et al (2007) STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem 282:9358\u20139363", "journal-title": "J Biol Chem"}, {"key": "948_CR37", "doi-asserted-by": "crossref", "first-page": "194", "DOI": "10.1038/sj.bjc.6604780", "volume": "100", "author": "C Martel de", "year": "2009", "unstructured": "de Martel C, Plummer M, Parsonnet J, van Doorn LJ, Franceschi S (2009) Helicobacter species in cancers of the gallbladder and extrahepatic biliary tract. Br J Cancer 100:194\u2013199", "journal-title": "Br J Cancer"}, {"key": "948_CR38", "doi-asserted-by": "crossref", "first-page": "529", "DOI": "10.1215/15228517-2009-004", "volume": "11", "author": "W Maes", "year": "2009", "unstructured": "Maes W et al (2009) DC vaccination with anti-CD25 treatment leads to long-term immunity against experimental glioma. Neurol Oncol 11:529\u2013542", "journal-title": "Neurol Oncol"}, {"key": "948_CR39", "doi-asserted-by": "crossref", "first-page": "693", "DOI": "10.1089/10430340050015590", "volume": "11", "author": "P Ng", "year": "2000", "unstructured": "Ng P, Parks RJ, Cummings DT, Evelegh CM, Graham FL (2000) An enhanced system for construction of adenoviral vectors by the two-plasmid rescue method. Hum Gene Ther 11:693\u2013699", "journal-title": "Hum Gene Ther"}, {"key": "948_CR40", "doi-asserted-by": "crossref", "first-page": "200", "DOI": "10.4049/jimmunol.176.1.200", "volume": "176", "author": "TC Yang", "year": "2006", "unstructured": "Yang TC et al (2006) The CD8+ T cell population elicited by recombinant adenovirus displays a novel partially exhausted phenotype associated with prolonged antigen presentation that nonetheless provides long-term immunity. J Immunol 176:200\u2013210", "journal-title": "J Immunol"}], "container-title": ["Cancer Immunology, Immunotherapy"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s00262-010-0948-4.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s00262-010-0948-4/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s00262-010-0948-4", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 24]], "date-time": "2019-05-24T16:33:26Z", "timestamp": 1558715606000}, "score": 20.732891, "issued": {"date-parts": [[2010, 12, 14]]}, "references-count": 40, "journal-issue": {"published-print": {"date-parts": [[2011, 3]]}, "issue": "3"}, "alternative-id": ["948"], "URL": "http://dx.doi.org/10.1007/s00262-010-0948-4", "relation": {"cites": []}, "ISSN": ["0340-7004", "1432-0851"], "issn-type": [{"value": "0340-7004", "type": "print"}, {"value": "1432-0851", "type": "electronic"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}